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Abstract 
Micronutrient deficiency is a public health problem thought to affect a third of the 
world's population. In Tasmania, selenium deficiency occurred in livestock, and it has 
been hypothesised that the human population may be at risk of inadequate intakes. 
There are few Australian studies of trace element status, and previous studies in 
Tasmania have been very limited and have provided conflicting results. 
The primary aim of this thesis was: 
• To assess the selenium status of people in northern Tasmania; 
• To identify factors that may influence selenium status in these people; 
• To determine groups in this population that may be at increased risk of low 
selenium status. 
A secondary aim was to conduct an opportunistic study to assess the copper and zinc 
status in the same population, and determine some of the factors which may be 
associated with copper and zinc status in this population. 
The main study was a cross sectional population study of approximately 500 subjects 
randomly selected from the electoral roll in the northern Tasmania; this was 
preceeded by a preliminary study which used a convenience sample from this same 
geographical region, and some technical work on the assessment of copper and zinc 
status. 
Indices of trace element status measured included dietary intake, serum levels and 
functional markers of status, such as glutathione peroxidase activity for selenium 
status. This was linked with data on lifestyle habits, anthropometric measurements, 
xviii 
dietary analysis for other nutrients, and the measurement of total antioxidant status 
and lipid profiles. 
Results from the preliminary research (n = 198) suggested that marginal selenium 
status may be reasonably widespread in this population, and that certain gender/age 
groups may also consume inadequate zinc. Hereditary haemochromatosis was not 
observed to have a major effect on trace element status. 
The population study on 498 subjects from the electoral rolls of north, north west and 
north eastern Tasmania, suggested a high prevalence of marginal selenium status. 
Northern Tasmanians had mean selenium intakes of 77.4 and 65.1 ilg,/d for men and 
women respectively; with 27% of all subjects consuming inadequate amounts of 
selenium as indicated by NH&MRC guidelines on dietary intakes. 
Mean serum selenium was 1.13 !Amon; and hence a large proportion of the 
population (80%) was estimated to have serum selenium concentrations below 
threshold levels associated with selenoprotein requirements. The majority of subjects 
also had serum selenium concentrations below the level suggested to offer 
chemopreventative benefits for some cancers. Associations with a common 
selenoprotein SNP were not found. 
In investigations of zinc status, men in particular appeared at risk of inadequacy. Zinc 
intakes were 12.6 and 10.9 mg/d for men and women respectively. Fifty two percent 
of men consumed inadequate zinc compared to only 9% of women. Mean serum zinc 
concentration was 13.0 Kno1/1_, and when compared to the WHO cut-off, 15% of all 
men had low serum zinc; the prevalence of which rose in older age ranges. 
Investigations of copper status suggested that copper deficiency was unlikely in this 
population. Mean serum copper concentrations were 15.5 and 18.9 mon for men 
and women respectively; well above the lower clinical reference range. 
xix 
These findings indicate that many Tasmanians may have marginal selenium status, and 
that particular population sub-groups may additionally be susceptible to inadequate zinc 
status. Further research is required. However, with our increasing understanding of the 
importance of these essential trace elements in maintaining health and for reducing 
susceptibility to some chronic diseases, the findings are important. There is potential, to 
be tested, that increased intakes could possibly benefit an aging Tasmanian population, 
which leads the country in chronic disease rates. 
XX 
Chapter 1 
General Introduction 
1.1 Introduction 
The last 25 years have seen our understanding of the importance of trace element 
nutrition increase many-fold. Selenium, in particular, has emerged from a time early 
last century where its reputation was one of a toxic nuisance, to now be considered an 
essential trace element and likely chemopreventative agent. Despite the developing 
knowledge of selenium requirements and potential significant benefits from 
improving selenium status, little is known in Australia about the status of most of the 
population. 
For much of the country, and especially Tasmania, there have been few concerted 
efforts to investigate trace element status in soils or the human populations which 
depend on them for their food supply. Due to the relatively old age of much of 
Australia in geological terms, large areas of the country are considered likely to be 
deficient in many nutrients due to constant weathering processes. Much of our 
understanding with regard to areas of high or low soil levels of trace elements comes 
from the agriculture industry where crops may have historically failed due to 
particular deficiencies, or where toxicity or deficiency have been observed in grazing 
animals. 
This is the case in Tasmania, where actual soil content data for most trace elements is 
non-existent or at best very limited. Problems relating to deficiencies in soils are 
recognised when they impact on crops, livestock or even the human population, as is 
the case with iodine (Guttikonda et al. 2002). 
1 
1.2 History of trace element deficiency in Tasmania 
Since the early 20th  Century, Tasmania has been recognised as a region of endemic 
iodine deficiency. In 1950 an iodine supplementation program was established (in 
Tasmanian school children) (Richards 2007b) and to more effectively increase overall 
population intakes of iodine, this program was eventually replaced by iodine 
fortification of bread in 1966-7. Fortuitous use of iodophors in disinfection procedures 
in the dairy industry in the 1970's contributed to iodine intakes (Richards 2007a). 
Attempts to improve iodine status have been reasonably successful, but iodine 
deficiency in Tasmania remains a recurring problem whenever such programs are 
halted or reduced; the fundamental cause of deficiency in the population lying in the 
soils upon which the state grows its crops and grazes its livestock. Leeching, due to 
the states' high rainfall and often steep terrain, combines with the effects of past 
glaciation to render the soils across much of Tasmania deficient in iodine. The 
environmental conditions that have lead to problems with iodine nutriture are known 
to also affect other elements of nutritional importance. 
Significant areas of Tasmania are thought to be affected by soil deficiencies of a 
number of other trace nutrients. Data is particularly scarce, but selenium (Judson and 
Reuter 1999), copper and cobalt (Green 1956) and zinc and molybdenum (Donald and 
Prescott 1975) have all been identified at various times as being present in lower than 
required amounts in many soils across Tasmania. 
2 
1.3 Selenium in Tasmania 
With recent findings regarding its importance to human health, selenium status is of 
particular interest for the maintenance of optimal health of a population. 
Selenium in soil is susceptible to removal by leeching and glaciation; as well as 
farming practices which lead to the acidification of soils, further reducing the metals' 
bioavailability. As with iodine, a deficiency of selenium in the soil does not manifest 
in plant life, as it appears to only be required by animals; it may therefore be difficult 
to detect prior to its effects being felt by animal or human populations. 
Although actual soil analysis data for Tasmania appears to be unavailable, evidence 
from the agricultural industry shows that deficiency problems have been encountered 
throughout the state (Mason 2007), particularly in sheep (Figure 1.1). Almost all areas 
of agriculturally active land in Tasmania have recorded incidences of low selenium in 
sheep, such that the use of livestock selenium supplements is now widespread; taking 
the form of fortified drenches, slow release rumen pellets, or fortified pasture 
fertilisers. 
Of course, animals such as these are generally entirely dependent on feed that is 
grown on the properties on which they reside and as such are more susceptible to 
potential deficiencies than humans who may consume food from local, interstate and 
international sources. The Tasmanian population however, being proportionally more 
rurally based than other Australian states (A.B.S. 2003) and an island state, may 
conceivably be more likely to be eat local foods than their interstate counterparts, and 
hence the impact of food importation may be lessened. 
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Figure 1.1: Geographical distribution of low selenium in sheep in Tasmania 1982- 
1989 (Mason 2007). 
Since the discovery of its essentiality, our knowledge regarding selenium and its 
importance in human health has increased greatly, yet much remains to  be discovered 
regarding the influence of this mineral. Apart from newly discovered proteins, 
selenium research has also brought a new understanding of the molecular mechanisms 
involved in the creation of proteins; the translational incorporation  of selenium into 
4 
peptide chains utilises unique molecular mechanisms to form selenoproteins (Hatfield 
and Gladyshev 2002). 
The known selenoproteins, though mostly poorly understood, generally possess a 
powerful reduction-oxidation (red-ox) capacity. With this ability, they function in 
wide ranging roles such as antioxidant defence and thyroid metabolism. It is in their 
role as powerful antioxidants that selenoproteins appear likely to assist in the 
prevention of cancer and cardiovascular disease, where the aetiology may be linked 
with oxidative stress and free radical damage. In addition to the influence of 
selenoproteins, many studies in the last two decades have suggested that low 
molecular weight selenium metabolites also possess potent chemopreventative 
abilities (Redman et a/. 1997; Ip et al. 2000; Zhong and Oberley 2001; Jiang et al. 
2002). Selenium nutrition has garnered great interest worldwide, due to the possible 
promise of an achievable reduction in disease through nutritional intervention. At 
least one large study has been conducted in the US, the recently concluded SELECT 
trial (Lippman et a/. 2009), which aimed to confirm the protective effect of supra-
supplemental selenium in cancer, while another (PRECISE trial) is planned for the 
UK and Europe, however only pilot studies have been completed as yet (Ravn-Haren 
et a/. 2008; Rayman et al. 2008). 
1.4 Copper and zinc 
Copper and zinc are also involved in numerous processes in humans, including 
antioxidant defence. Indeed copper, zinc and selenium enzymes work in conjunction 
in the front line of antioxidant defence - as the primary antioxidants Cu/Zn superoxide 
dismutase and glutathione peroxidase, respectively. 
Copper is an essential constituent of numerous metalloproteins, functioning in 
hormone metabolism, biological membranes, cellular respiration and connective 
5 
tissue metabolism. Though severe deficiency is rare in humans, mild deficiency is 
thought to impair immune function and increase the risk of cardiovascular disease 
(Percival 1998; Klevay 2000). 
Zinc, in addition to antioxidant defence, plays wide ranging roles as a comPonent of 
>300 enzymes; active in DNA and RNA metabolism, signalling, hormone receptors 
and biological membranes (Coleman 1992). After iron, zinc is the second most 
abundant trace metal in the human body, and even mild deficiency can affect growth 
and development (MacDonald 2000) and impair immune system function (Ills and 
Rink 2003). 
There has been no data relating to Tasmanian copper or zinc status published to date. 
1.5 Rationale 
There is great interest in selenium nutrition and a growing concern over copper and 
particularly zinc status in many populations. Nutritional problems that have generally 
been considered a concern for developing countries may indeed affect some 
developed countries as well, as has been the experience with iodine in Tasmania. In a 
state with a rapidly aging population, the second highest cancer incidence nationally, 
the highest rate of cardiovascular disease and overall chronic disease (A.B.S. 2006a), 
as well as the second highest rate of smoking in Australia (A.B.S. 2006b), the 
identification of factors that may assist in the reduction of chronic disease rates would 
be an important finding. 
With increasing evidence that selenium may provide protection against some chronic 
diseases, and with further results expected from larger studies in the future, it is an 
opportune time to determine whether Tasmania does indeed have a problem with 
marginal deficiency of selenium. 
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Given that these three trace metals, selenium, copper and zinc, may be assessed in the 
population in a similar manner and share roles in antioxidant protection, a combined 
study to assess the three nutrients was considered the most judicious use of the time 
and resources committed to a single study. The potential benefit of such a study is the 
identification of a population or a subset of the population that might subsequently be 
responsive to an increased trace element intake, which might improve general health 
and perhaps decrease the susceptibility to chronic disease. 
The approach to meet these aims involved a cross-sectional population study to 
provide a representative sample from northern Tasmania. 
1.6 Aims of thesis 
The primary aim of this thesis was: 
• To assess the selenium status of people in northern Tasmania; 
• To identify factors that may influence selenium status in these people; 
• To determine groups in this population that may be at particular risk of low 
selenium status. 
A secondary aim was to conduct an opportunistic study to assess the copper and zinc 
status in the same population, and determine some of the factors which may be 
associated with copper and zinc status in this population. 
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Chapter 2 
Literature review 
2.1 General Introduction 
In humans, there are at least nine trace minerals for which there is a nutritional 
requirement: chromium, copper, iodine, iron, manganese, molybdenum, selenium and 
zinc (Solomons and Ruz 1998). Due to more overt effects of deficiency, the majority 
of interest has previously focussed on iron and iodine; however zinc and particularly 
selenium have seen much interest more recently. 
As these minerals enter the human food chain mostly through the soil, the mineral 
content and availability in soils used for food production plays a critical role in human 
nutriture. This is especially the case for a mineral such as selenium where the content 
of most foods is quite low normally; meaning compensation for lowered content in 
some foods is not easily achieved with other foods. 
In Australia, due to the geological age of much of the land, and natural weathering 
processes that strip away nutrients, there are many instances of trace element 
deficiency. Although much of the arid interior of the continent sees little agricultural 
activity, the more temperate regions of south Western Australia, South Australia, 
Victoria, Tasmania and New South Wales are cropped and grazed extensively. Here, 
trace element deficiencies have caused white muscle disease in sheep (selenium), and 
coastal disease (copper and cobalt) and goitre (iodine) in ruminants (Judson and 
McFarlane 1998). Crops grown in these regions have also suffered from soil 
deficiencies of iron, molybdenum, zinc, manganese, cobalt and copper (Peverill et al. 
1999). 
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While nutrient deficiencies in humans have traditionally been considered to be 
confined mostly to developing countries, it is thought now that mild deficiencies in 
zinc (Brown et a/. 2001) and selenium (Combs 2001) at least, may be widespread, 
affecting many millions worldwide. 
2.2 Selenium: an introduction { TC "Introduction to selenium" C \l "I" } 
The mineral selenium is an essential trace element in animal biology. In the form of 
what is now considered the twenty first aminoacid, selenocysteine, and incorporated 
using a specialised mechanism, selenium is an integral component of numerous 
selenoproteins, of which there are more than 20 known. 
Selenium (Se) was first discovered in 1817 by the Swedish chemist Jons Jakob 
Berzelius. With an atomic weight of 78.96, selenium belongs to group 16 of the 
periodic table; other members of this group include oxygen, sulphur and tellurium. 
Selenium and sulphur in particular share many chemical properties and it is as 
selenomethionine (Sem) and selenocysteine (Sec), analogues of the sulphur 
containing amino acids methionine (Met) and cysteine (Cys), that selenium is found in 
tissues in mammals (Terry et al. 2000). 
For many years after its discovery, selenium was considered a toxic element due to 
the effects of excessive consumption, seen very rarely in certain parts of the world in 
both livestock and humans, where soil and hence food crops have very high selenium 
content (Yang et a/. 1983). A change in this perception came with the discovery that 
selenium could help prevent specific necrotic conditions in mice and rats (Schwarz 
and Foltz 1957), and the subsequent observation of selenium deficiency syndromes in 
pigs, sheep, cattle and poultry (Oldfield 2003). The first specific biological function 
was finally elucidated when the research groups of Rotruck (1973) and Flohe (1973) 
demonstrated the essentiality of a selenium atom in each subunit of the enzyme 
9 
glutathione peroxidase (GPx), and then by the end of the decade, human selenium 
deficiency diseases, known as Keshan disease and Kashin-Beck disease, were 
described in China (Lancet Editorial 1979). 
As research efforts have expanded further, details regarding its important and in some 
ways unique place in animal biology have begun to emerge. 
2.3 Selenium and selenoproteins: structure and function{ TC "Selenium and 
selenoproteins: structure and function" \f C "1" 
2.3.1 Selenocysteine: the 21 st amino acid{ TC "Selenocysteine: the 21 st amino 
acid" \f C \I "2" } 
Selenium may be incorporated into proteins as either Sem or Sec. Sem is included into 
a protein non-specifically as a substitute for methionine. The term selenoprotein 
however is reserved for proteins in which Sec is specifically encoded for in protein 
mRNA. For a number of years the mammalian glutathione peroxidases, along with a 
small number of bacterial enzymes, remained the only proteins known to incorporate 
selenium as an essential component (Stadtman 1977). The process of Sem 
incorporation into proteins is a case of simple substitution during 'charging' of the 
Met transfer RNA (tRNAmt). As the methionyl-tRNA synthetase does not 
differentiate between Sem and Met, the amount incorporated during protein synthesis 
is related to the ratio of Sem and Met available for attachment to the tRNA met . Such 
non-specific incorporation can also occur with Sec (Bit-ringer et al. 2002). 
The specific incorporation of Sec is coded for in RNA by the normal stop codon 
UGA. A number of specialized molecular components are required to ensure 
successful co-translational incorporation of Sec (Hatfield and Gladyshev 2002). 
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2.3.2 Selenoproteins{ TC "Selenoproteins" \f C \I "2" } 
Early work utilised 75Se labelling in rats to identify nearly 20 mammalian 
selenoproteins (Hawkes et al. 1985; Evenson and Sunde 1988). Subsequent computer 
based screening of sequenced genomes has identified a total of 25 selenoproteins 
(Kryukov et al. 2003). A number of these have well defined enzymatic functions but 
most remain poorly described. The inclusion of Sec at the active centre of these 
enzymes is a definite advantage, as the catalytic activity has been shown to be 
decreased markedly when replaced with a Cys residue (Lee et al. 2000). A selenol 
(pKa = 5.2), in contrast to a normal thiol (pKa = 8.3), is fully ionised at physiological 
pH and therefore fully active (Stadtman 1996). The first selenoprotein discovered, 
cellular glutathione peroxidase, is a member of a family of at least five glutathione 
peroxidase enzymes that, in addition to various specific functions, metabolise 
hydrogen peroxide and other organic peroxides. Other selenoproteins with known 
functions belong to the iodothyronine deiodinase and thioredoxin reductase families, 
while those with lesser defined functions include selenoprotein P, selenoprotein W 
and 15 kDa selenoprotein. 
2.3.3 Glutathione peroxidases{ TC "Glutathione peroxidases" \f C \I "3" } 
The glutathione peroxidase family consists of five known enzymes; cellular 
glutathione peroxidase (GPx-1), gastrointestinal glutathione peroxidase (GPx-2), 
extracellular glutathione peroxidase (GPx-3), phospholipid hydroperoxide glutathione 
peroxidase (GPx-4) and olfactory glutathione peroxidase (GPx-6). With the exception 
of GPx-4 all are similar structurally, consisting of tetramers of approximately 20-22 
kDa each. In contrast GPx-4 is a monomeric protein of around 19 kDa. Functionally 
GPx-1, GPx-2, GPx-3 and GPx-6 are again similar, efficiently catalysing the 
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reduction of hydrogen peroxides, other organic peroxides (Allan et al. 1999) and 
peroxynitrite (Arteel et al. 1999; Klotz et al. 2003), while GPx-4 functions primarily 
in the catalysis of the reduction of fatty acid hydroperoxides, cholesterol 
hydroperoxides and other lipoprotein hydroperoxides (Thomas et al. 1990; Sattler et 
al. 1994). All enzyme forms utilise glutathione as a reducing substrate yet both GPx-3 
and GPx-4 may also use a range of other substrates (Birringer etal. 2002). 
The tissue distribution of GPx-1 is broad but uneven. It is primarily measured in the 
red blood cell fraction as a useful functional index for the assessment of those with 
low selenium intakes. It is a major antioxidant enzyme due to its ability to metabolise 
various peroxides to water or alcohol, however Se-deficient and GPx-knockout animal 
models reveal no obvious pathological phenotypes in the absence of oxidative 
challenge (Arthur 2000; Belme and Kyriakopoulos 2001). In contrast, mice over 
expressing GPx-1 have been observed to spontaneously develop hyperglycaemia, 
hyperinsulinaemia, insulin resistance and obesity (McClung et al. 2004), while strong 
associations have been observed between increased GPx-1 activity and insulin 
resistance in gestational diabetes (Chen et al. 2003). 
The major site of expression of GPx-2 is the gastrointestinal epithelium. Studies of 
mRNA stability under Se-depletion and the rate of biosynthesis after repletion suggest 
that GPx-2, along with GPx-4, is the highest ranked of the glutathione peroxidases in 
the selenoprotein hierarchy (Wingler et al. 1999; Muller et al. 2003). Due to tissue 
distribution and substrate specificity, it is theorised that GPx-2 is important in the 
defence against ingested lipid hydroperoxides and possibly the early stages of 
tumourogenesis in the colon (Brown and Arthur 2001). 
Synthesis of GPx-3, found in plasma, primarily occurs in the renal proximal tubular 
cells (Avissar et al. 1994). Extracellular levels of glutathione appear insufficient to be 
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a suitable substrate in vivo and hence others such as thioredoxin and glutaredoxin may 
be utilised (Behne and Kyriakopoulos 2001). 
Early studies showed that GPx-3 may be active in regulating the bioavailability of 
nitric oxide (NO) from platelets and vascular tissue (Freedman et al. 1995), and found 
associations between GPx-3 deficiency and platelet hyperactivity and subsequent 
thrombosis (Freedman et al. 1996). More recent studies have observed an association 
between GPx-3 gene polymorphism and an increased risk of thrombosis and stroke 
(Voetsch et al. 2007; Voetsch et al. 2008), these findings though, have not been 
replicated in all studies (Grond-Ginsbach et al. 2009). 
The monomeric GPx-4 has the lowest specificity for substrates of all glutathione 
peroxidases (Birringer et al. 2002), although its main substrate appears to be 
phospholipid hydroperoxides in membranes (Conrad et al. 2007). It is clearly an 
important component of the defence of biological membranes from oxidative attack 
due to its unique ability to directly reduce complex peroxides such as phospholipid 
and cholesterol hydrogen peroxides. (Thomas et al. 1990) and lipoprotein-associated 
cholesterylesters (Sattler et al. 1994). A recent study has shown over expression of 
GPx-4 delays the development of atherosclerosis in mouse models by protecting 
against lipid peroxidation and limiting the sensitivity of vascular cells to oxidised 
lipids (Guo et al. 2008). While knockout models of other forms of GPx have to date 
not provided overt pathological phenotypes, embryonic lethality is observed in null 
GPx-4 (-/-) mice (Imai et al. 2003), with embryos dying between 7 1/2 to 8 1/2 days of 
gestation, GPx-4 appearing to be essential for embryological brain development (Ufer 
et al. 2008). 
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Gpx-4 also plays important roles in male fertility. Functioning as an active peroxidase 
in immature spermatozoa before converting to an important structural protein during 
sperm maturation (Ursini et al. 1999). Another form of GPx-4 is known as sperm-
nuclei glutathione peroxidase (snGPx). Localised in the sperm nuclei, snGPx acts to 
protect the germ line from peroxidative damage and also assist the stabilisation of 
condensed chromatin (Pfeifer etal. 2001). 
In addition to protection against general lipid peroxidative damage and its role in 
fertility, GPx-4 also functions in the modulation of inflammation via regulation of 
eicosanoid metabolism. It appears to achieve this through the control of peroxide tone 
(Weitzel and Wendel 1993). By controlling the levels of hydrogen peroxide, GPx-4 
regulates the activity of cyclooxygenase and lipoxygenase (Weitzel and Wendel 1993; 
Schnurr et al. 1996; Sakamoto et al. 2000), enzymes directly responsible for the 
synthesis of prostaglandins and thromboxanes, and leukotrienes respectively. 
GPx-6 is the most recently discovered isoform and shares a close homology with 
GPx-3 but understanding of its function is limited. At this time it is thought to be 
expressed only in the embryo and in adult olfactory epithelium (Kryukov et al. 2003). 
2.3.4 Iodothyronine deiodinases{ TC "Iodothyronine deiodinases" \fC \I "3" } 
The iodothyronine deiodinase group of enzymes plays a major metabolic role in 
vertebrates. The family consists of three distinct membrane bound deiodinases 
approximately 30 kDa in size, differing in tissue distribution and responsible for the 
catalysis of the activation and inactivation of thyroid pro-hormones. 
Type I iodothyronine deiodinase (ID 1) is found primarily in the thyroid, kidney, liver 
and pituitary (Berry et al. 1991). Able to catalyse the deiodination of both phenolic 
and tyrosyl rings, it preferentially catalyses the 5'-deiodination of thyroxine (T4) to 
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form the active hormone 3,3',5-triiodothyronine (T3) but may also catalyse the 5- 
deiodination to form the inactive 3,3',5'-triiodothyronine (reverse T3). The 
conversion of T3 and reverse T3 to the inactive T2 is also catalysed by the 5- 
deiodination and 5'-deiodination of these iodothyronines respectively (Larsen and 
Berry 1995). 
Type II iodothyronine deiodinase (ID2) shares similar catalytic functions with ID1 but 
exhibits differing tissue distribution, being found predominantly in brain, cardiac, 
pituitary and placental tissues (Croteau et al. 1996; Salvatore etal. 1996). Unlike ID1, 
the catalytic activity of ID2 is restricted to the 5'-deiodination of the phenolic ring but 
is able to convert T4 to T3 and reverse T3 to T2. 
Type III iodothyronine deiodinase (ID3) is mostly expressed in the central nervous 
system, lung and placenta. In contrast to the dual activation/inactivation functions of 
ID1 and ID2, ID3 acts only to catalyse the deiodination of the tyrosyl rings of T3 and 
T4 producing inactive T2 and reverse T3 respectively (Salvatore et al. 1995). 
The iodothyronine deiodinases major biological functions are therefore the supply of 
active T3 in plasma and the inactivation of T4, T3 and reverse T3 (ID 1), intracellular 
conversion of T4 to active T3 (ID2) and the inactivation of T4 and T3 (ID3). Despite 
the importance of the thyroid hormones for growth and development, ID1 and ID2 
knockout studies in mice have described relatively mild phenotypes (Schneider et al. 
2001; Schneider et al. 2006); the major deficits observed being decreases in regulation 
of thyroid stimulating hormone (TSH) (Schneider et al. 2001), thermogenesis (de 
Jesus et al. 2001), and auditory function (Ng et al. 2004). The ID1/ID2 knockout 
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model has demonstrated that although important, the enzymes may not be essential for 
T3 production. 
The iodothyronine deiodinases appear to be relatively high in the hierarchy of 
selenoproteins with regard to selenium supply during selenium restriction and as a 
result are reasonably resistant to selenium deficiency (Croteau et al. 1996; Bates et al. 
2000). As such their usefulness for assessing selenium status appears limited. 
2.3.5 Thioredoxin reductases{ TC "Thioredoxin reductases" Vf C \I "3" } 
The thioredoxin reductases were only recognised as selenoproteins in 1996 
(Gladyshev et al. 1996); the TGA codon coding for the Sec positioned as the 
penultimate C-terminal residue was initially thought to be a stop codon. The three 
member family of thioredoxin reductases (TR1, TR2 and TR3) are homodimeric 
enzymes, consisting of 55 kDa subunits (Gasdaska et al. 1995), whose primary 
function is the catalysis of the NADPH-dependent reduction of thioredoxin (Sun et al. 
1999). The enzymes also efficiently reduce the antioxidant lipoic acid (Amer et al. 
1996), dehydroascorbic acid (May et al. 1997), hydrogen peroxides (Bjornstedt et al. 
1995; Sun et al. 1999) and other proteins (Lundstrom and Holmigen 1990; 
Lundstrom-Ljung etal. 1995). 
The thioredoxin reductases play a major regulatory role in the process of cell growth 
and proliferation by providing reduced thioredoxin for various redox-dependent 
reactions of cellular signalling (Sun et al. 1999), DNA synthesis and inhibition of 
apoptosis (Mustacich and Powis 2000). Work with mice has demonstrated the 
essentiality of TR1 and TR3 for life, with knockout models resulting in embryonic 
death (Conrad et al. 2004; Jakupoglu et al. 2005). 
As well as playing vital roles in normal cells, the thioredoxin reductases are also 
important in many cancers where they support the growth and progression of tumours. 
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Perhaps not surprisingly, thioredoxin reductases are over expressed in many cancers 
cells (Rundlof and Amer 2004; Biaglow and Miller 2005; Amer and Holmgren 2006; 
Fujino et al. 2006). Reduction in tumour growth resulting from the inhibition of TR 
activity has been observed in recent studies (Yoo et al. 2006; Yoo et al. 2007; Wang 
et al. 2008; Honeggar et al. 2009) and hence the TR's have emerged as a potential 
cancer therapy target of numerous inhibitors, including nitrosureas and gold, platinum 
and phosphole complexes (Urig and Becker 2006). 
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Table 2.1: Summary of tissue expression and known functions of selenoproteins (modified from Reeves and Hoffman (2009)). 
Selenoprotein Abbreviation Important insights into function and significance Dietary selenium effects Sub-cellular localization 
Cytosolic glutathione peroxidase GPx-I GPX I knockout is more susceptible to oxidative challenge. 
Over-expression of GPX I increases risk 
of diabetes 
Very sensitive to Se status, following 
insufficient Se, or oxidative stress rapid GPx I 
recovery. Se deficiency leads to nonsense 
mediated decay of GPx1 mRNA 
Cytoplasmic 
Gastrointestinal glutathione 
peroxidase 
GPx-2 GPX I/GPX2 double knockout mice progressively 
develop intestinal cancer, one allele of GPX2 
added back confers protection 
Relatively resistant to dietary Se changes Cytoplasmic 
Plasma glutathione peroxidase GPx-3 Important for cardiovascular protection, perhaps 
through modulation of Nitrous Oxide levels; 
antioxidant in thyroid gland 
Sensitive to Se status Secreted 
Phospholipid hydroperoxide 
glutathione peroxidase 
GPx-4 Genetic deletion is embryonic lethal; GPX4 acts as 
crucial antioxidant, structural protein in sperm, 
and sensor of oxidative stress and pro-apoptotic 
signals 
Relatively resistant to dietary Sc changes Cytoplasmic 
Olfactory glutathione peroxidase GPx-6 Importance unknown 
Thioredoxin reductase Type I TRI,TncRI Localized to cytoplasm and nucleus. Genetic 
deletion is embryonic lethal 
Increased Se increases activity. Se deficiency 
decreases activity, but does not change 
mRNA levels 
Cytoplasmic, nuclear 
Thioredoxin reductase Type II TR3, TrxR2 Localized to mitochondria. Genetic deletion is embiyonic 
lethal 
Subject to dietary Se changes 
(i.e. increased Se increases expression) 
Mitochondria 
Thioredoxin reductase Type Ill TR2, TrxR3 Testes-specific expression 
lodothyronine deiodinase Type I ID!, D101 Important for systemic active thyroid hormone levels Membrane-associated 
Iodothyronine deiodinase Type II 1D2, D102 Important for local active thyroid hormone levels Expression levels are stable under low Se 
conditions 
Membrane-associated  
lodothyronine deiodinase Type III 1D3, D103 Inactivates thyroid hormone Membrane-associated 
Table 2.1 continued. 
Selenoprotein H 	 Sel H 
	
Nuclear localization, involved in transcription. 	 Highly dependent on adequate dietary Se 	Nuclear 
Essential for viability and antioxidant defence in Levels 
Drosophila 
Selenoprotein I 	 Sel I, hEPT1 	 Possibly involved in phospholipid biosynthesis 	 Transmembrane 
Selenoprotein K 	 Set K 	 Transmembrane protein localized to endoplasmic 	 ER, plasma membrane 
reticulum 
Selenoprotein M, Selenoprotein 15 	Sel M, Sep15 	 Thiol-disulfide oxidoreductases localized to 	 ER 
endoplasmic reticulum 
Selenoprotein N 	 Sel N, SEPNI, 	 Potential role in early muscle formation; involved in RyR- 	 ER 
SepN 	 related calcium mobilization from ER; 
mutations lead to multiminicore disease and other 
myopathies 
Selenoprotein 0 	 Sel 0 	 Contains a Cys-X-X-Sec motif suggestive of redox 
function, but importance remains unknown 
\Jo 	Selenoprotein P 	 Sel P 	 Selenium transport to brain and testes; Sel P knockout 	Serves as a biomarker for Se status, and is 	Secreted, cytoplasmic 
leads to neurological problems and male sterility. Sel P moderately sensitive to Se status 
also functions as intracellular 
antioxidant in phagocytes 
Selenoprotein R 	 Sel R, MsrBI 	 Functions as a methionine sulfoxide reductase and 	 Cytoplasmic 
Sel R knockouts show mild damage to oxidative 
insult 
Selenoprotein S 	 Sel S. SEPS1, 	 Transmembrane protein found in plasma membrane 	 ER 
SELENOS, and endoplasmic reticulum. May be involved in 
VIMP 	 ER stress 
Selenoprotein T 	 Se! T 	 Endoplasmic reticulum protein involved in calcium 	 ER 
mobilization 
Table 2.1 continued. 
Selenoprotein V 	 Sel V 	 Testes-specific expression 
Selenoprotein W 	 Sc! W, SEPW I 	 Putative antioxidant role, perhaps important in 	 Highly dependent on adequate dietary Se 	Cytoplasmic 
muscle growth 	 levels as well as levels of Sel P 
Selenophosphate synthetase 	 SPS2 	 Involved in synthesis of all selenoproteins, including itself 	 Cytoplasmic 
2.3.6 Selenoproteins with poorly understood functions{ TC "Selenoproteins with 
poorly understood functions" \f C \l "3" } 
The remaining known selenoproteins are generally less well described and while some 
basic functions may be known, further research is needed to determine definitive 
biological functions. 
A protein of much interest, the 57 kDa selenoprotein known as Selenoprotein P 
(SelP), accounts for almost 50-60% of selenium in plasma (Himeno et al. 1996; 
Mostert 2000). It is a secreted protein predominantly expressed in the liver and is the 
only known selenoprotein with more than a single Sec residue per peptide chain 
(Himeno et al. 1996). The incorporation of between 7 to 10 Sec residues in the 
sequence of the protein (Read et al. 1990; Himeno et al. 1996) led to the hypothesis 
that the main function of SelP was that of a selenium storage and supply protein; a 
number of recent studies have supported this (Hill et al. 2003; Schomburg etal. 2003; 
Schweizer et al. 2005). Evidence exists to demonstrate the ability of SelP to restore 
selenoenzyme activity in selenium depleted cells (Saito and Takahashi 2002) and it 
appears to be an important, but not exclusive, supplier of selenium to the brain (Burk 
et al. 2003; Hill et al. 2004). SelP may also possess antioxidant abilities (Read et al. 
1990) as suggested by its reduction of lipid hydroperoxides (Saito et al. 1999) and 
peroxynitrite (Sies et al. 1997) although an efficient in vivo reductant is yet to be 
identified. 
Due to recent advances in our understanding of the role of SelP, its expression and its 
regulation, it has emerged as a useful index for the assessment of selenium status. A 
greater selenium intake requirement for maximal expression compared to GPx has led 
to the suggestion that it may be a better biomarker for selenium status than GPx (Xia 
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et al. 2005) and its use as such has been reported in some recent studies (Koyama et 
al. 2009; Rasmussen et al. 2009). 
Selenoprotein W (Se1W) is a small intracellular protein of 9.5 kDa; so named because 
it is one of the proteins absent in lambs with the selenium deficiency condition white 
muscle disease (Whanger 2002). The Sec residue is incorporated in a likely catalytic 
centre suggesting a possible redox role (Vendeland et al. 1993). The tissue 
distribution of SelW is broad with highest levels found in skeletal and cardiac muscle 
and the kidneys (Yeh et al. 1997; Gu et al. 2000; Whanger 2002). Due to this, SelW 
likely functions in protecting muscle cells from oxidative stress, however no 
definitive role has been determined for this protein. 
The 15 kDa selenoprotein (Sep15) is another small selenoprotein (Gladyshev et al. 
1998) predominantly expressed in the prostate, liver, brain and kidney 
(Kumaraswamy et al. 2000). While its function remains unknown, the isolation of 
Sep15 in association with UDP-glucose: glycoprotein glucosyltransferase reveals a 
possible protein-folding role (Korotkov et al. 2001; Ferguson et al. 2006). Despite 
uncertainty over its function, Sep15 has been associated with various tumour types, 
including prostate (Hu etal. 2001) and lung (Apostolou etal. 2004). 
The remaining selenoproteins include selenoprotein I, K, M, N, 0, R, S, T and V, and 
are briefly summarised in Table 2.1; a number of these were only identified as a result 
of in silico screening of likely nucleotide sequences for SECIS-like structures or in-
frame TGA codons encoding Sec (Kryukov et al. 1999). 
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2.4 Selenium in the diet{ TC "Selenium in the diet" \f C "1" } 
2.4.1 Food selenium content dependency on soils 
Selenium enters the food cycle from the soil via passive uptake into plants, which 
appear to have no requirement for the element. Thus the selenium content of soils in 
cropping and grazing areas is critical in its influence on selenium intakes in humans. 
While the majority of soils contain sufficient levels of selenium (0.1-2.0 lig Se /kg) 
(Combs 2001) there are a number of areas throughout the world including New 
Zealand, Finland, Zaire and parts of China in which the soil selenium content is very 
low and as a result populations are at risk of sub-optimum selenium intakes. 
Conversely there are areas of seleniferous soils in North America, Venezuela, 
Colombia and China where soil content may be as high as 90 mg Se/kg (Combs 
2001). Many seleniferous soils originate from sedimentary shale type rocks, while 
soils with low selenium content are often associated with igneous parent material such 
as granite and basalt. 
The availability of soil selenium to plants is affected by soil type, rainfall and farming 
practices. Poorly aerated and acidic soils result in insoluble forms of selenium, as do 
soils with high iron content. Soils may be naturally acidic or result from the 
application of agricultural fertilisers. Selenium is also removed from the soil due to 
leaching in areas of high rainfall or irrigation. Australia as a whole is generally not 
thought to suffer from severely deficient soils, but many coastal areas have such 
terrain and climate that leads to trace element removal and significant areas of 
selenium deficient soil have been identified (Figure 2.2). 
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Figure 2.2: Distribution of seleniferous and selenium depleted soils in Australia 
(Judson and Reuter 1999). 
The form of selenium with the greatest bioavailability for plants in the soil is selenate, 
however plants may also absorb selenite as well as Sem and Sec. Selenate is 
assimilated into plants via the sulphate pathway and incorporated non-specifically into 
proteins, primarily as Sem (Terry et al. 2000). Plants therefore, especially grain crops, 
are a major source of Sem in the human diet. 
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Animal tissues contain both Sem and Sec, forming the major source of Sec in human 
diets. Organ meats such as kidney and liver generally contain high concentrations. 
Dietary supplements consist mostly of inorganic forms such as selenite and selenate 
but also Sem, as found in selenized yeast (Sunde 2001). 
Dietary analysis reveals that a large proportion of the selenium consumed in the 
normal diet is generally provided by a relatively small group of foods (Duffield and 
Thomson 1999; Combs 2001). Major contributors to dietary selenium intake are 
animal products (meat, seafood, dairy products and eggs) and grain-based products 
(bakery goods, cereals). In comparison fruits and vegetables are relatively small 
contributors to dietary selenium (Duffield and Thomson 1999). A wide geographical 
variation of food sources is possible in modern diets due to importation of food 
products. The importation of significant selenium sources (such as wheat) can 
therefore result in an increase in selenium intakes in areas of low soil selenium status 
(De Jong et al. 2001), as a consequence the estimation of dietary intakes is 
complicated and without food analysis calculated intakes may lack accuracy. 
The homeostasis of selenium in humans is not regulated by absorption, unlike other 
minerals such as iron. Indeed both inorganic and organic forms of selenium when 
ingested exhibit high rates of absorption (Thomson 2004a). The immediate fate of the 
absorbed selenium depends on its chemical form. Sem, as an analogue of Met, enters 
the general aminoacid protein pool for non-specific incorporation during protein 
synthesis. Despite being the aminoacid specifically incorporated into selenoproteins, 
Sec, and the inorganic forms selenite and selenate are not immediately available for 
incorporation into protein. All three are converted to the key intermediate hydrogen 
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selenide (H2Se) which undergoes conversion to selenophosphate (Figure 2.3), the 
immediate donor of selenium to selenocysteyl-tRNA[serl'. This catabolism of Sec is 
catalysed by selenocysteine lyase (Mihara et al. 2000). Once in the form of H2Se it 
may be utilised in selenoprotein synthesis. At normal intake levels, selenium is 
excreted by the kidneys primarily as selenosugar 1 (Se-methyl-N-
acetylgalactosamine) (Gammelgaard and Bendahl 2004; Kuehnelt et al. 2005). In 
cases of very high selenium intake, trimethylselenonium (TMSe) ((CH 3 )3 Se+) may 
also be excreted in the urine (Kuehnelt et al. 2005), and dimethyl selenide ((CH3)2Se+) 
may be excreted on the breath, causing the characteristic garlic odour that is 
experienced in selenosis (Allan et al. 1999). The methylation of selenium compounds 
is therefore a critical step in selenium metabolism, enabling the body to excrete the 
element easily but also synthesise metabolites with purported anticarcinogenic 
abilities. 
The form of selenium consumed in the diet therefore has some influence on its fate 
within the body. Sem is a relatively poor provider of selenium for selenoprotein 
synthesis. With lower levels of Met intake, Sem is more likely to be incorporated non-
specifically in place of Met and is therefore adept at increasing the level of selenium 
in the body but not necessarily at increasing the functional activity of selenoproteins. 
Sec, selenite and selenate however, contribute better to the intermediate pool that 
contributes to the synthesis of selenoproteins. Sem can still enter this pool but it must 
first undergo catabolism through Sec to H2Se (Combs 2001). 
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General body proteins 
Selenomethionine 
Selenocysteine ERIS, 
Selenoproteins 
Selenophosphate 
Hydrogenselenide 
%  
Selenite 
GS-Se-SG 
GS-SeH 
Methylselenol 
Dimethylselenide 
GS-Seleno-N-acetyl-galactosamine 
Se-methyl-N-acetylgalactosmine 
Trimethylselenonium 
Figure 2.3: Metabolism of selenium at adequate and excessive intake levels (Gammelgaard 
and Bendahl 2004). 
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2.4.2 Minimum requirements{ TC "Minimum requirements" \f C \I "2" } 
There is growing interest in selenium nutriture worldwide, with much work focusing 
on resolving the 'adequate' versus 'optimal' intake debate. Currently, recommended 
dietary intake values throughout the world are proposed on the basis of avoiding 
selenium deficiency diseases and/or to meet the requirement, or a portion of the 
requirement, for the selenoenzyme GPx. The rationale for this latter approach is 
founded in the belief that maximizing selenoenzyme activity is sufficient to ensure 
selenium related health requirements are met (GPx is low in the selenoenzyme 
hierarchy and therefore most other selenoenzyme activity is maximized when GPx 
requirements are met). The potential flaw in this approach is that numerous studies 
have indicated supranutritional amounts of selenium - substantially more than is 
required for enzyme expression - may provide significant protection from a number of 
cancers (Clark et al. 1996), the mode of which may not be due to the action of 
selenoenzymes (Clark et al. 1996; Ip 1998). 
The minimum dietary intake required to avoid Keshan disease was established by 
Chinese scientists to be around 19.4 and 14.1 rig/day for males and females 
respectively (Yang et al. 1988). This group also concluded that the physiological 
requirement for glutathione peroxidase was approximately 41 gg/day. More recently, 
a New Zealand study by Duffield and co-workers (1999) assessed the response of a 
number of selenium biomarkers to supplemental selenomethionine (10-40 pg/day), 
and initially determined that a total intake of 90 jig/day was required for the saturation 
of subjects' plasma and whole blood glutathione peroxidase activity. This study data 
was subsequently reanalysed (Institute of Medicine 2000) and, due to an inability to 
statistically differentiate the GPx activity increases between supplementation levels, 
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the physiological requirement was revised down by this group to a conservative value 
of 38 pg/day. The Chinese and New Zealand findings have both been referred to 
when recommended dietary intakes have been formulated in many countries around 
the world. 
2.4.3 Recommended intakes{ TC "Recommended intakes" \f C \1 "2" } 
Using the Chinese value as a base, the U.S. National Academy of Sciences' Food and 
Nutrition Board (Neve 2000) calculated their original recommended daily allowance 
(RDA) of 55 and 70 pg/day for women and men respectively. Since then, and 
considering the New Zealand data, the same authority revised the RDA down to 55 
jig/day for both men and women (Food and Nutrition Board 2000b). Other countries 
have adopted recommended daily intakes that vary above and below these values. The 
German, Austrian and Swiss recommendation is a range of 30-70 jig/day for persons 
>10 years of age, while British values are 75 and 60 jig/day for adult men and women 
respectively (Thomson 2004a). The German/Austrian/Switzerland lower limit of 30 
jig/day may suffice for children, but for adults may prove insufficient considering the 
Chinese and New Zealand experimental data. 
In Australia, the National Health and Medical Research Council (NHMRC) in 
conjunction with the New Zealand Ministry of Health, recently released updated 
recommended dietary intake (RDI) and estimated average requirement (EAR) values 
(NHMRC 2006). The NHMRC working party determined the EAR, a value 
considered to meet the requirements of 50% of healthy individuals in a particular age 
group or gender, based on New Zealand (Duffield et al. 1999) and Chinese (Xia et al. 
2005) supplementation data, to be 60 mg/day and 50 jig/day for adult males and 
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females respectively. The new RDI values were derived from EAR values using the 
formula RDI = EAR + 2SDEAR . (assuming an EAR CV of 10%) resulting in 
recommended daily adult intakes of 70 jig/day and 60 jig/day for males and females. 
New recommendations were also produced for infants, adolescents and pregnant and 
lactating women (Table 2.2). 
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Table 2.2: Australian and New Zealand nutrient reference values for selenium 
(NHMRC 2006). 
• Infants 
0-6 months 
7-12 months 
Al 
12 
15 
Upper level 
of intake 
45 
60 
Children and Adolescents 
All 
EAR RDI 
1-3 yrs 20 25 90 
4-8 yrs 25 30 150 
Boys 
9-13 yrs 40 50 280 
14-18 yrs 60 70 400 
Girls 
9-13 yrs 40 50 280 
14-18 yrs 50 60 400 
Adults 
Men 
19-30 yrs 60 70 400 
31-50 yrs 60 70 400 
51-70 yrs 60 70 400 
>70yrs 60 70 400 
Women 
19-30 yrs 50 60 400 
31-50 yrs 50 60 400 
51-70 yrs , 50 60 400 
>70yrs 50 60 400 
Pregnancy 
14-18 yrs 55 65 400 
19-30 yrs 55 65 400 
31-50 yrs 55 65 400 
Lactating 
14-18 yrs 65 75 400 
19-30 yrs 65 75 400 
31-50 yrs 65 75 400 
Al — Adequate intake; EAR — Estimated average intake; RDI — Recommended dietary intake; all 
intakes ug/d 
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Intakes in the upper part of these recommended ranges may indeed be adequate for 
normal selenoenzyme function, but recent research indicates that they could fall well 
short of providing the maximal health benefits associated with selenium. Results from 
a number of studies so far suggest that intakes of >150 jig/day are likely to be 
effective in the reduction of cancer incidence (Schrauzer 2000). Beyond the action of 
antioxidant selenoenzymes, the exact mechanism for this protective effect remains 
unclear, but it appears methylselenol is the key metabolite. Numerous studies have 
shown that methylselenol, which can be derived most effectively from 
monomethylated forms of selenium such as Se-methylselenocysteine (Se-MCys), is 
capable of modulating a number of molecular mechanisms involved in controlling 
cellular division and cell death (Redman et al. 1997; Ip et al. 2000; Zhong and 
Oberley 2001; Jiang et al. 2002), even at low concentrations. 
While Se-MCys is the most effective precursor for methylselenol, it is, unfortunately, 
not consumed in significant amounts in normal diets. The major dietary forms of 
selenium are Sem and Sec, and while quite effective for induction of selenoenzyme 
activity (Finley and Davis 2001), they are poor precursors of methylselenol. This may 
explain why a much higher dietary intake is required to provide the 
chemopreventative effects against cancer than is needed to maximize selenoenzyme 
expression. 
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2.4.4 Toxicity and safe upper limits of intakes{ TC "Toxicity and safe upper 
limits of intakes" \f C \I "2" } 
The symptoms of toxicity include hair and nail loss and in more severe cases skin and 
nervous system lesions. The symptoms of selenosis are very rare in humans and 
ironically, given the country's association with selenium deficiency, the most 
widespread example occurred in China, specifically Enshi County in Hubei Province 
(1983). The severity of selenium overload resulted in a morbidity rate of almost 50% 
of the 248 inhabitants of the most heavily affected villages. The average estimated 
daily intake in these cases was 4.99 mg/day. Nearby villages without symptoms of 
selenosis had estimated average intakes of 750 jig/day. The recent study by Reid et al 
(2004) assessed the response of 24 men with prostate cancer to supra-nutritional doses 
of either 1600 or 3200 jig/day for between 6 months and 2 years with up to four years 
follow up. Despite the limitations of this study, the lack of reports of widespread overt 
symptoms of chronic toxicity at such high levels suggests perhaps that the safe 
maximum intake is likely to be significantly higher than early estimates. 
There is a lack of official agreement on the safe upper level of intake. The European 
Commission — Scientific Committee on Food (2000) determined a rather conservative 
tolerable upper intake level of 300 jig/day. In contrast, the NHMRC (Table 2.2) 
recommends a safe upper limit for adults of 400 jig/day which considering previous 
findings (Yang et al. 1983; Reid etal. 2004) may also be deemed conservative. 
Despite data indicating possible benefits of dietary selenium intakes in the range of 
150-300 jig/day for some people, national dietary intake recommendations are likely 
to remain at current levels for the time being. This is primarily because of the 
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potential for toxicity due to the relatively narrow therapeutic range for selenium. Also 
of concern are recent findings from some randomised controlled trials that have 
suggested that higher selenium status may actually be associated with increased risk 
of diabetes and hypercholesterolaemia (Bleys et al. 2007; Stranges et al. 2007; 
Lippman et al. 2009; Stranges et al. 2009). Such findings indicate intakes at the 
higher end of the normal range may actually increase risk of some chronic diseases; 
however causality and/or potential mechanisms are still to be determined. 
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2.5 Associations with disease { TC "Associations with disease" \f C \I "1" } 
In the 30 years subsequent to the discovery of the requirement for selenium in 
glutathione peroxidase, widespread research has indicated that selenium is likely to 
play a greater biological role than previously understood. The findings that have 
prompted the most interest are those that have indicated selenium has apparent anti-
cancer properties, which appear to be corroborated by findings in large scale 
epidemiological and intervention studies. Selenium is postulated to protect against 
cardiovascular disease, although the extent is still uncertain, and also appears to play 
an important role in a number of other areas including the immune system and in 
some viral infections. 
2.5.2 Cancer{ TC "Cancer" \f C I "2" } 
Since the 1960s a number of geographical studies have indicated a likely association 
of low selenium status with increased rates of cancer. Jansson and co-workers (1975) 
assessed death rates from all cancers across all continental US counties between 1950 
and 1969, and found the highest rates of colon and rectal cancer occurred in the areas 
of lowest soil and plant selenium concentrations. Soon after, Schrauzer and colleagues 
(1977) also found inverse correlations between estimated dietary selenium intakes and 
a number of cancers, in particular colorectal, prostate and breast cancer. More 
recently, Clark et al (1991) reanalysed, more thoroughly, the data used by Jansson, 
and found significant inverse associations between low forage selenium levels and 
adjusted rates of cancer of the lung, rectum, bladder, oesophagus, breast and cervix. In 
China, a study encompassing 65 counties by Kneller and co-workers (1992) found 
geographical areas where populations had higher blood selenium levels had strongly 
significant decreases in mortality rates for stomach cancers. 
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While not conclusive, these findings have since found support from numerous human 
case control and intervention studies, and from many animal studies. 
An early Chinese trial of 29,584 adult subjects assessing the effects of combinations 
of vitamins and minerals on cancer hinted further at this possible protective ability of 
selenium. The Nutrition Intervention Trial (Blot et al. 1993) was conducted in Linxian 
County, China between 1984 and 1991. In this region of China the mortality rates for 
oesophageal cancer are 100 fold that of the white North American population. The 
nutrient treatment groups consisted of (A) retinol and zinc; (B) riboflavin and niacin; 
(C) vitamin C and molybdenum; and (D) beta-carotene, vitamin E and selenium (50 
gg). A total of 2127 deaths were recorded during the trial; 1298 cases of cancer were 
detected and it ranked as the major cause of death, responsible for 32% of deaths. It 
was found that treatment A, B and C had no significant effects on total mortality rates. 
Those receiving treatment D had 9% lower total mortality (RR, 0.91; 95%CI, 0.84- 
0.99; P = 0.03) with 13 % lower cancer incidence (RR, 0.87; 95%CI, 0.75-1.00); the 
greatest effect was seen with stomach cancer (RR, 0.79; 95%CI, 0.64-0.99). Thus a 
protective effect was attributed to the combination of beta-carotene, vitamin E and 
selenium. 
Wei and co-workers (2004) later evaluated a sub-sample of this cohort, using baseline 
blood selenium levels, and found significant inverse relationships between serum 
selenium and mortality from oesophageal cancer (RR, 0.83; 95%CI, 0.71-0.98; P =- 
0.03) and gastric cardia cancer (RR, 0.75; 95%CI, 0.59-0.95; P = 0.02). The mean 
serum selenium for this cohort was 0.93 gmol/L and the risk ratios estimated the 
change in risk due to a 25% increase in serum selenium across the population 
distribution. 
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The study that elicited the greatest interest in the chemopreventative potential of 
selenium was an American trial originally designed to assess the effects of supra-
nutritional selenium on the occurrence of non-melanoma skin cancers. The National 
Prevention of Cancer (NPC) trial by Clark et al (1996), which ran from 1983 to 1991 
was a double blind, randomised placebo controlled trial involving 1312 older subjects 
(mean age 63 years) with histories of non-melanoma skin cancers. Intervention was 
oral supplementation of 200 jig/day selenium as selenized yeast or placebo. The 
primary end-points were incidences of basal or squamous cell carcinomas of the skin. 
After 4.5 years treatment the group found no reduction in the incidence of skin 
cancers. There was however an effect on secondary end-points with 37% lower total 
cancer incidence (RR, 0.63; 95%CI, 0.47-0.85; P = 0.001), 50% lower total cancer 
mortality (RR, 0.50; 95%CI, 0.31-0.80; P = 0.002), 63% fewer prostate cancers (RR, 
0.37; 95%CI, 0.18-0.71; P = 0.002), 58% fewer colorectal cancers (RR, 0.42; 95%CI, 
0.18-0.95; P = 0.03) and 46% fewer lung cancers (RR, 0.54; 95%CI, 0.30-0.98; P = 
0.04). Case numbers were too small to reach statistical significance for cancers at 
other sites. 
After 10 years the effects were lessened but the trend still indicated a protective effect 
(Duffield-Lillico et al. 2002). The treatment group exhibited a 25% lower incidence in 
total cancers (HR, 0.75; 95%CI, 0.58-0.97; P = 0.03), prostate cancer incidence was 
significantly reduced by 52% (HR, 0.48; 95%CI, 0.28-0.80; P = 0.005) while 
reductions in lung and colorectal cancers were non-significant. The protective effect 
was also only evident in males (HR, 0.67; 95%CI, 0.50-0.89; P = 0.005), however 
there was a large gender bias in the sample (931 males; 319 females). The effect was 
also most pronounced in former smokers. 
37 
Significantly, the protective effect against total -cancer incidence was strongest in 
participants in the lowest tertile (<1.33 pmol/L) of baseline plasma selenium (HR, 
0.51; 95%CI, 0.32-0.81; P = 0.005), while there was no significant reduction in those 
with baseline plasma selenium above the median of 1.43 1.1mol/L. This finding is 
particularly interesting considering much of the Australian population (and many 
other countries) is likely to have selenium levels near to or below 1.33 gluon, as 
indicated by the very few Australian studies to date. 
More recently the Selenium and Vitamin E Cancer Prevention Trial (SELECT) 
(Lippman et al. 2009) was conducted; a phase III randomised double-blind placebo 
controlled trial of supplementation with selenium (200 gg/day) or vitamin E (400 
IU/day), or a combination of the two. The US trial, involving 35,533 male volunteers 
(minimum age of 50 yrs) began in 2001 and chose to study the potential for protection 
against prostate cancer by these two agents primarily because of the positive findings 
from the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (ATBC Study) 
and the aforementioned NPC trial. It was planned to run SELECT for a maximum of 
12 years but it was recently halted after 5.5 years follow up. It found no significant 
differences in hazard ratios for any of the trials primary or secondary cancer 
endpoints. Of concern were non-significant associations with increased incidences of 
diabetes in subjects receiving selenium. Unfortunately SELECT did not include 
significant numbers of men of low or marginal selenium status, where selenium 
supplementation appears likely to have its greatest effect. Indeed, median baseline 
selenium levels (1.71 iimol/L) indicate most of the trial participants were likely to be 
selenium replete and a beneficial effect from further increasing selenium levels is 
probably unlikely. 
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A second large trial has been proposed in the UK and Europe (Rayman 2000). The 
Prevention of Cancer by Intervention with Selenium (PRECISE) trial is an extended 
repeat of the NPC trial, testing the efficacy of selenium supplementation in marginal 
selenium status populations, such as those in Europe. The trial aims to accrue 42,000 
participants, via the interne, who will receive 100 lig, 200 jig or 300 jig/day of 
selenium yeast supplement or placebo for a minimum of 5- years. At this time two 
small pilot studies have been completed in the UK (Rayman et al. 2008) and Denmark 
(Ravn-Haren et al. 2008). 
In addition to intervention trials there have been numerous case control studies that 
have assessed selenium levels, either in toenails or plasma, in relation to the incidence 
of various forms of cancer. Notably there is further evidence of a relationship between 
selenium and prostate cancer. Large studies in the United States (Yoshizawa et al. 
1998; Helzlsouer etal. 2000; Nomura etal. 2000; Brooks etal. 2001; Li etal. 2004) 
and the Netherlands (Van den Brandt et al. 2003) all determined that subjects with 
lower levels of selenium had a significantly increased risk of prostate cancer. Brooks 
and co-workers (2001) findings regarding a potential threshold effect agreed with a 
later animal based study by Waters and colleagues (2005), which suggested the 
existence of a baseline threshold, above which further selenium supplementation 
provided no added protection. 
Associations between low selenium status and gastric cancer (Knekt et al. 1990; Mark 
et al. 2000), oesophageal cancer (Mark et al. 2000; Rudolph et al. 2003) and bladder 
cancer (Zeegers et al. 2002; Kellen et al. 2006) have also been observed. Conversely, 
no association was evident in similar studies between selenium and breast (Mannisto 
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et al. 2000), cervical (Thompson et al. 2002) or colorectal cancer (Wallace et al. 
2003). 
The mechanisms of the anticarcinogenic effects of selenium have been the focus of 
much interest. Monomethylated forms of selenium, such as methylselenic acid, that 
lead directly to the generation of the key metabolite methylselenol, appear to have 
numerous actions even at very low concentrations in both in vitro and in vivo studies 
(Ip et al. 2000). Findings from this work suggest likely actions to be the induction of 
cell cycle arrest and apoptosis and the inhibition of tumour invasion (Redman et al. 
1997; Zhong and Oberley 2001; Jiang etal. 2002). 
In cell culture, Dong and co-workers (2002; 2003) used flow cytometry and cDNA 
microarray technology to investigate gene expression during selenium induced growth 
inhibition in human breast and prostate cancer cell lines. They reported cell cycle 
arrest with apparent inhibition of the treated cells' progression to S phase, as well as 
the induction of apoptosis. From the cDNA microarray analysis, methylselenic acid 
was found to down-regulate cell cycle factors including cyclins and cdk proteins, 
inhibitors of apoptosis (survivin) and invasion activators (integrins, endonexin). Up-
regulation was demonstrated for cell cycle regulators (RAD9, CHK2, GADD153), 
apoptosis promoters (caspase 9, c-fun, cyclin DI, cdk5) and invasion suppressors 
(cadherins). Several other in vitro studies have provided supporting evidence of the 
ability of various selenium metabolites to induce cell cycle arrest and apoptosis, 
specifically through their effects on the activity of cdk4 (Sinha and Medina 1997), 
caspases (Wang et al. 2002; Zu and Ip 2003; Ghosh 2004) and various protein kinases 
(Jiang et al. 2002; Gopee et al. 2004). Additionally, recent studies by Jiang and 
colleagues (1999; 2000) using human umbilical vein endothelial cells and rat 
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mammary carcinomas have demonstrated that methylselenol precursors inhibited the 
expression of both vascular endothelial growth factor (VEGF) and matrix 
metalloproteinase 2 (MMP-2), two proteins with critical roles in angiogenesis. 
Selenium has also been shown by several groups (Malcropoulos et al. 1996; Kim and 
Stadtman 1997; Otsuka et al. 1999; Gopee et al. 2004) to inhibit in vitro activity of 
the powerful transcription factor, nuclear factor-KB (NF-KB), thus identifying another 
possible mechanism by which selenium exerts an anti-carcinogenic effect. The 
findings to date suggest the protective effects of selenium occur at levels that are 
possible to achieve in vivo and therefore may represent a realistic picture of the 
mechanisms of the epidemiologically observed benefits of higher selenium status in 
humans. Coincidently, these effects on cell growth and proliferation may provide a 
possible explanation for the symptoms of selenosis in mammals such as hair and nail 
loss, neurological impairment and even death. 
The findings of cancer related research so far suggest that increasing dietary selenium 
intakes may not decrease cancer incidence in those populations where plasma 
selenium levels are reasonably high, such as in South America and central North 
America. However, in Europe, as well as Australia, New Zealand and numerous other 
countries, where perhaps 50% or more of the population are considered by Combs 
(2001) to have low or marginal selenium status, there is reason to be optimistic about 
the positive effects increasing selenium intakes could provide. There is also some 
evidence that the benefit of increasing selenium status may be greater for men than 
women. 
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2.5.3 Cardiovascular disease{ TC "Cardiovascular disease" \t' C \l "2" } 
Compared to cancer, the case for a protective role for selenium in cardiovascular 
disease (CVD) is more tenuous. Despite the identification of potential mechanisms for 
protection, studies in human populations have provided conflicting evidence. 
The proposed mechanism of the protective role of selenium in CVD is based largely 
on the ability of selenoproteins, particularly glutathione peroxidase, to prevent 
oxidative damage of lipids and membranes. The oxidation of LDL is believed to be a 
key development early in the process of atherogenesis (Weiland et al. 1993), going on 
to accumulate in arterial walls where it is taken up by foam cells. The phospholipid 
hydroperoxide glutathione peroxidase, GPx-4, is known to function primarily in the 
reduction of fatty acid hydroperoxides, cholesterol hydroperoxides and other 
lipoprotein hydroperoxides. As discussed earlier, recent work has shown over 
expression of GPx-4 can delay the development of atherosclerosis in mouse models 
by protecting against this lipid peroxidation and by decreasing the sensitivity of 
vascular cells to oxidised lipids (Guo et al. 2008). 
In addition to a basic protective function GPx-4 may also act to control the 
inflammatory reaction that is involved in the formation of atherosclerotic plaques. 
Through its effect on eicosanoid metabolism, GPx-4 is able to modulate the activity of 
cyclooxygenase and lipoxygenase (Schnurr et al. 1996; Sakamoto et al. 2000). Hence 
in low selenium states a reduced GPx-4 activity may lead to an imbalance in the 
synthesis of prostaglandins (vasodilators and inhibitors of platelet aggregation), 
thromboxanes (vasoconstrictors and promoters of platelet aggregation) and 
leukotrienes (influence vascular permeability and cell migration). In such a scenario 
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there would be an increased tendency for platelet aggregation and cell migration as 
seen in the formation of atherosclerotic plaque and associated thromboses. 
Despite this theoretically important role for selenium in the prevention of CVD, 
evidence from epidemiological studies is not compelling. Analysis of the results 
(Rayman 2000) from such studies points to a relatively low threshold above which 
increasing selenium status has little or no effect and hence only those in populations 
of quite low selenium intake may benefit from selenium supplementation. Such a low 
threshold value seems consistent with the hypothesised selenoprotein involvement, as 
most have maximal activity at only moderate intakes. 
The early Finnish study by Salonen et al (1982) determined a 2-3 fold increase in total 
cardiovascular morbidity and mortality when serum selenium levels were below 0.57 
!mon. Similar results were found by Suadicani et al (1992) who reported that serum 
selenium below 1.01 prno1/1. resulted in a significantly increased risk of ischaemic 
heart disease in Danish men. In contrast, subsequent Scandinavian studies (Marniemi 
et al. 1998; Kilander et al. 2001) in which serum selenium was similar to the risk 
threshold from Suadicani and colleagues' study, show no association with CVD. The 
Health Professionals Follow-up Study (Yoshizawa et al. 2003), using toenail selenium 
analysis, also found no association with total CVD though they could not exclude a 
possible association with myocardial infarction. While toenail selenium has often 
been used in long term epidemiological studies, the selenium in nails is in the form of 
Sem, and it is questionable whether this is necessarily an accurate indication of the 
selenium available for selenoprotein synthesis. 
More recently, analysis of data from the NPC trial by Stranges and colleagues (2006) 
found no significant association between selenium and CVD endpoints after 7.6 years 
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follow up among the 1004 participants who had no baseline CVD. The study's lower 
tertile baseline plasma selenium was < 1.33 Amon which, considering earlier 
research, may have been too high to detect a possible effect. 
Meta-analysis of 25 observational studies between 1966 and 2005 identified a 
significant inverse association between selenium levels and coronary disease 
outcomes (Flores-Mateo et al. 2006). The authors also analysed 6 randomised trials 
and found subjects that were supplemented had a non-significant reduction in 
cardiovascular events. 
In work regarding hypertension, Nawrot et al (2007) analysed data from 710 
participants from the FLEMENGHO study in Europe and found significant 
associations between selenium and blood pressure. In men higher blood selenium was 
associated with lower systolic and diastolic blood pressure. Furthermore, a 1 SD 
increase in blood selenium resulted in a 37% lower risk (P = 0.001) of the 
development of hypertension. 
Another recent meta-analysis, of 13 prospective cohort studies (Navas-Acien et al. 
2008), also found a small inverse relationship between selenium concentrations and 
coronary heart disease. The authors, however, warned of confounding factors in the 
analysis, and pointed to recent studies which have suggested the potential for 
increased risk from supplementation of already replete populations, as a cause for 
concern. 
Clearly more research is required, particularly in populations of low selenium intake, 
and perhaps to assess gender based differences also, before more definitive statements 
can be made regarding selenium and cardiovascular disease. 
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2.5.4 Immune function and viral infections{ TC "Immune function and viral 
infections" V* C \I "2" } 
There is clear evidence that selenium has important associations with some aspects of 
immune function. It appears to be involved in the pathogenesis of one if not several 
viral diseases. The best described is the involvement of selenium in the formation of 
cardiovirulent strains of the Coxsackie B3 virus, now acknowledged as a co-
contributor in the pathogenesis of Keshan disease. The work of Beck (1997) 
demonstrated, using mice, that a previously non-virulent strain of Coxsackie B3 virus 
will become virulent following mutation due to oxidative stress in selenium deficient 
hosts. The virulent strain may then go on to infect and cause disease in selenium-
replete animals. Beck and colleagues believe RNA viruses in general are susceptible 
to oxidative mutations; presenting evidence of such an effect in an influenza virus 
(Beck et al. 2001) as well as suggesting an enterovirus implicated in an optic and 
peripheral neuropathy epidemic in Cuba (Beck et al. 2003) had also undergone such a 
process. With this in mind, the emergence of many virulent influenza viruses from 
China may be no coincidence, with its high population density and known regions of 
severe selenium deficiency. Indeed one author (Rayman 2000) has even postulated 
that selenium deficiency may have been a contributing factor in the first emergence of 
HIV in Africa. 
Selenium is certainly associated with HIV and the progression to AIDS, but whether it 
is a causal relationship is still unclear. In both paediatric and adult HIV cases, low 
plasma selenium has been observed to be an independent predictor of mortality, 
associated with increased disease progression (Campa et al. 1999). In one study of 
HIV positive drug users, those who were selenium deficient had 10.8 times greater 
mortality rates (Baum et al. 1997). Selenium supplementation has also been found to 
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suppress HIV progression. Hurwitz et al (2007) supplemented with 200 1g/day of 
high selenium yeast in a double blind randomised placebo controlled trial of 174 
participants over 9 months treatment. Supplementation resulted in increased blood 
selenium levels (P <0.001), decreased viral load (P < 0.02) and increased CD4 T-cell 
count (P <0.04). 
In addition to direct pathogen associations, selenium is important in cellular 
immunity. Selenium deficiency results in functionally defective neutrophils, the 
reduction in cellular glutathione peroxidase activity thought to result in an inability to 
control the free radical production that is part of the neutrophils' bactericidal action 
(Arthur et al. 2003). Selenium supplementation has also been shown to enhance 
cytotoxicity of natural killer (NK) and cytotoxic T-lymphocyte (CTL) cells in animal 
models (Petrie et al. 1989), an effect also seen in elderly humans (Woods et al. 2000). 
Mouse models have also shown selenoproteins to be important for the production of 
mature T-cells and for the T-cell dependant antibody responses (Shrimali et al. 2008). 
A large body of work in veterinary science has shown selenium supplementation to 
enhance B cell lymphocyte function in animals, with titres of immunoglobulins 
increased following immunological challenges (Spallholz et al. 1973; Reffett et al. 
1988; Droke and Loerch 1989; Knight and Tyznik 1990; Stabel et al. 1991). As well 
as aiding the fight against infectious disease, such an up-regulating effect on the 
immune system would likely assist in the response to the development of malignant 
cells. 
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2.5.5 Selenoprotein polymorphisms{ TC "Selenoprotein polymorphisms" \t* C \1 
11211 } 
With the developing understanding of the importance of selenoproteins in many 
processes required for normal health, there has been a significant effort to determine 
the effect of genetic variation in selenoproteins. A number of single nucleotide 
polymorphisms (SNPs) have been identified in various selenoprotein genes and have 
been shown to affect protein expression and/or cancer risk. 
Polymorphisms in GPx genes have been the focus of much interest, in particular the 
SNP affecting codon 198 of GPx-1. Working with a cohort from the ATBC Study, 
Ratnasinghe and colleagues (2000) found a significant association between GPx-1 
genotype and lung cancer. Participants with the heterozygous genotype Pro/Leu had 
an 80% greater risk of lung cancer, and homozygous Leu/Leu 130% greater risk, 
compared to those with the homozygous wild type Pro/Pro. The authors also found 
significant associations between genotype and lung cancer histological subtypes. 
These associations were observed in a Caucasian population, and the group have 
previously found ethnic Chinese do not possess this polymorphism and therefore are 
not susceptible to the increased risk conferred by it. 
The GPx-1 Pro198Leu polymorphism was also found to be associated with bladder 
cancer in a Japanese population (Ichimura et al. 2004); with an adjusted 263% 
increase in risk compared to the wild type, and those with the Pro198Leu genotype 
were at greater risk of advanced disease. Furthermore, there was an interaction with 
the manganese superoxide dismutase (MnSOD) MnSOD Ala-9Val polymorphism; 
risk of bladder cancer increased to 631% when patients had at least one Ala allele in 
conjunction with the GPx-1 Pro198Leu genotype. Loss of Pro198 heterozygosity at 
the GPx-1 locus is thought to be a common occurrence in other malignant tumours 
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including those of the head and neck (Hu et al. 2004), colon (Hu et al. 2005), lung 
(Hardie et al. 2000) and breast (Hu and Diamond 2003; Ravn-Haren et al. 2006), 
however there have been conflicting results in regard to breast cancer associations 
(Cox et al. 2004; Knight et al. 2004; Alm et al. 2005). Other studies have observed no 
significant association between polymorphisms in the GPx-1 gene and cancers such as 
early onset prostate cancer (Kote-Jarai et al. 2002) and basal cell carcinoma (Vogel et 
al. 2004). 
Research with Type 2 diabetics has also found the GPx-1 Pro198Leu genotype to be 
associated with increased risk of coronary heart and peripheral vascular disease; and 
in combination with another GPx-1 polymorphism (Ala6), the 198Leu gene product 
had 40% lower enzyme activity than wild type in in vitro functional analyses 
(Hamanishi et al. 2004). Hu and Diamond (2003) also noted that the 198Leu variant 
was less responsive to selenium supplementation. Ravn-Haren and co-workers (2006) 
have recently observed in the Danish 79,729 subject Diet, Cancer and Health study, 
that each copy of the variant Leu allele resulted in approximately 5% lower GPx-1 
activity. 
Sep15, another selenoprotein which appears to have functional variants, is expressed 
primarily in prostate, liver, kidney, testis and brain tissue. To date, some of the 
strongest epidemiological evidence for the involvement of selenium with cancer has 
come from prostate cancer. The Sep15 gene is located at p31 on chromosome 1, an 
area which is commonly deleted or mutated in cancers. Kumaraswamy and co-
workers (2000) found significantly reduced amounts of Sep15 in malignant tumours, 
that polymorphisms influence the expression of the protein and that they respond 
differently to selenium supplementation. Another group observed a significant 
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difference in allele frequency by ethnicity, and found a significant reduction in 
heterozygosity in tumours of African Americans (Hu et al. 2001). 
More recently, other selenoprotein polymorphisms have been observed to modify the 
response of selenoproteins to selenium supplementation, an important finding given 
the numerous studies suggesting a benefit from supplementation, and also disease 
risk, particularly in conjunction with other factors. This includes recent reports of a 
GPx-4 SNP (Meplan et al. 2008) and two common SelP SNPs (Meplan et al. 2007) 
which appear to affect not only selenoprotein activity but their responses to selenium 
supplementation. In smokers, the homozygous mutant genotype of the Sep15 
1125G/A polymorphism is reported to benefit from higher selenium status, while in 
the other genotypes higher selenium status was associated with increased lung cancer 
risk (Jablonska et al. 2008). Another SelP SNP (Ala234), in association with a 
superoxide dismutase (SOD) SNP (Alal6Val), increases the overall risk of prostate 
cancer and that of aggressive prostate cancer in subjects with marginal selenium 
status, particularly in current or former smokers (Cooper et al. 2008). 
Clearly the identification of the —25 selenoprotein genes has been an important step 
and is one that is likely to shape the future research regarding selenium and quite 
possibly the view on the optimal selenium intake for different groups of people. With 
emerging data indicating that higher selenium status may be associated with adverse 
health effects (Stranges et al. 2007; Lippman et al. 2009), a greater understanding of 
the effects of genetic variation on selenoprotein function and its relation to health and 
disease could lead to the point where optimum selenium intakes are determined on an 
individual basis using genetic and other factors. 
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2.6 Assessment methods for selenium status{ TC "Assessment methods" \f C 
The assessment of selenium status is commonly a multifaceted one. The estimation of 
dietary intake is useful but is generally used in conjunction with one or more 
biochemical measures. A functional measure is preferred to give greater context to the 
analyte measured, and this is possible for selenium, through the measurement of 
various selenoproteins. 
2.6.1 Dietary assessment{ TC "Dietary assessments" \f C \l "2" } 
There are a number of different methods that may be employed in order to estimate 
dietary nutrient intake including diet records, duplicate diets and food frequency 
questionnaires. All such methods have various shortcomings, including random and 
systematic error, which may arise from limited periods of data collection, daily 
variation, failure to report usual habits or a change in habits, inaccurate estimation of 
portion sizes or the use of food composition data which does not accurately reflect the 
actual composition of food eaten (Bingham 2002). 
Diet records may utilise weighed or estimated food amounts and weighed diet records 
are considered, although imperfect, as the dietary assessment 'gold standard'. 
Recording periods are typically 3-7 days in duration, though longer periods may be 
used to increase representativeness but are associated with a decrease in reported 
intake due to respondent fatigue (Thompson and Subar 2008). Such records are 
usually comprised of a detailed description of the food type and amount. In the case of 
weighed records each portion is weighed on scales prior to the meal. For estimated 
portion sizes, pictures of varying portion sizes or measuring cups and spoons are 
commonly provided. The final calculation of the estimated nutrient intake usually 
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utilises standard food composition data. Weighed diet record methods impose a 
relatively high load upon the participants in terms of time taken to fulfil requirements, 
which may result in altered intake or reduced compliance. Estimated records reduce 
the participant burden but overall the process is still quite time-consuming and 
expensive. Such methods are widely used and generally provide a reasonable 
indication of dietary nutrient intakes at the time of assessment, however seasonal 
variations in eating habits will not be detected. A strength of the diet record is that 
meals are recorded as they are consumed, however it is thought in some cases this 
may alter the amounts normally eaten (Bathalon et al. 2000; Golis et al. 2000) and 
hence lead to the underreporting that has been observed in several studies (Bathalon et 
al. 2000; Goris et al. 2000; Hill and Davies 2001; Trabulsi and Schoeller 2001). 
The 24 hour diet recall asks the subjects to remember all food and beverages 
consumed over the previous 24 hours. The diet information is generally collected by 
an interviewer, and the ability of the interviewer to extract all relevant information 
from the subject is important to ensure the accuracy of the data. Although this method 
requires direct contact and a well trained interviewer, its strength is that the data is 
collected soon after the period of interest and does not rely on the ability of the 
subject to interpret the question or record the response correctly (Thompson and 
Subar 2008). Despite this strength, the 24 hour recall cannot be used to estimate usual 
diet because of day to day variations. The 24 hour recall has also been observed to 
under report when compared with biomarker measures (Bathalon et al. 2000; Tran et 
al. 2000; Trabulsi and Schoeller 2001; Hebert et al. 2002; Subar et al. 2003). 
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A food frequency questionnaire in its most basic form is a list of foods in combination 
with a number of options that relate to the frequency of their consumption. The 
questionnaire provides consumption options between 'several times a day' to 'once a 
month'. Semi-quantitative food frequency questionnaires collect information on 
serving sizes, commonly by including photographs of portions of varying sizes. For 
foods in which portion size information is not collected, standard portion size data is 
utilised to estimate daily food intakes (Thompson and Subar 2008). The calculation of 
daily nutrient intakes also requires the use of standard food composition data. This 
method provides an assessment of eating habits over a long period, generally taking 
into account a large number of foods and may allow for some seasonal variation 
depending on the instruction given at the time of assessment. As a one off, self-
administered questionnaire, participant burden is lower than other methods. Low cost 
and ease of the distribution and processing enables large numbers of participants to be 
easily assessed. The major drawbacks of the food frequency questionnaire are the 
reliance on estimated food portion sizes and food composition data of varying 
accuracy. Subjects may also find it difficult to estimate how frequently they eat 
particular foods, and mixed food items such as pizzas and tacos may not be 
represented well. The close-ended nature of most FFQ also means unusual or 
specialist foods (eg gluten free foods) can go unreported. 
Duffield and Thomson (1999) conducted a comparison of methods of dietary 
assessment specifically for the estimation of selenium intake. Comparisons were made 
between a food frequency questionnaire (n = 110) and 3-day diet records and 
duplicate diets (n = 43). In addition to dietary intake, the selenium status of each 
participant was assessed using whole blood, plasma and urinary selenium analysis. 
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From dietary analysis, mean selenium intakes were similar for both duplicate diets (29 
13 jig/day) and diet records (28 + 15 jig/day), but the mean estimated intake from 
the food frequency questionnaire was 75-80% greater (51 ± 26 jig/day). Interestingly, 
all three methods found significantly different intakes between sexes, a difference that 
was not reflected in blood selenium levels and was suggested to be due to body mass 
variation between sexes. 
Significant correlations were found for selenium intake by duplicate diets (r 0.3, P < 
0.05) and diet records (r 0.4, P < 0.05) with plasma selenium concentration, and 
selenium intake from the food frequency questionnaire with whole blood selenium (r 
0.3, P <0.05). There was a strong correlation between duplicate diets and diet records 
(r 0.7, P = 0.0001), however Bland and Altman difference plot analysis indicated a 
lack of agreement. The authors suggested the large difference in estimated intakes 
may be due to the food frequency questionnaire providing a measure of longer term 
intakes compared to the other methods. 
The reliability of the FFQ as an assessment tool has however been questioned for 
some time (Byers 2001; Kristal et al. 2005). In general comparisons of FFQs with 
reference methods, poor overall agreements between the methods are reported (Riboli 
et al. 1997; Subar et al. 2001; Schatzkin et al. 2003; McNaughton et al. 2005), but 
high cost and subject burden of the diet records which are considered more reliable, 
ensure that the FFQ is still commonly employed in epidemiological studies. 
Thus, while possibly not suitable for a stand alone assessment of dietary selenium 
exposure, a well designed and administered food frequency questionnaire could still 
provide a convenient and cost effective method for ranking subject intakes but some 
may lack accuracy in providing absolute values. 
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Due to the error inherent in all dietary assessment methods there has been 
considerable effort toward the development of biomarkers for validating estimates of 
dietary intake (Schatzkin et al. 2003; Subar et al. 2003; Neuhouser et al. 2008). Such 
markers include doubly labelled water for estimating energy intake and expenditure, 
24 hour urine nitrogen for nitrogen and hence protein intake, and 24 hour urine 
potassium (Bingham 2002). 
Another major issue for all dietary analysis of selenium is the limited data on 
selenium in foods and the variations in food selenium content between different 
geographical areas. 
2.6.2 Biochemical assessments{ TC "Biochemical assessments" \f C \l "2" } 
The primary measure of selenium status is the determination of selenium within 
tissues of the body. There are a number of commonly used specimens including hair, 
toenails, blood and urine; however, estimation of selenium in plasma or whole blood 
is the preferred measure for most studies. Plasma or serum selenium is widely used 
and reliably reflects short-term intake. Whole blood, due to the turnover time of the 
red cell population, is thought to provide a longer-term measure (Thomson 2004a) but 
unfortunately also brings with it analytical difficulties. 
Measures of plasma or serum selenium have been used as the accepted biomarker of 
selenium status in many studies, from some of the earliest to the most recent (Salonen 
et al. 1982; Knekt et al. 1990; Thompson etal. 2002; Wallace etal. 2003; Bleys et al. 
2008; Rasmussen et al. 2009), including the key studies associated with selenium and 
cancer risk, such as the NPC trial (Clark et al. 1996) and the recent SELECT trial 
(Lippman et al. 2009). 
The measurement of toenail selenium has been used in numerous long-term studies 
(Yoshizawa et al. 1998; Mannisto et al. 2000; Zeegers et al. 2002; Van den Brandt et 
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al. 2003; Yoshizawa et al. 2003), and is considered a reliable indicator of selenium 
status over the 4-12 month period that is required for nail growth (Ovaskainen et al. 
1993). Toenail samples have proven particularly useful in large studies due to the ease 
of collection and storage; however analysis of toenail specimens is more involved 
than methods for fluid samples as the solid nail sample requires digestion before 
analysis. 
Hair, like toenails, should provide a convenient and reasonably reliable index of 
selenium status but in reality its usefulness is limited due to various factors that 
complicate the analysis and interpretation of hair selenium content. The selenium 
content of hair appears easily altered by selenium-containing shampoos and the 
selenium stripping action of some dyes (BoreIla et al. 1998), both of which have a 
wide usage, especially in developed countries. Additionally, concerns over the 
inadequacy of pre-digestion washing procedures, make inter-laboratory comparisons 
very problematic. 
The measurement of urine selenium has been considered to be of little use in the 
assessment of nutritional status (Neve 2000). It lacks the necessary sensitivity for 
detecting nutritional deficiency (Sheehan and Halls 1999); and due to the complexities 
of the relationship between urine selenium excretion and selenium intake, 
interpretation is difficult. Urinary selenium excretion is however used as a method for 
screening for excessive occupational exposure. 
There are a number of analytical methods in use for determining selenium in 
biological tissues and fluids. Techniques include molecular fluorescence spectrometry 
(MFS), hydride generation (HGAAS) and graphite furnace atomic absorption 
spectrometry (GFAAS) and, in more recent years, inductively coupled plasma-mass 
spectrometry (ICP-MS) (Sieniawska et al. 1999). All methods, provided calibration is 
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addressed correctly, perform well, with MFS, HGAAS and ICP-MS considered being 
perhaps slightly superior in terms of sensitivity. Currently though, due to the ease of 
sample preparation and throughput, GFAAS remains the method of choice in most 
laboratories, particularly for plasma and serum samples (Sheehan and Halls 1999). 
With no commonly accepted reference range for blood selenium levels, a functional 
marker is often measured in conjunction with selenium itself. The discovery of 
numerous selenoproteins has in theory provided multiple options for such a functional 
index of selenium status. The classic functional marker of selenium status is 
glutathione peroxidase in plasma (GPx-3), red cells or platelets (GPx-1). It remains 
the preferred method due to ease of analysis, responsiveness to selenium intake and its 
positive correlation with blood selenium up to an activity saturation point (Neve 
2000). Glutathione peroxidase may be measured using spectrophotometric (enzyme 
activity) or ELISA based assays (protein levels). The most widely used methods 
measure enzyme activity using variations of the classic method of Paglia and 
Valentine (1967), which is based on the ability of GPx to catalyse the glutathione 
dependent reduction of an organic hydrogen peroxide. 
The correlation between glutathione peroxidase activity and selenium levels below a 
threshold value makes it a particularly useful marker in populations with marginal 
selenium intakes. The lower ranking of glutathione peroxidase in the selenoprotein 
hierarchy means it requires higher blood selenium levels to reach saturation of activity 
in comparison to other selenoproteins. 
Other selenoproteins that have been considered as alternative or additional measures 
of selenium status are Selenoprotein P (SelP) and some of the selenium containing 
thyroid hormones. SelP is likely a storage protein for selenium and can be measured 
56 
in plasma using a number of methods (HPLC-ICPMS, radioimmunoassay, 
luminometric immunoassay). Previous studies have shown it to be significantly 
associated with other indices such as plasma selenium, GPx-1 and GPx-3 (Hill et al. 
1996; Neve 2000). Our improving understanding of SelP has seen it begin to be used 
as a biomarker for selenium status (Koyama et al. 2009; Rasmussen et al. 2009); it is 
believed by some to be a more sensitive index than GPx (Xia et al. 2005). 
The potential of monitoring thyroid hormone levels as a rather indirect assessment of 
selenium status has been suggested (Neve 2000). Duffield and co-workers (1999) 
investigated thyroid hormones as an indicator of selenium status as part of a 
supplementation trial using members of the selenium-depleted New Zealand 
population. Supplementation appeared to cause a decrease in T4 levels, probably due 
to increases in deiodinase activity. The group concluded that the iodothyronine 
deiodinases would be maximised at a selenium level of approximately 0.85 !mon. 
These proteins therefore appear to be unsuited for assessing selenium status in many 
populations. 
At this point, cellular or extra cellular GPx activity remains the most common 
functional measure, due to the well established relationship with selenium and the 
ease of analysis; the measurement of SelP is however becoming more common due to 
improved methods and better understanding of the protein response to selenium 
intake. 
2.7 Dietary selenium intakes in Australia{ TC "Australian Intakes" \f C \I "1" } 
As the selenium content of food is dependent on the soil content where crops and 
livestock are raised, geological differences around the world result in corresponding 
variations in human dietary intakes. The increase in importation of foods in many 
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countries may positively influence dietary intakes in countries with low or marginal 
selenium status, but it is unlikely to be a method with which to rectify such a problem 
completely. Countries including New Zealand, Zaire and parts of China consume diets 
with much lower selenium content in comparison to seleniferous countries on the 
continents of South and North America. The global variations in dietary selenium 
intake and selenium status as compiled and reviewed by Combs (2001) indicates 
numerous European countries only consume approximately 50 1g/day of selenium in 
their normal diets. Combs goes on to estimate that in over 20 countries worldwide the 
prevalence of low selenium status is >50%. Conversely, many people in certain 
regions of the United States, Canada and especially Venezuela consume over 200 
1.tg/day in normal diets. 
In Australia there have been few surveys that have attempted to -estimate daily 
selenium intake. Fardy, McOrist and Farrar (1989) analysed 50 representative foods 
using neutron activation analysis as part of the NHMRC Market Basket survey. They 
estimated a daily selenium intake of 87 and 57 pg/day for men and women 
respectively. Reilly (1992) used a similar approach by analysing local foods in 
Brisbane, Queensland, estimating the daily intake to be 89 and 59 big/day for males 
and females respectively. 
Market basket surveys have major limitations, however, including that they may not 
be an accurate representation of population consumption, nor take into account 
geographical variations in food content levels. 
The 19th  Australian Total Diet Survey (ANZFA 2001), formerly the Australian 
Market Basket Survey, reported selenium as a contaminant in/on food. Daily intake 
was expressed as a range in units of jig/kg body weight. Selenium content below 0.01 
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mg/kg of food was the lower limit for reporting, and intakes were based on food 
consumption data from the 1995 National Nutrition Survey (NNS). The estimated 
dietary exposure was 1.2-1.7 jig/kg body weight/day and 0.97-1.4 jig/kg body 
weight/day for adult (25-34 years) males and females respectively. The subsequent 
20th  Australian Total Diet Survey (FSANZ 2003) estimated the selenium dietary 
exposure as 1.17-1.41 jig/kg body weight/day and 0.96-1.18 jig/kg body weight/day 
for adult (25-34 years) males and females respectively. 
The mean estimated selenium intakes for both surveys surpass the Australian RDI — 
expressed in mg,/kg body weight/day as 0.85 jig/kg body weight/day and 0.89 jig/kg 
body weight/day for adult males and females respectively. Thus, although Australian 
data on selenium intake is sparse, and has methodological limitations it suggests a 
moderate standing on a world scale, with many Australians from the surveyed areas 
likely to meet the national EAR values, but likely to fall short of intakes that may be 
optimal for disease prevention. 
There has been no previous detailed assessment of dietary intakes of selenium in 
Tasmania. For a number of years Tasmania has been considered at risk of low 
selenium status, due to deficiency in grazing animals. The Tasmanian climate and 
topography is such that leaching of trace elements is highly probable; the state also 
has a well documented history of recurring iodine deficiency (Guttikonda etal. 2002). 
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2.8 Australian blood selenium levels{ TC "Australian blood selenium levels" C 
n 
In accordance with the widely fluctuating selenium intakes reported from around the 
world, blood selenium levels between regions are also starkly different. Combs (2001) 
has, to date, compiled the most comprehensive list of blood selenium analyses 
performed around the world. Not surprisingly, countries with well 'documented 
histories of animal or human deficiency diseases have recorded selenium levels 
below, and in some cases far below, the range of 1.14 - 1.27 !Amon which has been 
suggested as the physiological requirement (Rayman 1997; Duffield et al. 1999). In 
New Zealand, following recognition of low selenium intakes, mean plasma selenium 
levels have risen to between 0.84 and 1.12 timol/L (Thomson 2004b). In the Keshan 
disease areas of China, plasma selenium values as low as 0.20 gmol/L are observed (n 
= 44). Many other countries are seen to have marginal to adequate levels (0.89 
!Amon to 1.27 Amon) while studies in seleniferous areas such as the United States 
(n = 142) and Zaire (n = 75) have recorded mean levels as high as 2.51 !Amon and 
2.56 gmol/L respectively (Combs 2001). 
In Australia, again there is very little data from representative adult populations. The 
most comprehensive data appears to originate in South Australia. Here, Lyons and co-
workers (2004) have compared plasma and whole blood selenium levels from a 
sample of the population in Adelaide in 2002 to previous levels from 5 studies carried 
out between 1977 and 1988 (total n = 834). The 2002 whole blood mean ± sd of 1.58 
± 20 'Amon represented an approximate 20% decline from the 1977 value of 1.96 ± 
27 grnol/L. While there was a change in methodology between analyses performed 
pre-2002 and those in 2002 (fluorometric v. hydride ICPOES), reanalysis of a batch of 
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samples found they gave similar results. The authors suggest the decline may be due 
to a decrease in wheat selenium content as a result of farming practices altering the 
availability of selenium in the soil. The possible gender bias in the studies of 1977 and 
1979 resulting in a higher ratio of men to women was unlikely to be a cause as men 
had only marginally higher selenium levels than women. The mean plasma selenium 
values of the four most recent studies (1987; 1.24 ± 0.19 gnol/L, 1987; 1.22 ± 0.18 
umol/L, 1988; 1.15 ± 0.15 union and 2002; 1.30 ± 0.14 pmol/L) compare 
reasonably with Daniels and colleagues (2000) mean values of 1.11 ± 0.25 pmol/L for 
19 South Australian adults. Included in this small study were 25 adult Tasmanian 
blood donors whose mean plasma selenium was a significantly lower 0.98 ± 0.16 
mmol/L (P < 0.05). 
The study by Dhindsa and co-workers (1998) sampled a population of Sikh (India) 
migrants in Sydney. Despite vegetarianism being common amongst this ethnic group 
the results indicated that both sexes appear to have a marginal selenium status. The 
overall population (n = 196) mean was 1.16 ± 0.19 pmol/L while the male (n = 115) 
value of 1.19 ± 0.21 union was significantly higher (P <0.01) than the 1.12 ± 0.16 
!mon values of females (n = 81). Lux and Naidoo (1995) reported a very limited 
study using a sample of twelve New South Wales adults to determine a mean plasma 
selenium value of 1.28 ± 0.13 gmol/L. 
The most recent Australian study reported the selenium status of two cohorts in 
Queensland (Lymbury et al. 2008). No significant difference in mean plasma 
selenium was found between cohorts of 140 healthy (1.27 ± 0.02 gmol/L) and 112 
CVD patients (1.26 ± 0.02 vtmol/L). The authors suggested a bell-curve effect 
between age and selenium status with lowest selenium status found in the youngest 
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and oldest age groups and selenium levels peaking in middle age groups. They also 
reported that just over half (53%) of the healthy subjects had selenium levels higher 
than 1.27 !Amon, a level associated with optimal GPx activity. 
In the largest Tasmanian study (McGlashan et al. 1996), the serum of 390 newly-
pregnant Tasmanian women was analysed in an attempt to detect a possible 
relationship between maternal selenium levels and sudden infant death syndrome 
(SIDS). Included as a normal component were 171 female blood donors who were 
found to have significantly lower serum selenium (1.02 ± 0.23 mol/1) compared to 
those from other Australian States (1.10 ± 0.21 grno1/1; n = 174); however, the authors 
did not collect other demographic and dietary data. 
Recently Jacobson and co-workers (2007) reported a mean plasma selenium level of 
1.39 ± 0.24 1.tmo1/1_, from a sample of 335 adults living in the Greater Hobart area, 
Tasmania; which is significantly higher than other reported plasma levels in Australia. 
However, the group used the more recently developed magnetic sector ICP-MS 
method rather than the commonly used GF-AAS method, and had concerns over its 
reliability; uncertainty over methodology differences makes it difficult to compare 
these results directly with other Australian data. The response rate of this study was 
26% of the original 1500 contacted, with a large proportion of positive responses 
being older (46 - 65 yrs) and more highly educated. This groups findings indicated 
that both lower educational status and younger age were associated with lower plasma 
selenium levels, so it is likely a more representative population sample could reveal a 
lower mean selenium level. 
While this study provided demographic and other health related data in reasonable 
detail, the method for dietary analysis was less thorough. A basic questionnaire was 
used to determine the frequency with which subjects consumed some major food 
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types, and an estimated daily selenium intake was not reported. Given the sample 
composition, limited dietary data and particularly the analytical method differences, it 
is difficult to interpret these results on a comparative population basis. 
Australian data is limited but it appears mean plasma selenium levels for the 
population may range between 1.1 and 1.3 mmol/L; the upper level of this range being 
similar to the physiological requirement. There would therefore be a significant 
proportion of the population considered selenium deficient by the definition of not 
meeting selenoprotein physiological requirements, which concurs with the views of 
Combs (2001). 
There is insufficient data to determine whether Tasmanians do have lower selenium 
status than their mainland counterparts. It does seem likely however, that a significant 
proportion of the Tasmanian population, like much of the rest of Australia, fail to 
consume levels of selenium associated with both maximizing selenoprotein activity 
and chemoprevention. Further study is therefore warranted to provide more 
comprehensive information on the selenium status in this population. 
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1.16 ± 0.19 umol/L 
1.11 ± 0.25 umol/L 
1.30 ± 0.14 pmol/L 
1.27 ± 0.02 umol/L 
1.26 ± 0.02 urnol/L 
1.02 ± 0.23 umo1/1 
0.98 ± 0.16 umol/L 
1.39 ± 0.24 umol/L 
(Dhindsa etal. 1998) 
(Daniels etal. 2000) 
(Lyons etal. 2004) 
(Lymbury et al. 2008) 
(McGlashan etal. 1996) 
(Daniels etal. 2000) 
(Jacobson etal. 2007) 
Table 2.3: Recent Australian data for selenium intakes and blood levels. 
Previous Australian Estimated Daily Intakes 
Brisbane 
Brisbane 
19th  ATDS 
20th  ATDS 
male 
female 
male 
female 
male 
female 
male 
female 
96 pg 
63 lig 
89 ptg (range 35-204) 
59 ug (range 23-141) 
1.2-1.7 ug/kg body-wt 
0.97-1.4 pig/kg body-wt 
1.17-1.41 pig/kg body-wt 
0.96-1.18 ug/kg body -wt 
(Fardy et al. 1989) 
(Reilly, 1992) 
(ANZFA, 2001) 
(FSANZ, 2003) 
Plasma Selenium Levels 
Sydney - Sikh migrants (n = 196) 
South Australia (n = 19) 
South Australia (n = 288) 
Queensland 
Healthy (n = 140) 
CVD patients (n = 112) 
Tasmania - female blood donors (n = 171) 
Tasmania - adult blood donors (n = 25) 
Tasmania (n = 335) 
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2.9 Copper 
2.9.1 A brief history 
With an atomic weight of 63.55, copper belongs to group 11 of the periodic table; 
other members of this group include the precious metals silver and gold. Copper has 
been in use for approximately 5000 years, first as a material for artistic objects and 
then as a component of the alloy bronze; the use of which spelt the end of the Stone 
Age and the beginning of the Bronze Age in human history (Stern et al. 2007). 
Copper remains an important commodity today, especially for its conductive 
properties. 
2.9.2 Essentiality of copper 
That copper is an essential trace element in mammals was not revealed until 1927 
where it was discovered that copper was required for erythropoiesis in rats (Hart et al. 
1927). Copper is a transitional metal with three oxidation states; it is the ability to 
cycle between Cu l+ and Cu2+ that gives rise to its importance in biological roles. With 
this ability copper can act as an electron donor or acceptor in redox reactions which 
are at the heart of many enzymatic reactions (Uauy etal. 1998). 
Copper is an essential component, either as a cofactor or as an allosteric component, 
of cuproenzymes. At least 11 cuproenzymes are known, with functions ranging from 
antioxidant protection and copper transport to iron metabolism, electron transport and 
pigment synthesis (Stern et al. 2007). The three major cuproenzymes are active in 
redox reactions: caeruloplasmin (also known as ferro-oxidase I), Cu-Zn-superoxide 
dismutase (Cu-Zn SOD) and cytochrome c oxidase. 
The 132 kDa caeruloplasmin is the major copper containing protein, with six copper 
ions in each molecule, accounting for >95% of copper in plasma. The six copper ions 
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are located at two separate molecular sites; three at a site involved in electron transfer; 
the remaining three at a location involved in oxygen activation (Hellman and Gitlin 
2002). These active sites give caeruloplasmin its oxidase function and a radical 
scavenging ability. 
Caeruloplasmin is an extracellular protein which is involved in the acute phase 
reaction in inflammation and may protect against oxidative damage by scavenging 
free radicals (Stern et al. 2007). Its major roles appear to be copper transport from the 
liver to the cells, and as a ferroxidase, active in iron metabolism by oxidising Fe (II) 
from ferritin to Fe (III) which then binds to transferrin to be distributed around the 
body (Hellman and Gitlin 2002). Deficiency in caeruloplasmin activity therefore 
results in iron metabolism abnormalities, seen commonly as a normochromic, 
normocytic anaemia with lowered serum iron levels (Hellman and Gitlin 2002). In the 
case of hereditary forms of acaeruloplasminaemia, the disturbed iron metabolism 
leads to parenchymal iron deposition in most tissues with clinical symptoms of 
diabetes, myeloneuropathy and retinal degradation (McNeill et al. 2008). Cu-Zn SOD 
is a cytoplasmic 32 kDa homodimer; each subunit of the enzyme normally containing 
one copper and one zinc ion at active sites where the substrate, the superoxide ion, 
binds to copper, and catalysis of the dismutation of superoxide (02) to hydrogen 
peroxide (H202) occurs (Zelko et al. 2002). Other major antioxidant enzymes such as 
the selenoprotein GPx or catalase may then complete the removal of the oxidant threat 
by catalysing the reduction of the resultant H202 to water. 
Cu-Zn SOD knockout studies in mice have described phenotypically normal animals, 
but mutations in the gene are associated with disease in humans. In cases of 
amyotrophic lateral sclerosis (ALS) at least 100 mutations have been identified in the 
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SODI (Cu-Zn SOD) gene (Sandelin et al. 2007). In many cases mutations in this gene 
result in reductions in SOD activity of 20% to 50% (Forsberg et al. 2001). 
Cytochrome c oxidase (COX) is a critical protein located on the inner mitochondrial 
membrane which, as the terminal enzyme of the respiratory chain, acts to catalyse the 
reduction of elemental oxygen to water and generate a transmembrane proton gradient 
to drive ATP generation. An integral membrane protein, COX consists of 13 protein 
subunits, and contains 3 copper atoms (Michel et al. 1998). Defects or deficiencies in 
COX may result in muscle weakness, hypothermia and neurological abnormalities 
(Stern et al. 2007). In Menkes disease, the classic hereditary copper metabolism 
disease, a major contributor to the severe neurological damage that occurs due to 
copper deficiency is thought be decreased COX activity leading to impaired 
myelination of neurons (Kaler 1998). 
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Table 2.4: Function of known cuproenzymes (modified from Stern et al (2007)). 
Enzyme 	 Function 
Superoxide dismutase (Cu-Zn SOD) 	Destruction of superoxide radicals 	Found in cytoplasm; during dismutation of 
superoxide radical (02), Cu at active site of 
enzyme is reduced to yield H202. 
Caeruloplasmin (CP) Copper transport, oxidation Contains 65-90% of vertebrate serum 
copper; human plasma level 0200-500 
mg/L. 
Cytochrome c oxidase 	 Electron transport, terminal oxidase 	Tenninal enzyme in the respiratory chain, 
located in the inner membrane of 
mitochondria and bacteria. Catalyses the 
reduction of 02 to water; pumps one proton 
across membrane for each proton consumed 
in the reaction to generate electro-chemical 
gradients that can be used for other cellular 
purposes (e.g., ATP synthesis). 
Dopamine I3-hydroxylase 	 Norepinephrine synthesis 	 Catalyses conversion of dopamine to 
norepinephrine. 
Lysyl oxidase (LOX) 	 Cross-linking of collagen and elastin 	Secreted enzyme catalyses the deamination 
of peptidyl lysine residues forming inter- or 
intra-chain covalent cross-links in elastin 
and collagens 
Monoamine oxidase 	 Neurotransmitter synthesis 	 Found predominantly on the outer 
mitochondrial membrane and throughout 
CNS. Two isozymes both of which oxidize 
the neurotransmitters dopamine, 
epinephrine, tyramine, and tryptamine 
Peptidylglucine a amidating 	 Neuropeptide processing 	 Multifunctional protein involved in the 
maturation of bioactive hormones (e.g., monooxygenase (PAM) 
neurotransmitters and growth hormones) 
containing two enzymes that act 
sequentially to catalyse the alpha-amidation 
of neuroendocrine peptides. 
Polyphenol oxidase/tyrosinase 
Prostaglandin reductase 
Amine oxidase 
Pigment (melanin) synthesis; amino acid 
metabolism, quinone biosynthesis 
Prostaglandin biosynthesis 
Deamination of primary amines 
Oxidizes tyrosine to the pigment melanin in 
mammals. Deficiency leads to 
hypopigmentation. 
Responsible for reduction of 15- 
oxoprostaglandins to 13,I4-dihydro 
derivatives. 
Catalyses the oxidation of amines 
(tyramine, histidine, and polyamines) 
producing oxidized organic products such 
as aldehydes, and generating NH3 and H202 
as by-products 
Ceramide glactosyltransferase 	 Myelin synthesis 	 Synthesis and maintenance of phospholipid 
membranes. 
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2.9.3 Copper intakes and requirements 
Copper is found, in varying amounts, in most foods; those in human diets with 
particularly high copper content include seafood (especially molluscs and 
crustaceans), organ meats (eg liver) and nuts (FSANZ 2006). Foods that are cereal or 
grain based are also good contributors to overall intake due to their importance in 
many diets. Humans may also consume some copper in drinking water, particularly 
when it is carried in copper pipes. Depending on the amount and the bioavailability of 
the ingested copper, the human gastrointestinal tract can absorb between 12% - 65%; 
mostly in the duodenum and stomach (van den Berghe and Klomp 2009). 
Previous estimates, derived from depletion/repletion experiments, have suggested 
dietary copper requirements in adults range between 1.2 - 2.0 mg/d (Milne 1998). The 
World Health Organization (WHO) has suggested men and women (aged 25 - 50 yrs) 
require between 1.5 - 3.0 mg/d (Solomons and Ruz 1998). A relative lack of 
comprehensive data in this area had led to several countries not publishing 
recommended dietary intakes, a situation now rectified in the US, but persisting in 
Australia and New Zealand. The US recommended dietary allowance (RDA) for 
adults is 0.9 mg/d (Food and Nutrition Board 2000a), but in Australia, EAR and RDI 
values have not yet been formulated. The Nutrient Reference Values for Australia and 
New Zealand (NHMRC 2006) provide an adequate intake (Al) - an intake level that is 
based on observed or estimated intakes of an apparently healthy group of people; used 
when evidence is considered insufficient for the establishment of an EAR and 
subsequently an RDI value. Currently the Al for men is 1.7 mg/d and 1.2 mg/d for 
non-pregnant women (Table 2.5). Safe upper levels of intake were derived from data 
relating to liver effects as those which produced a no observable adverse effect level 
(NOAEL) of 10 mg/d. Values for children were extrapolated from the adult values. 
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Table 2.5: Australian nutrient reference values for copper (NHMRC 2006). 
Infants 
	 Adequate 	Upper level 
Intake of intake 
0-6 months 
	 0.20 
7-12 months 0.22 
Children and Adolescents 
All 
1-3 yrs 	 0.7 
	 1 
4-8 yrs 1.0 3 
Boys 
9-13 yrs 	 1.3 
	
5 
14-18 yrs 1.5 
Girls 
9-13 yrs 
	 5 
14-18 yrs 8 
Adults 
Men 
19-30 yrs 	 1.7 	 10 
31-50 yrs 1.7 10 
51-70 yrs 	 1.7 	 10 
>70yrs 1.7 10 
Women 
19-30 yrs 	 1.2 	 10 
31-50 yrs 1.2 10 
51-70 yrs 	 1.2 	 10 
>70yrs 1.2 10 
Pregnancy 
14-18 yrs 	 1.2 	 8 
19-30 yrs 1.3 10 
31-50 yrs 	 1.3 	 10 
Lactating 
14-18 yrs 	 1.4 	 8 
19-30 yrs 1.5 10 
31-50 yrs 	 1.5 	 10 
Units for all intakes - mg/d 
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2.9.4 Disease associations 
Overt copper deficiency is rare, but has been observed in very low birth weight infants 
and in patients receiving total parenteral nutrition (TPN) with inadequate copper 
content (Stern et a/. 2007). Of more interest recently is marginal copper deficiency, 
which is thought to be much more common and has been associated with 
haematological abnormalities (Halfdanarson et a/. 2008), altered immunity (Percival 
1998; Bonham et a/. 2002), hypercholesterolemia and cardiovascular disease (Klevay 
2000; Uriu-Adams and Keen 2005). Such deficiency may result from low dietary 
intakes and also from reduced absorption (e.g. in coeliac disease), the rare X-linked 
Menkes syndrome (Ala and Schilsky 2004) and from high zinc intakes (Stern et al. 
2007). Although uncommon, copper toxicity generally occurs as a result of accidental 
ingestion of copper salts, the consumption of drinking water with high copper content, 
or industrial exposure. Wilson disease, a hereditary condition of altered copper 
metabolism, is also a rare cause of excessive copper accumulation in major organs 
(Ala and Schilsky 2004) . 
2.9.5 Biochemical markers of copper status 
Biomarkers for copper status have often been considered to lack the sensitivity 
required to provide reliable indications of copper status, a situation that has 
contributed to the uncertainty over recommended intakes in some countries. Among 
those currently used for this purpose or suggested as possible markers are 
serum/plasma/red cell copper, caeruloplasmin, Cu-Zn SOD and COX (Danzeisen et 
al. 2007; Harvey et al. 2009). 
A recent meta-analysis included 16 studies (including randomised controlled trials, 
controlled clinical trials and before and after studies) covering possible copper 
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biomarkers (Harvey et a/. 2009). Due to a paucity of well designed studies on copper 
biomarkers, the authors were unable to reach a conclusion on the usefulness of 
numerous markers including plasma, red cell, and platelet copper and COX. They did 
however find that both serum copper and caeruloplasmin appeared to reflect changes 
in copper status, albeit to a different extent. Caeruloplasmin appeared to reflect 
changes in highly depleted subjects whereas serum copper reflected changes in both 
depleted and replete individuals. As a result, the authors suggested serum copper 
appeared to be the most useful biomarker of copper status at the population level. 
Previously, the most commonly used methods for the determination of trace elements 
such as copper were atomic absorption, using either flame or electrothermal 
atomisation, however newer methods such as inductively coupled plasma mass 
spectrometry (ICP-MS) are also becoming more widespread, allowing rapid multi-
element analysis (Huang and Beauchemin 2003). 
2.9.6 Australian data 
Published data regarding trace element status in Australia is sparse. To date there are 
very few reports of copper intake or measures of blood copper levels in the Australian 
population. 
Of the very few studies, an early one assessed copper intakes for female residents (n = 
47) of an Australian nursing home; measuring intakes by duplicate diet analysis 
(using AAS) and reported limited findings which included mean intakes of 1 mg/d 
(Roesch et al. 1984). The largest study was of a cohort of 556 women (aged 20-88 
yrs) from the Barwon electorate in Victoria. Cleverdon and Ball (2004) assessed 
dietary copper intake using a semi-quantitative FFQ and reported mean copper intake 
to be 1.55 ± 0.55 mg/d; suggesting the intakes of the majority of subjects met the Al 
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for Australia. Those considered at greatest risk of low copper intakes in this cohort 
were younger women (<40 yrs). 
The only other published data on copper status from Australia comes from a study 
which assessed the relationship between maternal copper and zinc status and neural 
tube defects in 592 pregnant women (McMichael et al. 1994). This study reported a 
mean serum copper concentration of 32.2 iimol/L in pregnant women with healthy 
foetuses; well above reference ranges but likely elevated by female hormones. 
Data from a representative population sample, including both genders and across a 
range of age groups is lacking, This is of concern, particularly with some suggestion 
that copper intakes have fallen in the last century (Klevay and Medeiros 1996) and 
that food content may be lower than estimated (Klevay 1998), combined with the 
proposal that copper may be related to cardiovascular disease.{ TC "Copper" W 
C \I "1" } 
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2.10 Zinc 
2.10.1 A brief history 
Zinc has an atomic weight of 65.39, and belongs to group 12 of the periodic table; 
other members of this group include cadmium and mercury (Brown et al. 2001). Zinc 
shares similar chemistry with the neighbouring Group 11 transition metal, copper. 
Zinc ores have been used in the manufacture of brass for many centuries. Metallic 
zinc was extracted in India as early as the 1200's and in Europe several centuries later 
(Deshpande 1996). 
2.10.2 Essentiality of zinc 
Zinc appears to be essential for all life. It was reported to be essential for growth in 
mammals in 1933 (Todd et al. 1933). Because of the wide distribution of zinc it was 
thought that deficiency in man would be an unlikely occurrence, however cases of 
dwarfism due to zinc deficiency were described in adolescent Egyptian males in the 
1960's (Sandstead etal. 1967). 
Due to its chemical properties, and in contrast to copper or iron, zinc is redox-inert in 
the body making it comparatively non-toxic; these same characteristics make it 
particularly useful for catalytic, structural and regulatory roles (Andreini et al. 2006). 
Such adaptability sees it involved in all six enzyme classes (oxidoreductases, 
transferases, hydrolases, lysases, isomerases, and ligases) (Brown et al. 2004). Zinc 
may be active at the catalytic site of enzymes or be involved in maintaining tertiary 
structure in proteins. Intracellular zinc also participates in cellular signalling and 
second messenger, protein kinase and protein phosphatase activity (Hambidge and 
Krebs 2007). Zinc metalloproteins include zinc finger motifs, which are contained in 
3% of all known human genes (Maret 2001), and hence influence gene expression 
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greatly. One group of researchers has estimated the existence of a minimum of 2840 
metalloproteins and that potentially 10% of the human proteome is zinc-binding 
(Andreini et al. 2006). Notable zinc metalloproteins include RNA polymerase, 
carbonic anhydrase, alcohol dehydrogenase and alkaline phosphatase. 
2.10.2 Zinc intakes and requirements 
Most foods contain zinc; those that contain high concentrations include muscle meats 
and fish. Other food types that constitute significant proportions of normal diets, such 
as cereal based foods, can also contribute significantly to zinc intakes. Zinc in an 
animal protein rich diet will generally have a greater bioavailability than when 
consumed as part of a vegetarian diet (Lonnerdal 2000). The absorption rate of dietary 
zinc has been estimated as 24% and 31% for men and women respectively for 
mixed/refined vegetarian diets (Brown et al. 2004). This estimated absorption drops to 
16% and 21% respectively for diets based on unrefined cereal. Factors affecting the 
absorption of zinc, other than the animal protein content of the diet, include actual 
zinc content (high zinc content will result in lower absorption rate) as well as dietary 
phytate and calcium (Brown et al. 2004). 
The physiological requirement, defined as the amount of zinc needed to be absorbed 
to balance zinc loss, has been estimated as 2.69 mg/d and 1.86 mg/d for men (65 kg) 
and women (55 kg) respectively (Brown et al. 2004). 
The Australian EAR figures are derived using the zinc absorption and physiological 
requirements estimated by the International Zinc Nutrition Consultative Group 
(IZiNCG) (Brown et al. 2004). The Australian EAR for men is 12.0 mg/d and 6.5 
mg/d for women; the RDIs calculated from these figures are 14.0 mg/d and 8.0 mg/d 
for adult males and females respectively (Table 2.6). The safe upper level of intake, 
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based on data relating to a reduction in Cu-Zn SOD activity, is 40 mg/d for both men 
and women (NHMRC 2006). A joint WHO/UNICEF/IAEA/IZiNCG meeting 
determined risk of zinc deficiency is elevated if >25% of a population consumes 
<EAR of zinc (de Benoist etal. 2007). 
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Table 2.6: Australian nutrient reference values for zinc (NHMRC 2006). 
Infants EAR RIM Upper level 
of intake 
0-6 months 2.0* 4.0 
7-12 months 2.5 3.0 5.0 
Children and Adolescents 
All 
1-3 yrs 2.5 3.0 7.0 
4-8 yrs 3.0 4.0 12.0 
Boys 
9-13 yrs 5.0 6.0 25.0 
14-18 yrs 11.0 13.0 35.0 
Girls 
9-13 yrs 5.0 6.0 25.0 
14-18 yrs 6.0 7.0 35.0 
Adults 
Men 
19-30 yrs 12.0 14.0 40.0 
31-50 yrs 12.0 14.0 40.0 
51-70 yrs 12.0 14.0 40.0 
>70yrs 12.0 14.0 40.0 
Women 
19-30 yrs 6.5 8.0 40.0 
31-50 yrs 6.5 8.0 40.0 
51-70 yrs 6.5 8.0 40.0 
>70yrs 6.5 8.0 40.0 
Pregnancy 
14-18 yrs 8.5 10.0 35.0 
19-30 yrs 9.0 11.0 40.0 
31-50 yrs 9.0 11.0 40.0 
Lactating 
14-18 yrs 9.0 11.0 35.0 
19-30 yrs 10.0 12.0 40.0 
31-50 yrs 10.0 12.0 40.0 
* AT (adequate intake); all intakes in mg/d 
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2.10.3 Disease associations 
Due to a very broad involvement of zinc in human metabolism, even mild zinc 
deficiency has been recognised as a significant public health concern throughout 
much of the world, especially in developing countries; with 20% of the worlds 
population estimated to be affected (Sanghvi et al. 2007). Arising from inadequate 
diets and poor bioavailability, it is associated with increased morbidity with stunted 
growth and development (MacDonald 2000; Beyersmann and Haase 2001), delayed 
wound healing (Lansdown et al. 2007) and altered immune function (lbs and Rink 
2003). 
More severe or overt zinc deficiency is uncommon. Classically seen in the rare 
genetic disorder of zinc absorption, acrodermatitis enteropathica (Maverakis et al. 
2007), but also caused by inadequate zinc in TPN formulations (Jeejeebhoy 2009) and 
by chelation therapy, it causes major dermal, gastrointestinal and neurological 
disorders (Brown et al. 2004). 
Zinc toxicity from a normal diet is very unlikely but can occur due to excessive 
consumption of zinc supplement preparations, from contaminated food and drink 
sources, and from industrial exposures (Cai et al. 2005). Symptoms of zinc toxicity 
include severe gastrointestinal effects such as nausea, vomiting, gastric pain and 
gastroenteritis (Brown et al. 2004) 
2.10.4 Biochemical markers of zinc status 
The apparent importance of zinc in human biology has seen many putative measures 
of zinc status employed in various studies; the tight homeostatic control over zinc 
levels in the body perhaps complicating the use of some markers for nutritional 
assessments. 
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A recent meta-analysis of 48 studies (randomised control studies and before and after 
studies) of 32 potential zinc biomarkers found data was insufficient to make clear 
conclusions of the viability of many markers for assessing zinc status (Lowe et al. 
2009). The most conclusive evidence related to the use of serum/plasma zinc. This 
was found to reflect zinc intakes across gender and age groups as well as those with 
low to moderate zinc status. These findings concur with those of the joint 
WHO/UNICEF/IAEA/IZiNCG meeting (de Benoist et al. 2007) which concluded that 
serum zinc is the biochemical marker of choice for zinc status at a population level 
and recommended serum zinc concentration age/gender/time of day specific cut-offs 
for determining populations at risk of low zinc status. Where >20% of a population 
subgroup has serum zinc below the cut-off, the population subgroup is considered to 
be at risk of zinc deficiency (Gibson et al. 2008). 
Table 2.7: WHO cut-off values for assessment of zinc deficiency using serum zinc 
concentrations (Gibson et al. 2008). 
Lower cut-offs for serum Zn (i.tmol/L) 
Children 	Females 	Males 
< 10 yrs 10 yrs ? 10 yrs 
Morning fasting n/a 10.7 11.3 
Morning non-fasting 9.9 10.1 10.7 
Afternoon 8.7 9.0 9.3 
Pregnancy 
1St Trimester 8.6 
2 nd 	rd ts 	Trimester 7.6 
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Measurement of zinc in biological samples such as serum has most commonly been 
performed using flame or electrothermal AAS methods, however more recently ICP-
MS methods have become more common. 
2.10.5 Australian data{ TC "Copper" \f C "1" } 
Assessment of zinc status by biochemical measures has not been conducted on a wide 
scale in Australia; the major published research has relied on zinc intake estimates as 
an indicator of zinc status of the population. 
Dietary intakes 
The 1995 National Nutrition Survey (NNS) (McLennan and Podger 1995) used a 24 
hour diet recall in conjunction with a FFQ to estimate the dietary intake of 13,858 
subjects (from 2 yrs of age), with all Australian states represented. Estimated intakes 
in Tasmanian men and women (>19 yrs) were both lower than the national average. 
Tasmanian men consumed 13.5 mg/d compared to 14.4 mg/d, while Tasmanian 
women consumed 9.1 mg/d compared to 9.7 mg/d; mean intakes for both genders 
nationally and in Tasmania exceeded the current EAR. 
A study by English and colleagues (1997) reported mean zinc intakes of adult non-
smokers (n = 4395). Using 24 hr diet recall, estimated mean intakes for men were 
15.1 mg/d and 10.5 mg/d for women, suggesting most of this cohort consumed 
sufficient zinc. 
The 20th  Australian Total Diet Survey (FSANZ 2003) reported mean zinc intakes for 
males aged 25-34 yrs of 14 mg/d; above the current Australian EAR of 12 mg/d; 
while women of the same age range consumed on average 8.4 mg/d; also above the 
EAR for women of 6.5 mg/d. 
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Blood zinc levels 
The study by Ball and Ackland (2000) appears to be the only published Australian 
study to measure blood zinc levels in healthy adults. The authors reported mean serum 
zinc from a small sample of 13.0 ± 2.1 timol/L in men (n = 21) and 13.9 ± 2.3 mon 
for women (n = 21). Zinc status was lower in the male subjects but both mean and 
median serum zinc were above the WHO cut-off for morning fasting samples, and the 
lower reference range (11 iimol/L). The sample was unfortunately small and sufficient 
detail was not provided to determine the proportion of subjects below the cut-off or of 
age group trends. 
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2.11 Conclusion{ TC "Conclusion" \fC \1 "1" } 
Micronutrient deficiency is acknowledged as a significant concern for a large 
proportion of the worlds' population (Sanghvi et al. 2007). Because of this 
involvement in many metabolic functions in humans, deficiencies in trace elements 
such as selenium, copper and zinc are potential contributors to morbidity and 
mortality in susceptible populations. 
Consequently, it is important to investigate populations where little data exists, 
particularly where there may be suspicion of increased risk of deficiency. Given the 
history of problems in with iodine deficiency in humans and with selenium, copper 
and cobalt deficiency in livestock, the human population in Tasmania, or at least 
subsections of it, may be at risk of deficiency or suboptimal status of trace elements 
such as selenium. As the Tasmanian population has high rates of cancer and 
cardiovascular disease (A.B.S. 2006a), this provides further impetus to identify 
factors which may contribute to these conditions. 
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Chapter 3 
General methodology 
From a methodological point of view, the aim was to utilise methods of analysis for 
both biological specimens and dietary data that were well established, to ensure the 
reliability of the data produced. Most analyses were performed by the candidate; as 
was the case for the trace element analyses, serum lipids, serum TAS, HFE 
genotyping and dietary estimates. The measurement of glutathione peroxidase and 
superoxide dismutase enzyme activity, and the genotyping of participants for the 
GPx-1 Pro/Leu polymorphism, was performed in collaboration with another study of 
antioxidant enzymes. The candidate also coordinated the recruitment of participants 
for both the pilot and population studies. 
For routine biochemical assays such as serum lipids and glucose, specialised 
antioxidant assays, as well as molecular techniques, the specific methods utilised are 
in common usage in many laboratories, and have been in use in the Human Life 
Sciences laboratory in their current form on existing analysers for several years. 
The methods employed for trace element analysis were carried out in a National 
Association of Testing Authorities (NATA) and Royal College of Pathologists of 
Australasia (RCPA) accredited hospital laboratory, have been in use for many years 
and perform well in external quality assurance programs. 
Where consideration was given to the use of an alternate method to that accepted as 
standard; as was case for the prospective use of colorimetric methods for serum 
copper and zinc determination; a full evaluation of the alternate method was 
performed in comparison to an accepted standard method. 
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Dietary analysis utilised a validated food frequency questionnaire sourced from the 
Cancer Council of Victoria Epidemiology Centre. As well as providing estimates on 
many standard nutrients, the raw food intake data from this analysis, in conjunction 
with standard food content tables, was used to estimate intakes for the trace elements 
of interest. 
The methodology adopted for the collection of all data, including subject recruitment, 
dietary estimates, standard biochemical and molecular techniques as well as statistical 
analysis are addressed in this chapter. The subsequent chapter (Chapter 4) details the 
method evaluation of the colorimetric serum copper and zinc assays which were 
considered as alternate methods to the more established atomic absorption 
spectroscopy which was eventually employed. 
3.1 Subject recruitment 
3.1.1 Pilot Study 
Recruited in a convenience sample, the subjects for the pilot study were 198 non-
institutionalised male and female adults residing in north and northwest Tasmanian 
townships. A significant number of these subjects were recruited from a database 
containing haemochromatotic and non-haemochromatotic individuals as part of the 
research project - 'The Influence of Diet, Health and Lifestyle Factors on Clinical 
Disease Development in the Tasmanian Population with Haemochromatosis Genes'. 
A substantial portion of the non-haemochromatotic subjects (n = 82) were recruited 
from outside this database, from other University of Tasmania studies. 
Ethics approval was provided by the Human Research Ethics Committee (Tasmania) 
Network (EC Ref: H0006375). 
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Blood samples were collected at the Pathology department of the Launceston General 
Hospital, Launceston, Tasmania, at NorthWest Pathology centres in Burnie and 
Devonport, Tasmania and at the School of Human Life Science, University of 
Tasmania. Blood samples from all participants consisted of a single 4 mL lithium 
heparin tube (BD Vacutainer) and two 7 mL trace element serum tubes (BD 
Vacutainer). Following collection, samples were kept at 4°C for a maximum of 24 
hours before processing. 
3.1.2 Population Study 
The subjects for the population study were 498 non-institutionalised male and female 
adults residing in north, northwest and northeast Tasmanian townships. Recruitment 
was via a random sample taken from an extract of the Australian electoral roll 
provided by the Australian Electoral Commission (AEC). Ethics approval was 
provided by the Human Research Ethics Committee (Tasmania) Network (EC Ref: 
H0009038). 
Blood samples were collected at the Pathology department of the Launceston General 
Hospital, Launceston, Tasmania; at NorthWest Pathology centres in Burnie, 
Devonport and Latrobe, Tasmania; at Scottsdale Doctors Surgery, Scottsdale; and at 
the Campbell Town Health and Community Services Centre, Campbell Town. Blood 
samples provided by subjects consisted of a single 6 mL lithium heparin Vacutainer 
tube, one 7 mL trace element serum tube, one 7 mL SST serum tube and one 4 mL 
EDTA tube (Becton Dickinson, Rutherford, USA). Following collection, samples 
were kept at 4°C for a maximum of 24 hours before processing. 
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3.2 Dietary analysis 
Normal dietary nutrient intake over a 12 month period was estimated with a self 
administered validated semi-quantitative food frequency questionnaire (FFQ) (Giles 
and Ireland 1996). The FFQ consisted of 121 types of food and beverages. For items 
such as milk, bread, sugar and alcohol, subjects indicated the amount normally 
consumed per day. Pictures were used to assist in the establishment of normal portion 
sizes for meals of potatoes, other vegetables and steak. For other foods and beverages, 
subjects were asked "Over the last 12 months, on average, how often did you eat the 
following foods?". Ten response options were provided, ranging from 'never' to '3 or 
more times per day'. Analysis for energy and nutrient intakes, excluding selenium, 
copper and zinc, was performed by the Cancer Council of Victoria. 
Data from NUTTAB 2006 food composition tables (FSANZ 2006) and responses 
from the FFQ were used to estimate daily selenium, copper and zinc intakes. All 
participants were asked specifically about Brazil nut consumption, due to their very 
high selenium content. Details of vitamin and mineral supplement use were also 
documented. Dietary selenium, copper and zinc estimates were calculated using 
Microsoft Excel 2003 software. 
3.3 Health and anthropometric data 
In addition to dietary information, health and lifestyle questionnaires were used to 
collect data on age, height, weight, smoking habits, basic medical histories covering 
major diseases, current medications and multivitamin usage. 
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3.4 Biochemical methods 
3.4.1 Sample processing 
Blood samples were processed within 24 hours of collection to produce serum and red 
cell lysates. Samples collected into trace element free serum tubes, SST serum tubes 
and lithium heparin tubes were centrifuged at 2500 rpm at 4 °C for 15 minutes in a 
refrigerated centrifuge. Five hundred microlitre aliquots of the resulting serum were 
stored at -80 °C until subsequent analysis for selenium, glutathione peroxidase (GPx), 
total antioxidant status (TAS) and lipid studies. Aliquots of 800 }IL were also stored 
for serum copper and zinc determinations. Lithium heparinised blood was used to 
produce a red cell lysate using a modification of the method of Abiaka and co-
workers (2000). After centrifugation, plasma and buffy coat were discarded and red 
cells washed twice in 1 volume of cold 0.9% NaC1 solution. Five hundred microlitres 
of washed red cells were lysed in 1 volume of cold reverse osmosis water to produce a 
50% lysate. The lysate was vortex mixed, centrifuged at 13000 rpm for 3 minutes to 
remove cell debris and stored in aliquots of 500 1.tL at -80 °C, until analysis for Red 
cell GPx, superoxide dismutase (SOD) and haemoglobin. 
3.4.2 Haemoglobin 
Haemoglobin concentration in assay samples for red cell GPx and SOD was 
determined using the Cobas Mira autoanalyser (Roche Diagnostics Ltd., Rotkreuz, 
Switzerland). One hundred microlitres of 50% lysate were diluted in 900 pl. of 
20mM, pH 7.4 tris(hydroxymethyl)aminomethane (Tris) buffer prior to analysis. 
Haemoglobin concentration was measured using a wavelength of 550 nm after 
incubation at 37 °C. Within-run and between-run precision for haemoglobin was 
0.89% (n = 20) and 3.5% (n = 35) respectively. 
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3.4.3 Glutathione peroxidase 
Analysis for GPx was performed at 37 °C using a Data Pro random access chemistry 
analyser (Thermo-Electron Corporation, Melbourne, Australia). Due to instability of 
the enzyme, GPx activity in red cells and serum was determined within 7 days of 
sampling. Serum and lysate for each subject were analysed within the same assay run. 
The method measured absorbance reduction at 340 nm over 3 minutes, due to 
oxidation of NADPH, using a coupled enzyme reaction with cumene hydroperoxide 
as a substrate (Ransel; Randox Laboratories Ltd., Crumlin, United Kingdom). One 
activity unit was defined as 1 jimol NADPH oxidised per minute per litre of serum or 
lysate. Ransel control (Randox Laboratories Ltd., Crumlin, United Kingdom) was 
used for internal quality control. 
Red cell glutathione peroxidase 
A 50 tit volume of red cell lysate was diluted with 1 mL of Ransel diluting agent and 
incubated at room temperature for 5 min to ensure the reduction of glutathione prior 
to reaction. This was followed by the addition of 1 mL of double strength Drabkins 
reagent, which inhibits other non-specific peroxidases. The Drabkins reagent was 
prepared by adding 250 iiL of 500g/L Brij 35 to 100 mg potassium ferricyanide, 25 
mg potassium cyanide and 70 mg potassium dihydrogen phosphate in 500 mL of 
reverse osmosis water (adjusted to pH 7.0). The final dilution of the whole blood 
sample was 1:82. Stored aliquots of pooled lysate analysed to determine between-run 
precision provided a CV of 4.3% (n = 21). Within run precision was 5.1% (n = 17). 
Activity was expressed as U/g Hb. 
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Serum glutathione peroxidase 
Three hundred microlitres of serum was diluted with 1 volume of Ransel diluting 
agent (Ransel reagent: Randox). If absorbance change per minute exceeded 0.1, the 
sample was again diluted 1:2 using Ransel diluting agent. Samples were measured in 
duplicate. Activity was expressed as U/L. Within run precision was 3.0% (n = 14). 
3.4.4 Red cell superoxide dismutase 
Analysis for red cell SOD was performed at 37°C using the Cobas Mira autoanalyser 
(Roche Diagnostics Ltd., Rotkreuz, Switzerland). The Ransod method (Randox 
Laboratories Ltd., Crumlin, United Kingdom) uses the xanthine-xanthine oxidase 
system to generate superoxide radicals that react with 2-(4-iodopheny1)-3-(4- 
nitrophenol)-5-phenyltetrazolium chloride (I.N.T.) to form a red formazan dye, which 
is measured at 500nm. SOD in the added sample inhibits the formation of the dye; 
therefore activity is measured as the degree of inhibition. Calibration was performed 
for each assay run using the supplied kit standards (S2-S6). Assay of 0.01 M 
potassium phosphate buffer (pH 7.0) provided a value for an uninhibited reaction and 
a log calibration curve was prepared. The unknown samples were diluted to bring % 
inhibition, the reduction in absorbance that the unknown produces when compared to 
the uninhibited reaction value of the phosphate buffer, to between 30% and 60%. 
Five microlitres of red cell lysate was diluted with 1.25 mL of 0.01 M potassium 
phosphate buffer (pH 7.0) to provide a total sample dilution of 1:500. Aliquots of 
pooled red cell lysate stored at -80°C were assayed for internal quality control. 
Control material was diluted 1:200 prior to analysis giving a total dilution of 1:400. 
Within-run and between-run precision was 1.9% (n = 19) and 5.7% (n = 35) 
respectively. Sample SOD activity was expressed as U/g Hb. 
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3.4.5 Total antioxidant status 
Analysis for TAS was performed at 37°C using the Data Pro clinical analyser 
(Thermo-Electron Corporation, Melbourne, Australia), using the TAS kit (NX2332; 
Randox Laboratories Ltd., Crumlin, United Kingdom). Incubation of 2,2'-Azino-di-
[ethylbenzthiazoline sulphonate] (ABTS) with metmyoglobin and H202 results in the 
formation of the radical cation ABTS + . The method measures, at 600 nm, the 
inhibition of ABTS + formation after 3 minutes. The level of inhibition is proportional 
to antioxidant concentration in the sample, expressed as mmol/L. 
Stored aliquots of approximately 500 pt serum required no pre-analytical preparation 
other than thawing and thorough mixing. Control serum (Randox Laboratories Ltd., 
Crumlin, United Kingdom) was used for internal quality control. Within-run and 
between-run precision was 2.8% (n = 20) and 2.8% (n = 17) respectively. 
3.4.6 Serum selenium 
Serum selenium concentration was determined by Zeeman-corrected graphite furnace 
atomic absorption spectrometry (GFAAS) in the Special Chemistry Laboratory at the 
Royal Hobart Hospital, Hobart, Tasmania using a Spectra 640Z spectrophotometer 
(Varian Inc., Palo Alto, USA) and a method based on that of Saeed and colleagues 
(1979). This method utilises a wavelength of 196 nm, a slit width of 1.0 nm and 
current of 10.0 mA. Calibration for the analysis used the standard addition method. 
The addition of volumes of 0, 25, 50 and 75 pl of 25.4 !mon selenium stock 
solution to 1 mL serum, made up to 1100 iL with deionised water, produced a four 
point curve of 0, 0.58, 1.15 and 1.73 pinol/L respectively. Analysis of Seronorm 
Trace Elements control serum (Sero, Billingstad, Norway) with a certified selenium 
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concentration of 0.92 pmol/L gave a mean of 0.88 ttmol/L (CV; 7.0%; n = 19). 
Within-run precision was 3.7% (n = 15). 
One hundred microlitre volumes of standard, control or sample were diluted with 
nickel chloride modifier in acid washed plastic tubes. Modifier was prepared by 
addition of 0.5g NiC12.6H20 and 500 tit Triton X-100 to 100 mL of distilled water, 
acidified with 100 pL Suprapur 65% nitric acid. All samples were analysed in 
duplicate to ensure reproducibility of results. Selenium concentration was expressed 
as pmol/L. 
3.4.7 Serum copper 
Serum copper concentration was determined by flame atomic absorption spectrometry 
(FAAS) in the Special Chemistry Laboratory at the Royal Hobart Hospital, Hobart, 
Tasmania using a Spectra 880 spectrophotometer (Varian Inc., Palo Alto, USA) at a 
wavelength of 324.8 rim, a slit width of 0.5 rim and current of 5.0 mA. Calibration for 
the analysis used the standard addition method. The addition of volumes of 0, 25, 50 
and 75 pi of 628 prnol/L copper stock solution to 1 mL serum, made up to 1100 pi 
with deionised water, produced a four point curve of 0, 14.3, 28.5 and 42.8 'Amon 
respectively. 
Three hundred microlitre volumes of standard, control or sample were diluted with 
600 'Ai of deionised water in acid washed plastic tubes. Analysis of Seronorm 
controls (Sero, Billingstad, Norway) with certified copper concentrations of 13.2 and 
27.4 pmol/L gave means of 11.4 (CV; 3.8%; n = 38) and 23.8 ttmol/L (CV; 3.2%; n = 
38) respectively. Within-run precision was 1.8% (n = 13). Copper concentration was 
expressed as prnol/L. 
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3.4.8 Serum zinc 
Serum zinc concentration was determined by flame atomic absorption spectrometry 
(FAAS) in the Special Chemistry Laboratory at the Royal Hobart Hospital, Hobart, 
Tasmania using a Spectra 880 spectrophotometer (Varian Inc., Palo Alto, USA) at a 
wavelength of 213.9 nm, a slit width of 1.0 nm and current of 5.0 mA. Calibration for 
the analysis used the standard addition method. The addition of volumes of 0, 25, 50 
and 75 tiL of 612 mon zinc stock solution to 1 mL serum, made up to 1100 1.11, 
with deionised water, produced a four point curve of 0, 13.9, 27.8 and 41.7 Knol/L 
respectively. 
Three hundred microlitre volumes of standard, control or sample were diluted with 
600 iaL of deionised water in acid washed plastic tubes. Analysis of Seronorm 
controls (Sero, Billingstad, Norway) with certified zinc concentrations of 14.0 and 
16.1 pmol/L gave means of 13.0 (CV; 4.8%; n = 38) and 17.8 'Amon (CV; 4.0%; n = 
38). Within-run precision was 3.5% (n = 13). Zinc concentration was expressed as 
[tmol/L. 
3.4.9 Serum ferritin 
Serum ferritin was determined using a two-site chemiluminescent immunometric 
assay (LKFE1) on the Immulite analyser (Siemens Healthcare Diagnostics; Deerfield, 
USA). 
In the automated protocol, serum sample (101AL) and alkaline phosphatase conjugated 
goat polyclonal anti-ferritin reagent were introduced into an Immulite test unit coated 
with monoclonal murine anti-ferritin antibodies. Following incubation at 37 °C and 
subsequent wash steps, the bound ferritin and conjugated alkaline phosphatase was 
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detected by its action on a chemiluminescent substrate. Ferritin concentration was 
reported in jig/L. 
3.4.10 Lipid profile 
The methods utilised for determining lipid profiles for subjects were all performed on 
serum samples using the Data Pro clinical analyser (Thermo-Electron Corporation, 
Melbourne, Australia). 
Serum Total Cholesterol 
Serum total cholesterol was measured at 37 °C using an enzymatic method (TR13303; 
Thermo-Electron Corporation, Melbourne, Australia) based on the conversion, by 
cholesterol oxidase, of cholesterol to cholest-4-en-3-one and hydrogen peroxide. The 
hydrogen peroxide produced combines with hydroxybenzoic acid and 4- 
aminoantipyrine to 	form 	the 	chromophore quinonemine measured 
spectrophotometrically at 505 nm. Total cholesterol was reported in mmol/L. 
Trace calibrator (TR43002; Thermo-Electro Corporation, Melbourne, Australia) was 
used for calibration, while internal quality control used two level Lyphochek controls 
(Bio-Rad, Hercules, USA) with between run precision (n = 17) of 2.9% and 2.8% for 
level 1 and level 2 respectively. Within-run precision was 1.8% (n = 11). 
Serum High Density Lipoprotein (HDL) Cholesterol 
Serum HDL cholesterol was measured at 37°C using an enzymatic method (TR39601; 
Thermo-Electron Corporation, Melbourne, Australia) based on the conversion, by 
cholesterol oxidase, of cholesterol to cholesterol-3-on and hydrogen peroxide. The 
hydrogen peroxide produced combines with N-(2-hydroxy-3-sulfopropy1)-3,5- 
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dimethoxyaniline (HDAOS) and 4-aminoantipyrine to form a quinone chromophore 
measured spectrophotometrically at 600 nm. Non-HDL lipoproteins are removed prior 
to the main reaction by selective reaction with cholesterol esterase and cholesterol 
oxidase. Serum HDL was reported in mmol/L. 
Calibration used Trace HDL calibrator (1913-003; Thermo-Electro Corporation, 
Melbourne, Australia); internal quality control used two level Trace Lipid Control 
(1919-030; Thermo-Electron Corporation, Melbourne, Australia) with between run 
precision (n = 17) of 2.4% and 3.2% for level 1 and level 2 respectively. Within-run 
precision was 2.3% (n = 11). 
Serum Low Density Lipoprotein (LDL) Cholesterol 
For subjects where fasting blood samples were used, serum LDL cholesterol was 
calculated using the equation developed by Friedewald and colleagues (1972). This 
equation estimates the LDL cholesterol concentration in mmol/L using serum total 
cholesterol, HDL cholesterol and triglyceride values for each subjects as follows: 
LDL = [Total Cholesterol]- ([HDL cholesterol] + 0.45 x [Triglycerides]). 
Where non-fasting samples were used, serum LDL cholesterol was measured directly 
at 37 °C using an enzymatic method (TR53202; Thermo-Electron Corporation, 
Melbourne, Australia) which, as with HDL cholesterol, is based on the conversion, by 
cholesterol oxidase, of cholesterol to cholesterol-3-on and hydrogen peroxide. The 
hydrogen peroxide produced combines with N-ethyl-N-(2-hydroxy-3-sulfopropy1)- 
3-methylaniline (TOOS) and 4-aminoantipyrine to form a quinone chromophore 
measured spectrophotometrically at 600 nm. Again, non-HDL lipoproteins are 
removed prior to the main reaction by selective reaction with cholesterol esterase and 
cholesterol oxidase. Serum LDL was reported in mmol/L. 
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Calibration used Trace HDL/LDL calibrator (1913-003; Thermo-Electro Corporation, 
Melbourne, Australia); internal quality control used two level Trace Lipid Control 
(1919-030; Thermo-Electron Corporation, Melbourne, Australia) with between run 
precision (n = 17) of 4.2% and 4.3% for level 1 and level 2 respectively. Within-run 
precision was 3.9% (n = 11). 
Serum triglycerides 
Serum triglycerides were measured at 37 °C using an enzymatic method (TR22215; 
Thermo-Electron Corporation, Melbourne, Australia) based on the conversion of 
triglycerides to glycerol and free fatty acids by lipase. The glycerol undergoes 
conversion, with catalysis by glycerol kinase and then glycerol phosphate oxidase, to 
form dihydroxyacetone and hydrogen peroxidase. The hydrogen peroxidase combines 
with 3,5-dichloro-2-hydroxybenzene sulphate (DHBS) and 4-aminoantipyrine to form 
a quinonemine which is measured spectrophotometrically at 505 nm. Serum 
triglycerides were reported in mmol/L. 
Trace calibrator (TR43002; Thermo-Electro Corporation, Melbourne, Australia) was 
used for calibration, while internal quality control used two level Lyphochek controls 
(Bio-Rad, Hercules, USA) with between run precision (n = 17) of 2.1% and 2.5% for 
level 1 and level 2 respectively. Within-run precision was 1.6% (n = 11). 
3.4.11 Plasma Glucose 
Plasma glucose was measured at 37 °C using the hexokinase enzymatic method 
(TR15003; Thermo-Electron Corporation, Melbourne, Australia). Hexokinase 
catalyses the phosphorylation of glucose by ATP to form ADP and glucose-6- 
phosphate. Glucose-6-phosphate is oxidised by glucose-6-phosphate dehydrogenase 
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with a concomitant reduction of NAD + to NADH; the change in absorbance due to 
NADH was measured at 340 nm and is proportional to glucose concentration. Plasma 
glucose was reported in mmol/L. 
Trace calibrator (TR43002; Thermo-Electro Corporation, Melbourne, Australia) was 
used for calibration, while internal quality control used two level Lyphochek controls 
(Bio-Rad, Hercules, USA) with between run precision (n = 20) of 4.4% and 4.3% for 
level 1 and level 2 respectively. Within-run precision was 1.9% (n = 11). 
3.5 Molecular methods 
3.5.1 DNA extraction 
Genomic DNA was extracted from whole blood using the Blood and Tissue Genomic 
DNA Extraction Miniprep method (Viogene; Sunnyvale, USA). 
DNA extraction was performed using two hundred microlitres of fresh or frozen (- 
80°C) lithium heparin or EDTA blood, which was added to an equal volume of 
extraction buffer and 20 tL of proteinase K (10mg/mL). After a thorough mixing by 
vortex, the sample was incubated at 60 °C for 20 minutes followed by 20 minutes at 
70 °C. During this time the sample was vortexed frequently to ensure complete 
mixing. Following the addition of three hundred and ten microlitres of 100% ethanol, 
and further vortexing, the entire sample was pipetted onto the Miniprep column and 
centrifuged at 8000 rpm for 2 minutes. Washing of the column was performed twice 
by addition of 500 pi, of wash buffer and centrifugation at 8000 rpm for 2 minutes. 
The column was dried by centrifugation at 13000 rpm for 2 minutes, after which time 
the DNA was eluted from the column with 200 [IL of 70 °C molecular grade water or 
Tris EDTA Buffer (pH 8.0). DNA samples were stored at -20 °C. 
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3.5.2 HFE genotype 
Participant genotyping for the hereditary haemochromatosis gene used a multiplex 
amplification refractory mutation system (ARMS) method to simultaneously detect 
the C282Y and H63D mutations in the HFE gene located on chromosome 6. 
The DNA template used was genomic DNA extracted using the Blood and Tissue 
Genomic DNA Extraction Miniprep method (Viogene; Sunnyvale, USA), and stored 
at -20 °C in molecular grade water. 
Sense primers for both C282Y and H63D were used together with specific antisense 
primers in a two-tube paired polymerase chain reaction (PCR): 
C282Y Oligonucleotide Primers 
Sense: 5'-TGGCAAGGGTAAACAGATCC-3' 
Antisense Normal: 5'-GCTGATCCAGGCCTGGGTGCTCCACCTGCC-3' 
Antisense Mutant: 5'-GCTGATCCAGGCCTGGGTGCTCCACCTGCT-3' 
H63D Oligonucleotide Primers 
Sense: 5'-ACATGGTTAAGGCCTGTTGC-3' 
H63D normal: 5'-AGTTCGGGGCTCCACACGGCGACTCTCAAG-3' 
H63D mutant: 5'-AGTTCGGGGCTCCACACGGCGACTCTCAAC-3' 
As an internal PCR control, primers for the human growth hormone (HGH) were also 
included: 
HGH Oligonucleotide Primers  
Sense: 5'-TGCCTTCCCAACCATTCCCTTA-3' 
Antisense: 5'-CCACTCACGGATTTCTGTTGTGTTTC-3' 
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Table 3.1: Primer allocation in two tube multiplex ARMS assay for HFE 
mutations. 
PCR Reaction Tube A 
C282Y sense primer 
C282Y Antisense 'normal' primer 
H63D sense primer 
H63D Antisense 'mutant' primer 
UGH sense primer 
HGH antisense primer 
PCR Reaction Tube B . 
C282Y sense primer 
C282Y Antisense 'mutant' primer 
H63D sense primer 
H63D Antisense 'normal' primer 
HGH sense primer 
HGH antisense primer 
Primers were added to Taq PCR master mix (Qiagen Pty Ltd., Melbourne, Australia) 
to give final concentrations for each pair of 1.05 gM for H63D, 0.52 pIVI for C282Y 
and 0.35 1.tM for HGH. Product fragment size for C282Y primers was 300 bp; for 
H63D fragments were 180 bp, while the HGH internal control produced a fragment of 
434 bp. 
The total reaction volume of 20 1AL consisted of 2 [IL of subject or positive control 
DNA template (or ddH20 as negative control) and 18 pl of the primer-master mix. 
PCR reactions were initiated at 94 °C for 10 minutes followed by 35 cycles of 20 
seconds at 94 °C (denaturation), 20 seconds at 58 °C (annealing) and 20 seconds at 
72°C (elongation), using the MJ PTC-200 Thermalcycler (GMI Inc., Ramsey, USA). 
Reaction products were separated by electrophoresis, producing six distinct genotype 
patterns (Figure 3.1). Electrophoresis used a 2% Ultra Pure agarose gel (Invitrogen 
Pty Ltd., Melbourne, Australia) at 100V for 50 minutes, stained with ethidium 
bromide and visualised using a UV lamp. 
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Figure 3.1: Electrophoresis band patterns of HFE ARMS product. 
3.5.3 GPx-1 genotype 
Genotyping for the single nucleotide polymorphism at codon 198 of the GPx-1 gene 
located on chromosome 3 results in the Pro/Pro, Pro/Leu and Leu/Leu variants of the 
enzyme. The DNA template used was genomic DNA extracted using the Blood and 
Tissue Genomic DNA Extraction Miniprep method (Viogene; Sunnyvale, USA), and 
stored at -20 °C in Tris EDTA Buffer at pH 8.0. The primers and protocol used were 
developed by Amanda Crawford at the School of Human Life Sciences (University of 
Tasmania, Launceston, Australia). 
GPx-1 Pro198Leu Oligonucleotide Primers  
Sense: 5'-CGC CAA GAA CGA AGA GAT TC-3' 
Antisense: 5'-CAG GTG TTC CTC CCT CGT AG-3' 
Primers were added to Taq PCR master mix (Qiagen Pty Ltd., Melbourne, Australia) 
to give final concentrations for each pair of 0.5 p,M. The total reaction volume of 10 
piL consisted of 1 1.11, of subject or positive control DNA template (or ddH20 as 
negative control) and 9 1tL of primers/master mix. The PCR reaction was initiated at 
94 °C for 15 minutes followed by 30 cycles of 45 seconds at 94 °C (denaturation), 45 
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seconds at 56 °C (annealing) and 30 seconds at 72 °C (elongation), using the MJ PTC-
200 'Thermalcycler (GMI Inc., Ramsey, USA). 
The PCR product was digested for 2 hours at 37 °C using 1 1.tL 50000 U/mL Apa-1 
restriction enzyme (New England Biolabs Inc., Ipswich, USA). Digest products were 
separated by electrophoresis, using a 3% Ultra Pure agarose gel (Invitrogen Pty Ltd., 
Melbourne, Australia) at 120V for 40 minutes, stained with ethidium bromide and 
visualised using a UV lamp. 
Electrophoresis of the restriction enzyme digestion product revealed up to four bands 
depending on subject genotype. The heterozygous Pro/Leu genotype resulted in four 
bands of 252, 208, 120 and 88 base pairs in size; homozygous Pro/Pro genotype gave 
three bands of 252, 120 and 88 base pairs in size, and homozygous Leu/Leu resulted 
in only 2 bands of 252 and 208 base pairs in size (Figure 3.2). 
252 bp =III IMI OM 
208 bp 	 41=0 
120 bp 	4=0 
88 bp 	II= 
Pro/Leu 	Prof Pro 	Leu/Leu 
Figure 3.2: Electrophoresis band patterns of restriction enzyme digestion product. 
3.6 Statistical Analysis 
Repeated measures ANOVA using general linear modelling (GLM) with robust 
standard error estimation was used to test for any differences in trace element or 
antioxidant status within different groups as defined by age, gender, genotype or 
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smoking habit (STATA version 9.2, StataCorp LP, USA). Post estimation Holm test 
analysis was then used to adjust p values for multiple comparisons (Aickin and 
Gensler 1996). The relationship between trace elements and antioxidant levels with 
dietary and other biochemical factors was also examined using GLM with robust 
standard error estimation. Z-scores of continuous independent variables [(subject 
variable — group mean)/standard deviation] were calculated for dietary and 
biochemical variables in order to show the relative effect of the actual variation of 
those variables within the subject population. The validity of regression assumptions 
was tested by post-hoc analysis to exclude significant heteroskedasticity and missing 
variable effects. 
In the population study, the response rate varied in different age and socio-economic 
status groups and as a result estimates were made that were both unweighted for these 
analyses, and also weighted for the age/gender numbers and their socio-economic 
status in the study sample compared with that of the northern Tasmanian region from 
the 2006 census. Adjustment for socio-economic status was achieved using the census 
collector district of residence SEIFA (socioeconomic indexes for areas) index as a 
proxy for the status of the individual subjects. 
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Chapter 4 
Evaluation of the Randox colorimetric serum copper 
and zinc assays against atomic absorption spectroscopy 
4.1 Introduction 
Serum concentrations of copper and zinc are currently the most frequently used 
biomarkers of the status of these essential trace elements and are useful in assessing 
both deficiency and toxicity. 
4.1.1 Copper deficiency and toxicity 
Severe copper deficiency is rare, but may be seen in low birth weight infants and in 
patients receiving total parenteral nutrition (TPN) with inadequate copper (Stern et al. 
2007); marginal copper deficiency however, is thought to be more common and is of 
increasing interest due to the association of low copper status with haematological 
abnormalities (Halfdanarson et al. 2008), altered immunity (Percival 1998), 
hypercholesterolemia and cardiovascular disease (Klevay 2000). As well as resulting 
from low dietary intakes, deficiency may also arise from reduced absorption (e.g. 
coeliac disease), the rare X-linked Menkes syndrome and from high zinc intakes 
(Stern et al. 2007). Although uncommon, copper toxicity generally occurs as a result 
of accidental ingestion of copper salts, the consumption of drinking water with high 
copper content, or industrial exposure. Wilsons disease, a hereditary condition of 
altered copper metabolism, is also a rare cause of excessive copper accumulation in 
major organs (Stern et al. 2007). 
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4.1.2 Zinc deficiency and toxicity 
Zinc, as a component of >300 proteins (Coleman 1992), has a wide range of roles in 
the body. Mild zinc deficiency is emerging as a significant public health concern 
throughout much of the world, especially in developing countries (Brown et al. 2001). 
Arising from inadequate diets and poor bioavailability, it is associated with increased 
morbidity with stunted growth and development (MacDonald 2000; Beyersmann and 
Haase 2001), delayed wound healing (Lansdown et al. 2007) and altered immune 
function (lbs and Rink 2003). Severe zinc deficiency, classically seen in the rare 
genetic disorder of zinc absorption, acrodermatitis enteropathica, but also resulting 
from inadequate zinc in TPN formulations and chelation therapy, causes major 
dermal, gastrointestinal and neurological disorders (Brown et al. 2004). Zinc toxicity 
may occur due to excessive consumption of zinc supplement preparations, from 
contaminated food and drink sources, and from industrial exposures. Symptoms of 
zinc toxicity include major gastrointestinal effects such as nausea, vomiting, gastric 
pain and gastroenteritis (Brown et al. 2004). 
The analysis of serum copper and zinc concentrations is most commonly performed 
using atomic absorption spectroscopy (AAS) techniques. However, established 
methods are not available locally. The use of colorimetric assays for serum copper 
and zinc were considered as alternatives which could be performed in the School of 
Human Life Sciences laboratory in Launceston. Colorimetric methods, such as those 
using the chromogen 4-(3,5-Dibromo-2-pyridylazo)-N-Ethyl-N-(3-sulphopropyl) 
aniline (3,5-Di-Br-PAESA) for copper, and the chromogen 2-(5-bromo-2-pyridylazo)- 
5-(N-propyl-N-sulfopropylamino)-phenol (5-Br-PAPS) for zinc and available in kit 
form from Randox (catalogue numbers CU2340 and ZN2341 respectively) are 
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potentially suitable for such an application. A search of the literature revealed a lack 
of comparative studies versus AAS for these reagent kits. Prior to embarking on 
clinical studies involving the analysis of >600 subject samples, it was necessary to 
thoroughly evaluate the proposed alternative methods in comparison to an accepted 
standard method such as atomic absorption spectroscopy, to determine their suitability 
for the purposes of the research. 
4.2 Methods 
Randox CU2340 and ZN2341 assay buffers, chromogens, standards and pre-treatment 
reagents were used (Randox Laboratories Ltd., Crumlin, United Kingdom). Forty 
eight blood samples were collected into Vacutainer Trace Element Free serum tubes 
(Becton Dickinson, Rutherford, USA); and after centrifugation at 2500 rpm for 15 
min, serum aliquots from these tubes were stored at 4°C. All laboratory glassware and 
consumables were acid washed in 1% Nitric acid; collection and storage methods 
were assessed to eliminate all possible sources of contamination prior to evaluation. 
Comparison data was subject to Bland and Altman analysis (Bland and Altman 1986), 
using Microsoft Excel 2003, with statistical significance set at P < 0.05. 
4.2.1 Atomic Absorption Spectrophotometry 
The flame atomic absorption (FAAS) methods were based on those of Meret and 
Henkin (1971) and performed well in anexternal Quality Assurance Program (QAP). 
Results, when compared with those from the QAP program (Quality Control 
Technologies, Charlestown, Australia), placed the copper FAAS method within 0.56 
standard normal deviates (SND) and zinc within 0.37 SND of the distribution means. 
Analysis was performed using a Spectra 880 atomic absorption spectrometer (Varian 
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Inc., Palo Alto, USA) maintained in a NATA accredited hospital laboratory. For 
copper, a wavelength of 324.8 nm, a slit width of 0.5 nm and lamp current of 5.0 mA 
was employed. Three hundred microlitres of sample were diluted in 600 IAL of 
deionised water prior to analysis. Calibration for the analysis used the standard 
addition method; 0 lit, 25 pt, 50 !IL and 75 111_, of a 628 mon copper nitrate 
working standard was added to 1 mL pooled human serum to produce concentrations 
of 0, 14.3, 28.5 and 42.8 pinion respectively. 
Zinc was also measured using the Varian Spectra 880; at a wavelength of 213.9 nm, 
using a slit width of 1.0 nm and lamp current of 5.0 mA. Again, sample volumes of 
300 1AL were diluted in 600 IA of deionised water prior to analysis. For calibration, a 
612 !Amon zinc nitrate standard was added in volumes of 0 ttL, 25 4, 50 lit and 75 
tit to 1 mL pooled human serum to produce concentrations of 0, 13.9, 27.8 and 41.7 
timol/L. 
4.2.2 Colorimetric Assay on the Data Pro 
Colorimetric analysis was performed using the Thermo Electron Data Pro analyser 
(Melbourne, Australia) with parameters based on those outlined in the Randox 
package inserts (Table 4.1). Copper was determined using a direct serum 
measurement at 37 °C against a reagent blank and single point calibration. Using this 
method, copper is released from caeruloplasmin by a reducing agent (ascorbic acid) 
which reacts to form a chelate with the chromogen 3,5-Di-Br-PAESA with a resulting 
rise in absorbance measured at 590nm. 
Prior to zinc analysis, samples and standards underwent protein precipitation; 500 ti,L 
of 370 mmol/L trichloroacetic acid was mixed with 500 t.EL of serum and centrifuged 
at 13000 rpm for 12 minutes. The supernatant was assayed at ambient temperature 
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against a reagent blank with single point calibration. Zinc in the sample forms a 
chelate with the chromogen 5-Br-PAPS and the resulting rise in absorbance is 
measured at 550nm. 
In an attempt to improve the calibration procedure of both assays, a simple multipoint 
aqueous calibration curve was utilised. Stock standard solutions of 35 mmol/L copper 
nitrate and 35 mmol/L zinc nitrate were used; dilution of 5 piL, 10 pi and 20 tL of 
each stock standard to 10 mL resulted in working standards of 17.5 gmol/L, 35 
!Anon and 70 !Amon respectively. 
4.2.3 Colorimetric Assay on the Cobas Mira 
The Cobas Mira (Roche Diagnostics Ltd., Rotkreuz, Switzerland) was also used to 
measure zinc in a smaller set of samples, using the same method, with parameters 
supplied by Randox (Table 4.1). These samples also underwent the serum 
deproteinisation step described earlier. 
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Table 4.1: Colorimetric assay parameters as stated in Randox package notes and as 
used on the Data Pro and Cobas Mira analysers. 
Package notes 
Volume 
1.1L 
Incubation 
secs 
Temp 
°C nm 
Samplet Reagent Chromogen 
Copper 60 1000 250 300 37 570-590 
Zinc 500 2500 - 300 20-25 550-570 
Data Pro 
Copper 12 200 50 300 37 590 
Zinc 40 200 - 300 20 550 
Cobas Mira 
Zinc 30 150 300 37 550 
+ Sample for copper analyses was serum; sample for zinc analyses was deproteinated serum 
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4.3 Results 
Pipette precision testing of the Data Pro analyser using assay sample volumes of 
potassium dichromate and combined reagent and chromogen volumes of deionised 
water gave CVs of 0.80% for the copper protocol and 0.50% for the zinc protocol (n =- 
12). 
Intra- and inter-assay precision data for both methods is presented in Table 4.2. Two 
level Lyphochek (Bio-Rad, Hercules, USA) and Seronorm (Sero, Billingstad, 
Norway) quality control materials were utilised during analysis of copper and zinc by 
colorimetric methods and FAAS, respectively. 
Least squares regression analysis for the comparison of the colorimetric copper 
method with FAAS (Figure 4.1A) yielded the following equation: 
y = 0.75x + 3.4 !Amon (r = 0.9227, n = 48, P <0.01). 
Colorimetric zinc using the Data Pro compared with the FAAS method (Figure 4.2A), 
produced the following regression line: 
y = 0.77x + 4.0 mon (r = 0.4376, n = 48, P <0.01). 
On the Cobas Mira, the comparison for the colorimetric zinc method demonstrated a 
poorer correlation with FAAS (Figure 4.3A), producing the regression line: 
y = 0.76x + 6.6 ['mon (r = 0.2541, n = 15, P = 0.06). 
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Table 4.2: Intra- and inter-assay precision data for FAAS and colorimetric analysis 
using QC material and pooled serum samples. 
	
Copper 	 Zinc 
.tmol/L 	 !mon 
Intra -assay* 
Target 
value 
Our Assay 
mean 
%CV 
Target 
value 
Our Assay 
mean 
%CV 
FAAS Pooled sera 14.5 (0.3) 1.8 13.6 (0.6) 4.4 
Colorimetric Pooled sera 9.8 (0.3) 3.5 18.3 (0.9) 4.7 
(Data Pro) 
Inter-assay 
QC Level 1 11.0 11.1 	(0.6) 5.4 12.8 12.5 	(0.7) 5.6 
FAAS 
QC Level 2 27.4 22.4 (1.0) 4.5 16.1 16.5 (0.9) 5.4 
QC Level 1 12.2 12.2 (0.7) 5.4 11.4 11.4 (0.7) 6.1 
Colorimetric 
(Data Pro) QC Level 2 7.4 7.4 (0.3) 4.1 7.5 6.7 (0.5) 7.6 
* Different batches of pooled sera were used for each methods inter-assay precision run. 
FAAS QC Level 1, 2 = Seronorm Lot # 0508348 and 0610542 
Colorimetric QC Level 1, 2 = Lyphochek Lot # 14121 and 14122 
Three samples determined by FAAS to be above the normal adult upper reference 
value for copper of 22 !Amon, were misclassified as normal by the colorimetric 
method (denoted by stars in Figure 4.1A). The colorimetric zinc method on the Cobas 
Mira misclassified two samples; of these two, FAAS determined one sample to be 
below and one sample to be within the reference range, but these were determined to 
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be within and above the reference range respectively, by the colorimetric method 
(denoted by stars in Figure 4.3A). 
Results from linear regression analysis of Bland and Altman plots (Figure 4.1B, 4.2B 
and 4.3B) for the copper method using the Data Pro and the zinc method on both the 
Data Pro and the Cobas Mira are presented in Table 4.3. These results indicate 
significant systematic and fixed bias between the colorimetric and FAAS methods for 
copper. The evaluation of the zinc colorimetric method however, showed that 
systematic and fixed biases did not reach statistical significance. The smaller 
comparison using the zinc method on the Cobas Mira indicated the error observed in 
the evaluation on the Data Pro was not unique to the one analyser. 
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Figure 4.1 A: Least squares linear regression analysis of copper measured 
colorimetrically on the Data Pro analyser compared to the flame atomic absorption 
method. The analysis yielded a regression line equation of: y = 0.75x + 3.4 [tmol/L (r 
= 0.9227, n = 48, P < 0.01). Dashed lines represent the upper and lower reference 
range limits of 22 innol/L and 11 tmol/L respectively. 
B: Bland and Altman analysis of copper comparison data: correlation r = 0.6669 (P < 
0.01), slope = -0.2499 (P <0.01), intercept = 3.219 (P <0.01). Statistically significant 
systematic and fixed bias was found, with a mean difference of -1.4 ± 3.4 timol/L. 
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Figure 4.2 A: Least squares linear regression analysis of zinc measured 
colorimetrically on the Data Pro analyser compared to the flame atomic absorption 
method. The regression line for the analysis was: y = 0.77x + 4.0 umol/L (r = 0.4376, 
n = 48, P <0.01). Dashed lines represent the upper and lower reference range limits of 
20 umol/L and 1011mol/L respectively. 
B: Bland and Altman analysis of zinc comparison data: correlation r = 0.1976 (P = 
0.18), slope = 0.1807 (P = 0.18), intercept = -1.922 (P = 0.33). 
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Figure 4.3 A: Least squares linear regression analysis of zinc measured 
colorimetrically on the Cobas Mira analyser compared to the flame atomic absorption 
method. The regression line for the analysis was: y = 0.76x + 6.6 umol/L (r = 0.2541, 
n = 15, P = 0.06). Dashed lines represent the upper and lower reference range limits of 
20 umol/L and 10 !mon respectively. 
B: Bland and Altman analysis of zinc comparison data: correlation r = 0.4379 (P = 0.10), 
slope = 0.5294 (P = 0.10), intercept = -4.074 (P = 0.37). 
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Table 4.3: Results from Bland and Altman analysis 
N 
Data Pro vs FAAS 
Correlation r P Slope P Intercept P 
Copper 	48 0.6999 <0.01 -0.2499 <0.01 3.219 <0.01 
Zinc 	48 0.1976 0.18 0.1807 0.18 -1.922 0.33 
Cobas Mira vs FAAS 
Zinc 	15 0.4379 0.10 0.5294 0.10 -4.074 0.37 
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4.4 Discussion 
4.4.1 Copper 
The Bland and Altman analysis of the copper data (Figure 4.1B) determined that a 
statistically significant negative systematic bias and a positive fixed bias affected the 
colorimetric copper method, as suggested by the initial linear regression of the 
comparison data (Figure 4.1A). The spread of data points across a reasonably wide 
range of copper concentrations enabled the analysis to reveal these biases between the 
colorimetric and FAAS methods leading to the conclusion that the colorimetric 
method was unsuitable for our purposes. 
4.4.2 Zinc 
A major issue with our zinc data was that it only covered about half the concentration 
range of the corresponding copper data; the zinc data ranged from approximately 10 - 
19 [tmol/L whereas the copper data ranged from about 9 - 37 Rmol/L. The smaller 
range for zinc meant that the systematic bias equivalent to 77% of the FAAS result 
and a fixed positive bias of 4.0 gmol/L, as suggested by the linear regression equation 
associated with the data plotted in Figure 4.2A, was lost when the Bland and Altman 
study was conducted. We confirmed that this kind of effect could be replicated in the 
corresponding copper data when only copper data points between 10 and 19 gmol/L 
were subjected to Bland and Altman analysis; the P value of the regression in that 
modified analysis then rose to insignificance at P = 0.15. We therefore made the 
decision that on the basis of the linear regression equation for the data in Figure 4.2A 
there was enough statistical evidence of systematic and fixed biases between the two 
zinc methods as to make the colorimetric method unsuitable for our purposes for 
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research measuring zinc levels in a population suspected of having lower than normal 
levels. 
4.4.3 Calibration procedures 
When multipoint calibration procedures were trialled for both methods rather than the 
supplied single aqueous standard, the comparison with the atomic absorption methods 
appeared to improve slightly but did not eliminate the sizeable differences evident 
between the methods.' This suggested that the supplied aqueous standards probably 
did not compensate for the matrix effect of serum in the colorimetric analysis. 
Serum calibrators, which have since been recommended by Randox, but are not listed 
in the standard package inserts, would most likely improve assay performance; in 
particular for the copper method which in our data exhibited statistically significant 
systematic bias when compared with FAAS, though it seems likely the zinc method 
would also improve similarly. The two methods evaluated however, also appear to 
suffer from substantial random error when performed on the Data Pro analyser; the 
magnitude of which did not seem entirely attributable to the pipetting imprecision of 
the Data Pro, but rather may have resulted from individual patient specific random 
interference. 
4.4.4 Decision on analytical method 
The overall performance of the two colorimetric methods was such that even with 
some improvements to the standardisation protocol they do not appear to allow 
reliable determination of copper or zinc in a complex matrix such as human serum 
using the Data Pro analyser. Given the intention of the present research was to 
determine the trace element status of a population and identify groups within that 
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population at risk of low copper or zinc status, the performance characteristics of the 
colorimetric assays were such that these methods were deemed to be inappropriate 
choices for this research. In order to ensure the reliability of the data collected, the use 
of colorimetric methods was abandoned and all further analyses of copper and zinc 
were performed using the flame atomic absorption method as described in this chapter 
and the general methodology chapter (Chapter 3). 
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Chapter 5 
Pilot study of trace element status in northern Tasmania 
5.1 Introduction 
The selenium content of foods consumed by human populations is dependent on the 
selenium content of soils in which the food is grown. Selenium, like other trace 
elements may be removed from soils by leaching and the effects of glaciation, or have 
reduced bioavailability due to acidification of soils as a result of common agricultural 
practices (Judson and Reuter 1999). Selenium deficiency in livestock in Tasmania 
(Mason 2007), particularly in sheep, where it causes white muscle disease and 
decreased fertility, indicates that soil content and bioavailability of selenium is most 
likely low in Tasmania. This has led to the hypothesis that human populations in this 
state may be at risk of marginal deficiency for this essential trace element. 
With mounting evidence of the importance of selenium for maintaining good health 
via its involvement in antioxidant protection, thyroid metabolism, immune function, 
cell signalling, reproduction (Rayman 2000; Gromer et al. 2005; Moghadaszadeh and 
Beggs 2006), and a potential role in preventing chronic disease such as cancer 
(Whanger 2004), combined with the high incidence of chronic disease in an aging 
Tasmanian population (A.B.S. 2006a), research to determine the potential 
susceptibility is warranted. 
A pilot study was designed which drew subjects from an established database of 
individuals from across northern Tasmania, who had taken part in other studies 
previously carried out in conjunction with the University of Tasmania, and hence 
were easily accessible to the researchers for the recruitment into the current study. It 
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was considered that the collection of a convenience sample was appropriate to allow 
timely and efficient recruitment of subjects and provide reliable indications of the 
viability and requirements of a larger study. The nature of the database from which 
many subjects were recruited also opened up further opportunity to investigate a 
secondary but related issue. 
The University of Tasmania study, 'The Influence of Diet, Health and Lifestyle 
Factors on Clinical Disease Development in the Tasmanian Population with 
Haemochromatosis Genes'; designed to assess the factors involved in development of 
disease in those with hereditary haemochromatosis, a disease common in Tasmania, 
created a database of recently diagnosed individuals. Included in this database with 
symptomatic (iron overloaded) subjects with abnormal HFE genotypes (C282Y and 
H63D), were asymptomatic subjects with abnormal HFE genotypes and other control 
members in which abnormal HFE genotypes and iron overload symptoms were 
absent. It was the control and asymptomatic component of the database which formed 
the sample for the pilot study of selenium (and other trace element) status to 
determine the area of interest for a larger population study. The inclusion of subjects 
with abnormal HFE genotypes (both symptomatic and asymptomatic) would allow 
the study, secondarily, to test the hypothesis that the HFE genotype and the increased 
intestinal iron absorption associated with such genotypes, could cause alterations in 
the status of other trace elements such as selenium, copper or zinc. 
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5.2 Study aims 
The primary aim for this preliminary study was; 
to investigate the selenium status of a healthy convenience sample, 
including the measurement of dietary selenium intakes and biomarkers of 
selenium status such as serum selenium and selenoprotein activity. 
• Secondary aims were; 
to conduct an opportunistic study to assess status of two other important 
trace elements, copper and zinc, in this convenience sample, including the 
measurement of dietary intakes and biomarkers such as serum copper and 
zinc, 
to investigate the potential effect of hereditary haemochromatosis and the 
related increase in iron absorption on the status of selenium, copper and 
zinc. 
Research conducted to achieve the primary aim, and two secondary aims as outlined 
here will be presented consecutively in this chapter as three separate studies: 
Study A: Selenium status in a convenience sample from Northern Tasmania 
Study B: Copper and zinc status in a convenience sample from Northern Tasmania 
Study C: Effect of increased iron absorption in hereditary haemoclusomatosis on trace 
element status 
120 
5.3 Methods 
All methods for data collection and handling, including all dietary and biochemical 
analyses, and statistical analysis performed for the pilot study of selenium, copper and 
zinc status referred to in this chapter, were described in Chapter 2: General 
methodology. 
5.3.1 Subject recruitment 
Participants in studies A, B and C (n = 198) were permanent residents of urban and 
rural areas in the north and north western region of Tasmania, Australia. 
Recruitment was initially from the database of the study, 'The Influence of Diet, 
Health and Lifestyle Factors on Clinical Disease Development in the Tasmanian 
Population with Haemochromatosis Genes'. A total of 161 potential participants from 
the haemochromatosis database were contacted via mail, of which 117 provided 
positive responses. The information letter provided an introduction to the study and 
instructions for interested persons to complete a brief diet-based questionnaire, to be 
returned by mail, and present to pathology to provide a blood sample within 4 weeks. 
Those choosing not to participate generally provided significant reasons such as ill 
health or having moved from the area. The convenience sample was added to, by 
recruiting from other studies at the School of Human Life Sciences, University of 
Tasmania (Launceston, Tasmania). Subjects provided fasting blood samples, prior to 
any treatment phases in other studies, at various public and private pathology 
laboratories, or at the School of Human Life Sciences. 
Recruitment and analysis for all three studies occurred concurrently. Subjects were 
considered abnormal and excluded from study A and B if they had abnormal iron 
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status (serum ferritin >300 pg/L and 200 [tg/L in men and women respectively). For 
study C, all subjects were included and classified by ferritin levels and HFE genoty 
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5.4 Study A: Selenium status of a convenience sample in Northern Tasmania 
5.4.1 Background 
Despite problems with selenium deficiency in livestock and a history of human 
deficiency of another important trace element, iodine, data relating to selenium status 
(and other trace elements) in Tasmania is sparse; no study of selenium status in the 
north of the state has occurred to date. The two previous Tasmanian studies on 
selenium status have had limited scope, used different methodologies and provided 
conflicting results; the study of McGlashan and co-workers (1996) reported a 
relatively low mean selenium level of 1.02 ± 0.23 !Amon in 171 female subjects 
while the most recent study found comparatively high selenium status (mean plasma: 
1.39 ± 0.24 jimol/L) in the south of the state (Jacobson et al. 2007). Both were 
undertaken in the south of the state centred on Hobart. Neither study included detailed 
dietary data or measures of functional biomarkers, such as GPx, the latter 
acknowledged for its value in assessing potentially marginal populations. 
There is no data from the north of the state. A study using a convenience sample from 
the northern and north west regions of Tasmania with a population over 120,000 or 
approximately 25% of the Tasmanian population was thus conducted, using detailed 
dietary and biomarker assessment. 
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5.4.2 Results 
Anthropometric data 
Study subjects had a mean ± sd age of 54.2 ± 13.3 yrs and tended to be slightly over 
weight with a mean BMI of 26.4 ± 4.3 (Table 5.1). Of the 160 subjects, 19 (12%) 
were current smokers. Men were significantly taller and heavier than women (both P 
<0.001), but there was no significant difference in age or body mass index. 
Dietary Intake 
The FFQ analysis indicated men consumed significantly more energy than women (P 
<0.001). Men also consumed significantly greater amounts of selenium (P = 0.004). 
The mean estimated dietary intake of selenium for both men (75.5 ± 25.3 pg/d) and 
women (63.5 ± 24.7 tg/d) was above the Australian EAR and RDI for selenium (60 
and 70 pg/day respectively for men; 50 and 60 [ig/day respectively for women). By 
these estimates over one quarter (28% of both men and women) consumed less than 
the EAR value, and around a half (48% and 53% for men and women respectively) 
consumed less than the RDI. 
Adjusted for bodyweight, selenium intakes were similar for both men and women at 
approximately 1 [tg/kg bodyweight. However, when intakes were adjusted for energy 
intake, women demonstrated a greater nutrient density, consuming significantly more 
selenium per MJ of energy (P < 0.001). 
Men in the youngest age range (25-34 yrs) had the lowest mean selenium intake of 59 
mg/d; significantly lower than men in the 35-44, 45-54 and 55-64 yrs age ranges (P < 
0.001, P = 0.02 and P = 0.03). 
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Biochemical measures 
The mean serum selenium concentration was 1.09 !mon, below the level associated 
with maximal GPx expression (-1.27 'Amon), indicating that a substantial proportion 
of the study subjects had serum selenium levels below the value required for maximal 
selenoprotein expression. This was supported by the positive association between 
serum GPx activity and serum selenium concentrations (P = 0.022); the association 
between RBC GPx and serum selenium was also positive but was not statistically 
significant (P = 0.332). Eighty five percent of subjects had serum selenium levels 
below the threshold associated with maximal GPx activity. Only 2 subjects had serum 
selenium above 1.50 pmol/L, a level suggested to represent the threshold for 
chemopreventative action of selenium. 
Selenium intake in absolute terms was not associated with serum selenium 
concentrations, but was positively associated with serum GPx activity (P = 0.048). 
When adjusted for body weight, selenium intake was not associated with serum 
selenium nor RBC GPx activity but was positively associated with serum GPx activity 
(P = 0.009). Adjusted for energy intake, dietary selenium was positively associated 
with serum selenium in women, and with serum GPx and RBC GPx activity in all 
subjects (P = 0.019, P = 0.046 and P = 0.008 respectively). 
Serum selenium was similar for men of all age range; however women in the 75-84 
yrs age range had significantly higher serum selenium (mean: 1.31 pmol/L) compared 
to women of all other age ranges, however there were only three women in this age 
range. 
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Other associations 
Mean serum selenium, serum GPx activity and RBC GPx activity were higher in non-
smoking subjects; however the differences were not statistically significant. 
Serum selenium and RBC GPx activity were not significantly associated with serum 
TAS, serum lipids, or plasma glucose levels. Serum GPx was however positively 
associated with serum HDL-cholesterol (P<0.001) and negatively associated with 
serum triglycerides (P = 0.041). 
Table 5.1: Anthropometric, dietary and biochemical characteristics of subjects. 
All Subjects Male Female 
n = 160 n =64 n = 96 
Smokers, n 19 8 11 
Age, years 54.2 ± 13.4 (25 - 79) 54.8 ± 13.2 53.9+ 13.4 0.671 
BMI, kg/m 2 26.4 ± 4.3 (18.8 -45.7) 26.6 ± 3.5 26.4 ± 4.8 0.650 
Weight, kg 75.2 + 14.1 (49 - 133) 83.6 ± 12.8 69.9 ± 12.2 <0.001 
Height, cm 1.69 	0.09 (1.48 - 1.93) 1.77 	0.07 1.63 ± 0.08 <0.001 
Energy, mJ 7.94 ± 3.21 (2.88 - 24.90) 9.85 ± 3.71 6.66 ± 2.02 <0.001 
Protein, g/d 89.5 	38.0 (31.9 - 305.6) 107.7 ± 4.7 75.2 ± 2.4 <0.001 
Carbohydrate, g/d 208.0 ± 87.0 (39.0 - 649.0) 243.3 + 10.9 180.6 ± 5.8 <0.001 
Fibre, g/d 23.0 ± 9.3 (5.7 - 52.6) 25.8+ 1.1 20.8 ± 0.8 <0.001 
Se intake, pg/d 68.2 ± 25.6 (24.2 -212.2) 75.5 ± 25.3 63.4 ± 24.8 0.003 
Se intake, pg/kg/d 0.94 ± 0.43 (0.33 - 3.86) 0.92 ± 0.36 0.95 ± 0.47 0.676 
Se intake, pg/MJ/d 9.20 ± 3.22 (4.7 - 23.3) 8.12± 2.11 9.89 	3.60 <0.001 
Serum Se, won, 1.09 ± 0.18 (0.67 - 1.96) 1.10 ± 0.17 1.08 ± 0.18 0.461 
Serum GPx, U/L 849.6 ± 147.4 (398 - 1378) 857.4± 134.6 844.4± 155.8 0.573 
RBC GPx, U/g Hb 46.7 ± 18.5 (11.2 - 98.9) 45.7± 17.2 47.4 ± 19.4 0.567 
TAS, mmol/L 1.25 	0.14 (0.51 - 1.61) 1.31 	0.11 1.22 ± 0.14 <0.001 
Values are mean ± sd, (range) 
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Figure 5.1: Selenium intakes across subject age ranges. * Intakes for men 25-34 yrs 
significantly lower than men 35-44 yrs (P <0.001), 45-54 yrs (P = 0.02) and 55-64 
yrs (P = 0.03). Values are mean ± sd. 
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Figure 5.2: Serum selenium across subject age ranges. Dotted line indicates selenium 
level associated with GPx saturation; dashed line indicates selenium level associated 
with potential chemopreventative effect. *P < 0.001 Women 74-84 yrs significantly 
different compared to all other women. Values are mean ± sd. 
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5.4.3 Discussion 
Dietary analysis for selenium indicated that the mean intake in this sample was above 
the Australian EAR and RDI values for this nutrient. The median intake was however 
below the RDI for both genders, and a large proportion of the study subjects actually 
failed to consume the EAR amount for selenium. Using the EAR cut-point method 
(Food and Nutrition Board 2000c) the prevalence of inadequacy of selenium in this 
population is estimated to be 28%. In Australia, FSANZ uses the US Food and 
Nutrition Board/Institute of Medicine definition of nutritional inadequacy as when 
>3% of a population has nutrient intakes below the EAR. By this definition, the 
sample from the current study has an inadequate intake of selenium. 
In comparison to previous Australian intake estimates, mean intakes for men in the 
current study are lower than those reported by Fardy and co-workers (1989) and 
Reilly (1992) (96 gg/d and 89 [tg/d respectively), but quite similar for women (63 
gg/d and 59 jig/d). When compared to intake estimates from the 20th  Australian Total 
Diet Survey (FSANZ 2003), men from the current study again consume considerably 
less; 0.92 gg/kg/d compared to 1.2-1.7 jig/kg/d. Women consumed slightly less than 
the bottom end of the range from the 20 t1 ATDS, at 0.95 gg/kg/d compared to 0.96- 
1.18 gg/kg/d. 
Differences in selenium intakes across age ranges is perhaps not unexpected, as it may 
be considered that consumption of selenium rich foods such as red meat may decrease 
with age, however the only significant difference observed was a lower intake in the 
youngest age range of men. This effect has been reported in other studies (Murphy et 
al. 2002), although with different dietary analysis methodology, and may be related to 
different consumption patterns in particular food groups; however data from the 
current study is not sufficient to make a firm conclusion. 
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Potentially a major issue in estimating dietary intakes of selenium is the dependency 
of food content upon the selenium content in soils where the food is grown. As a 
result there is an inherent inaccuracy in estimated intakes if food content data is not 
derived from the same source as much of the populations food supply. The NUTTAB 
2006 database (FSANZ 2006) contains food content data from direct analyses of 
Australian foods, from estimations based on similar food types, and also from other 
food content databases from other countries, for foods where local data was not 
available, and hence may affect the accuracy of dietary estimations. The ability of the 
food frequency questionnaire to capture accurate estimations of dietary intake of 
specific nutrients, and the prevalence of under-reporting or over-reporting by study 
subjects are also factors that can influence such dietary analysis. In this case the FFQ 
has been validated (Hodge et al. 2000), but was not compared to a gold standard 
method as part of this study, for the estimation of selenium intake. Furthermore, the 
level of under or over reporting by subjects could not be estimated from the 
information we collected nor from biomarkers of intake now being used, such as 
doubly-labelled water or 24 hr urine nitrogen (Bingham 2002; Subar et al. 2003; 
Neuhouser et al. 2008). The use of biomarkers such as blood selenium and a 
functional marker such as GPx is therefore necessary to confidently assess selenium 
status in such a population, and was undertaken in this study. 
Mean serum selenium in this study was substantially lower than the most recent 
Tasmanian data of 1.39 ttmol/L (Jacobson et al. 2007) and that from South Australia 
(1.30 umol/L) (Lyons et al. 2004), but similar to other published data from Tasmanian 
populations (1.02 umol/L and 0.98 umol/L) (McGlashan et al. 1996; Daniels et al. 
2000) as well as older South Australian (1.11 umol/L) and NSW data (1.16 mon) 
(Dhindsa et al. 1998; Daniels et al. 2000). Globally, selenium levels were similar to 
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those in recent French (1.09 gmol/L for women; 1.14 mon for men) and British 
studies (1.13 pmol/L) (Arnaud et al. 2006; Sunde et al. 2008), where there has been 
recent concern regarding falling selenium intakes. Selenium levels were similar to 
those reported for the North Island of New Zealand (1.08 prnol/L) but higher than 
those from the South Island (0.84 — 0.98 timol/L) where low selenium intakes are well 
documented (Thomson 2004b). A trend seen in other studies of a decrease in serum 
selenium levels in the elderly (Brooks et al. 2001; Bates et al. 2002) is observed in 
male subjects in the current study, but not in females; however this may be a result of 
the low female subject numbers in this age range. 
The serum selenium data, in conjunction with the finding of a positive association 
with serum GPx indicates that, as suggested by the dietary data, the population may a 
have an inadequacy for selenium. This inadequacy is not overt; it is not of a level that 
would be expected to result in the classical deficiency disease Keshan disease, but 
rather a moderate inadequacy that may be associated with impaired selenoprotein 
activity, potentially affecting their many important roles in immune function, thyroid 
metabolism, reproduction and antioxidant protection (Rayman 2002). 
Also of interest is the failure of most subjects to reach a serum selenium of 1.50 
gmol/L, a level postulated to be the threshold where chemopreventative effects 
against some cancers may occur (Combs 2001). This is potentially a significant 
finding in light of the high rates of chronic disease observed in the aging population of 
Tasmania. As observed elsewhere (Suadicani et al. 1992; Gamez et al. 1997; Bleys et 
al. 2008), selenium status was also associated with cardiovascular risk factors such as 
HDL-cholesterol and triglycerides, which perhaps further reflects the relationship 
between selenium status and other health factors. It must be noted, however, that 
numerous previous studies have failed to find associations between low selenium and 
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cardiovascular disease (Alissa et al. 2003; Navas-Acien et al. 2008), but recent work 
has observed some associations between higher selenium status and increased risk of 
diabetes and hyperlipidaemia (Bleys et al. 2007; Stranges et al. 2007; Lippman et al. 
2009; Stranges et al. 2009), although mostly at higher selenium concentrations than 
generally observed in Australian populations. 
The preliminary findings from this pilot study indicate that a more representative 
population study is warranted to assess the extent of marginal selenium status in the 
Tasmanian population. 
132 
5.5 Study B: Copper and zinc status in a convenience sample from Northern 
Tasmania 
5.5.1 Background 
The trace elements copper and zinc are essential for numerous vital metabolic 
processes in humans through the influence of many hundreds of metalloproteins 
which contain these metals. The effects of mild copper, and in particular zinc 
deficiency, have received greater interest as associations with growth, immune 
function, wound healing, fertility and cardiovascular and bone health have become 
more established (Shankar and Prasad 1998; Hambidge 2000; Lansdown et al. 2007; 
Prasad 2008; Merrells et a/. 2009). Marginal zinc deficiency has emerged as a serious 
public health concern and is suggested to affect approximately 20% of the worlds' 
population (Sanghvi et al. 2007). 
There is a paucity of published data from Australian populations regarding copper and 
zinc status. 
Due to a relative lack of comprehensive data world-wide regarding requirements for 
copper, the NHMRC has not established an RDI value for this element, opting instead 
to provide an Al value. To date, the only large study of copper status in Australia 
reported dietary copper intakes in women only, residing in the Barwon area of 
Victoria (Cleverdon and Ball 2004). At this point there is no published data on copper 
intake or status in Tasmanian populations. 
Zinc status in Australia has received more interest, with dietary estimates reported 
from comparisons between smokers and non-smokers, and in vegetarian and non-
vegetarians (English et al. 1997; Ball and Ackland 2000). The 20 th Australian Total 
Diet Survey (FSANZ 2003) also reported estimated zinc intakes in Australia. 
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However the only study to provide Tasmanian data was the 1995 National Nutrition 
Survey (NNS) (McLennan and Podger 1995) which estimated the dietary intake of 
13,858 subjects in total, and reported estimated intakes in Tasmanian men and women 
that were both lower than the national average. 
The small study of vegetarians versus non-vegetarians (total n = 42) by Ball and 
Ackland (2000) appears to be the only published Australian study to measure blood 
zinc levels in healthy adults. 
This pilot study will therefore investigate the status of two important trace elements 
for which there is currently very little data not only in Tasmania but elsewhere in 
Australia. 
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5.5.2 Results 
Anthropometric data 
The sample of 62 men and 93 women had a mean age of 54.1 ± 13.5 yrs and BMI of 
26.4 ± 4.3 kg/m 3 . A total of 19 (12%) of subjects were current smokers. Men were 
significantly taller and heavier than women (P <0.001). 
Copper 
Men had significantly higher energy intakes compared to women (P < 0.001), and 
also consumed greater amounts of copper (mean 1.50 v. 1.26 mg/d; 95%CI of 
difference 0.09-0.40; P = 0.002). Adjusted for bodyweight, copper intake remained 
higher in men (P = 0.002) but when intakes were adjusted for energy, women were 
observed to have a greater nutrient density (0.19 v. 0.16 mg/MJ/d; 95%CI of 
difference 0.02-0.05; P <0.001). Intakes for each gender within 6 age ranges were not 
significantly different; however, the lowest mean intake for both genders was 
observed in the youngest age range (25-34 yrs), whilst the highest mean intakes were 
in the 35-44 yrs and 74-85 yrs age ranges for men and women respectively. 
Mean intakes for men were below the Australian Al (1.7 mg/d) whilst for women 
were just above the Al (1.2 mg/d); thus nearly three quarters of men (72%) and one in 
two women (51%) consumed less than the AT value for copper. 
Despite lower intakes in absolute terms and by kg/bodyweight, serum copper was 
considerably higher in women (mean 19.0 v. 15.5 umol/L; 95%CI of difference 2.5- 
4.6; P < 0.001). Serum copper in the oldest age range in women (74-85 yrs) was 
significantly lower than all other age ranges of women (P < 0.05). The highest mean 
copper in women was in the 25-34 yrs age range. The effect of age on serum copper 
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was not statistically significant in men; the highest mean serum copper was in the 25- 
34 yrs age range; the lowest mean serum copper was in the 35-44 yrs age range. 
Table 5.2: Anthropometric, dietary and biochemical characteristics of study subjects. 
Current smoker, n 
All Subjects 
n = 155 
19 
Male 
n = 62 
8 
Female 
n = 93 
11 
P 
Age, years 54.1 ± 13.5 (25.0 - 79.0) 55.1 ± 13.3 54.2 ± 13.3 0.624 
BMI, kg/m 2 26.4 ± 4.3 (18.8 - 45.7) 26.7 ± 3.5 26.3 ± 4.8 0.560 
Height, m 1.68 ± 0.10 (1.48 - 1.93) 1.77 ± 0.07 1.63 ± 0.08 _ <0.001 
Weight, kg 75.3 ± 14.3 (49 - 133) 83.9 ± 12.9 69.8 ± 12.3 <0.001 
Energy, m.1 7.83 ± 2.91 (2.88 - 17.7) 9.60 ± 3.17 6.66 ± 2.02 <0.001 
Cu intake, mg/d 1.36 ± 0.48 (0.55 - 3.41) 1.50 ± 0.51 1.26 ± 0.44 0.002 
Cu intake, gg/kg/d 18.7 ± 6.7 (7.5 - 47.1) 20.7 ± 7.1 17.3 ± 6.7 0.002 
Cu intake, gg/MJ/d 0.18 ± 0.05 (0.09 -0.40) 0.16 ± 0.04 0.19 ± 0.0 <0.001 
Zn intake, mg/d 11.3 ± 3.7 (4.4 - 27.1) 12.8 ± 4.2 10.3 ± 2.8 <0.001 
Zn intake, pg/kg/d 155.5 ± 50.4 (60.5 - 373.4) 176.4± 58.2 141.8 ± 39.1 <0.001 
Zn intake, gg/MJ/d 1.51 + 0.38 (0.82 - 3.31) 1.38 ± 0.28 1.60 ± 0.42 <0.001 
Serum Cu, gmol/L 17.6 ± 3.9 (6.5 - 35.6) 15.5 ± 2.6 19.0 ± 4.1 <0.001 
Serum Zn, pmol/L 13.4 ± 2.7 (7.3 - 25.3) 13.3 ± 2.4 13.4 ± 2.9 0.831 
RBC SOD, U/g Hb 1246 ± 329 (268 - 1939) 1245 ± 309 1247 ± 342 0.960 
Serum TAS, mmon 1.25 ± 0.14 (0.51 - 1.61) 1.31 ± 0.11 1.22 ± 0.14 <0.001 
Values are mean ± sd, (range) 
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Zinc 
Zinc intakes followed the same pattern as for copper; absolute intakes were 
significantly higher in men (12.8 v. 10.3 mg/d; 95%CI of difference 1.3-3.7; P < 
0.001), as were intakes adjusted for subject bodyweight (176.4 v. 141.8 pg/kg/d; 
95%CI of difference 18.1-51.2; P < 0.001). Again, when intakes were adjusted for 
energy, women had significantly higher nutrient density compared to men (1.60 v. 
1.38 mg/MJ/d; 95%CI of difference 0.11-0.33; P <0.001). As well as higher energy 
intakes, men also consumed an average of 33 g more protein (44%) than women 
(95%CI of difference 21-45; P < 0.001). 
Mean zinc intakes were lowest in the 25-34 yrs age range for both genders; 
significantly lower than intakes in the 35-44 yrs age range for men (P < 0.001) and 
women (P = 0.036). One half of men (50%) consumed less than the EAR (12 mg/d) 
while only 8% of women failed meet the EAR (6.5 mg/d) for zinc. The prevalence of 
low zinc intakes in men was high (>40%) in all age ranges, excluding 35-44 yrs where 
only one of eleven subjects consumed less than EAR. The 35-44 yrs and 75-84 yrs 
age ranges in women had no subjects with low zinc intakes, while the other four age 
ranges had low proportions of subjects (4% -11%) with inadequate intakes. 
When combined, the total proportion of subjects consuming less than the EAR of zinc 
was 25%. The proportion below EAR was high (33%) in the youngest age range (25- 
34 yrs), but dropped to 5% in the next age range (35-44 yrs) and then increased with 
age (19%, 26%, 36% and 33% in the 45-54, 55-64, 65-74 and 75-84 yrs age ranges 
respectively). 
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Although men consumed considerably more zinc on average, there was no significant 
difference in serum zinc between genders; mean ± sd serum zinc was 13.3 ± 2.4 
[talon in men, and 13.4 ± 2.9 [mon in women. Age range differences in serum 
zinc were not significant in women; however men aged 45-54 yrs had significantly 
higher serum zinc than men aged 75-84 yrs (14.4 v. 12.1 [mon; 95%CI of difference 
0.3-3.7; P = 0.039). The greatest proportion of men with serum zinc below the WHO 
morning/fasting cut-off of 11.3 iimol/L was in the younger (33% and 17% in 25-34 
and 35-44 yrs age group respectively) and oldest age groups (33% in 74-84 yrs age 
group). In women, no subjects aged 25-34 yrs had serum zinc below the 10.7 [tmol/L 
cut-off, but the proportions increased steadily with each successive age group, 
peaking in the oldest age group (11%, 13%, 14% 22% and 33%). 
Other associations 
The significant effects of age and gender on indices of copper and zinc status meant 
that analyses between copper and zinc and measures of antioxidants and risk factors 
for cardiovascular disease (eg. serum cholesterol, serum HDL-cholesterol) were 
adjusted for age and gender. 
Dietary copper was not associated with antioxidant or cardiovascular markers 
including GPx, TAS, lipids and glucose. Serum copper however, was positively 
associated with both serum cholesterol (P = 0.017) and serum LDL-cholesterol (P 
Dietary zinc intake was negatively associated with serum HDL-cholesterol (P = 
0.028) and positively associated with serum LDL-cholesterol (P = 0.010), however 
serum zinc was not significantly associated with antioxidant or cardiovascular 
markers. 
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5.5.3 Discussion 
Copper 
The lack of EAR values for copper complicates the assessment of the adequacy of a 
population's intake. The US Food and Nutrition Board/Institute of Medicine (2000c) 
reports that the EAR cut point method is a reliable means of assessing likely nutrient 
inadequacy in a population; unfortunately this method is not suitable for use with an 
AT value as used in Australia. An Al is used when data is considered insufficient to set 
an EAR, and is an amount generally expected to meet or exceed the requirements of a 
healthy population. 
The Al for copper in Australia, determined by the National Health and Medical 
Research Council (NHMRC), was based on median population copper intakes 
reported in an Australian Bureau of Statistics (ABS) national nutrition survey 
(NHMRC 2006). Results from the current study suggest that the dietary intake of the 
female subjects compare reasonably with national intakes given the median copper 
intake (1.19 mg/d) was just below the Al of 1.20 mg/d. Although definitive statements 
cannot be made from assessments using the Al, in this instance, where the mean 
intake is slightly above the AI, it is suggested that the prevalence of inadequate 
intakes is likely to be low (Food and Nutrition Board 2000c). 
As approximately three quarters of male subjects consumed less than Al amounts of 
copper, male intakes in this sample appear to be lower than those in the national 
survey data used by the NHMRC in setting the Al. This, however, does not 
necessarily indicate increased risk of inadequacy as an Al value should be above the 
true EAR, and therefore any attempt to estimate the prevalence of inadequacy using 
the AT would be expected to overestimate the true prevalence. In fact, in comparison 
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to the U.S EAR value of 0.7 mg/d, no male subjects and just six females from this 
current study consumed inadequate amounts of copper. A similar comparison of 
Australian nutrition survey data made by FSANZ (2005) estimated that no gender or 
age groups consumed less than the US EAR. As it stands, and until the adoption of an 
EAR value in Australia, assessment of adequacy of copper intakes will be made with 
a degree of uncertainty due to the lack of clear and accepted intake requirements. 
Studies of copper intake in Australia are limited. One of the few published studies 
assessed a sample of women residing in Victoria (Cleverdon 2003). The women 
consumed on average 1.56 mg/d, an amount only approached by the oldest age group 
(75-84 yrs) of the current study (1.48 mg/d), but much higher than the lowest age 
group intake of 1.05 mg/d (25-34 yrs). As observed in the current study, Cleverdon 
also found intakes increased with age, with young women most at risk of low copper 
intakes, and suggested dietary patterns in the younger women, which included greater 
consumption of refined foods and "takeaway" dishes as a likely reason. 
Copper intakes have also been estimated as part of the multi-country Total Diet Study 
(Parr et al. 2006). In this study, direct analysis of duplicate diets from six Australian 
cities was used and a median intake of 1.82 mg/d was reported; again considerably 
higher than the intakes estimated in this current study. Unfortunately no demographic 
data from the surveyed sample was provided. 
The 20th  Australian Total Diet Survey (FSANZ 2003) reported mean dietary 
exposures to "pesticide residues, contaminants and other substances" which included 
copper. However only data for men and women 25-34 yrs was provided, with mean 
intakes per kg body weight estimated to be 16 prg/kg/d and 14 pg/kg/d for men and 
women respectively, which compares very well with estimated intakes for this age 
group of 16.1 ug/kg/d and 14.4 ug/kg/d respectively. 
142 
The comparison between the current intake estimates and those from previous studies 
is obviously complicated by the use of different methodology in each case. As well as 
some weaknesses in FFQs that have been discussed previously (Byers 2001; Kristal et 
al. 2005), the use of food content data that is, to a significant degree, not derived from 
the food sources for the target population is likely to affect the accuracy of the dietary 
intake estimates, and must be considered in all comparisons. The degree of under and 
over reporting by study subjects is another factor affecting such analyses but was not 
able to be estimated in this study. 
The higher serum copper in women of most ages compared to men (Figure 5.3) was 
not unexpected. Female hormones, including those in oral contraceptives, have been 
associated with higher serum copper (Johnson et al. 1992; Louro et al. 2001). The 
influence of hormones is possibly related to the decrease of serum copper in women 
with age, where despite an apparent increase in dietary intakes, it would coincide with 
likely lower circulating hormone levels which would be expected particularly in the 
post menopausal women in the older age ranges. Serum copper in men, in contrast to 
women, was relatively stable across all age ranges. Differences in serum copper 
between men and women of each age range decrease with increasing age; the only age 
range where women do not have higher mean serum copper is in the 75-84 yrs age 
range; possibly due to the lack of hormone influence in this age range. 
At this point there is not an accepted cut-off value for the estimation of copper 
inadequacy using any biochemical measure, including serum copper, despite 
suggestions that it remains the most reliable indicator of copper status, particularly in 
copper depleted individuals (Harvey et al. 2009). In the absence of such cut-offs, 
comparison with the clinical reference range of 11 — 22 mon is the only method 
that may be employed at this time. In this study, only 3 men and no women had serum 
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copper below the reference range lower limit of 11 umol/L. By this comparison, 
inadequacy of copper in this sample appears unlikely. 
Zinc 
The assessment of zinc status is a simpler task due to the adoption of EAR values for 
dietary intakes by the NHMRC (2006), and WHO lower cut-off values for serum zinc 
(Gibson et al. 2008). 
The WHO considers the risk of zinc deficiency to be elevated when the prevalence of 
sub-EAR intakes in a population is >25% (de Benoist et al. 2007). In this study one 
quarter of subjects consumed low zinc intakes, however a far greater proportion of 
men had intakes <EAR compared to women (50% v. 8%). Zinc intakes in men were 
reasonably constant across the age ranges and this was reflected in the proportions of 
each age consuming <EAR; prevalence of low intake dropped below 40% only in the 
35-44 yrs age range where overall energy intake was considerably higher than other 
men. This pattern was not evident in women; however, the 35-44 and 75-84 yrs age 
ranges which had no subjects with <EAR intakes, did have higher zinc density in their 
diets compared to other age ranges. 
The WHO considers the risk of zinc deficiency to be elevated when the prevalence of 
inadequate intakes in a population is >25% (de Benoist et al. 2007). Given the overall 
prevalence in this sample was 25%, and using the WHO guideline, the risk of 
deficiency is borderline. If the genders were considered as separate sub-populations, it 
is clear that men, but not women, would be considered to be at risk of deficiency. 
Zinc intake estimates for men in the current study were similar to the only other 
Tasmanian data published to date. The National Nutrition Survey (NNS) of 13,858 
subjects >19 yrs, reported estimated intakes of 13.5 mg/d for men; lower than the 
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national average of 14.4 mg/d (McLennan and Podger 1995). Men in the current study 
had lower intakes (by 15% and 8% respectively) than those reported in large studies 
by English et al (1997) and the 20th ATDS (FSANZ 2003). Women, in contrast, 
consumed similar intakes as estimated by English and colleagues' study (10.3 v. 10.5 
mg/d), but consumed 13% more zinc than Tasmanian women in the NNS and 23% 
more than estimated in the 20 th ATDS. The variations observed may reflect actual 
eating habit differences, but may also be a result of methodological differences or 
changing food nutrient content which has been suggested by several researchers with 
regard to other trace elements (Klevay and Medeiros 1996; Lyons et al. 2004). These 
possible influencing factors make further comparisons inappropriate. 
The lack of difference in serum zinc between genders despite significantly different 
zinc intakes is most likely due to differences in zinc loss between men and women 
(Brown et al. 2004), but may also be influenced by variations in zinc absorption 
caused by different dietary patterns in men and women. 
In comparison to the WHO cut-offs for serum zinc, overall 12% of subjects were 
below the respective serum zinc cut-offs. From this analysis, the sample as a whole 
would not be considered to be at increased risk of zinc deficiency. Analysis of gender 
and age sub-groups resulted in low sub-group subjects numbers but nevertheless 
indicated an interesting trend. Ten percent of all men and 14% of women were below 
the WHO cut-off for zinc. While the analysis of the male age ranges was certainly 
hindered by low subject numbers, the distribution of men below the cut-off was 
relatively even across the age ranges, however in women, where there were greater 
sub-group sizes, a greater proportion (18%) of women > 55 yrs fell below the 
respective cut-off level. This is despite a trend of increased zinc intakes with age in 
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women. This may be explained by the decrease in protein intake observed in these age 
ranges, a factor which is known to decrease zinc absorption (Brown et al. 2004). 
The discrepancy between the proportions of men consuming inadequate zinc and 
those with low serum zinc concentrations was reasonably large. As discussed earlier, 
there is certainly potential for inaccuracy, including the possibility of under-reporting, 
in the FFQ methodology as used for estimating zinc intakes in this study. However, 
assuming the methodology was sound, it may be that at least for the men in this 
population, the EAR is higher than required, resulting in a large proportion of men 
being considered to consume inadequate zinc, with much fewer actually having low 
serum zinc concentrations. This could explain why the discrepancy was only evident 
in men, while methodological problems would generally be expected to affect both 
genders. 
Associations with cardiovascular risk factors 
Copper has previously been associated with cardiovascular risk factors and the 
development of atherosclerosis and cardiovascular disease. Copper has been found to 
be inversely associated with cardiovascular risk factors such as BMI, total cholesterol 
and LDL-cholesterol, directly associated with HDL-cholesterol levels, and considered 
important for cardiovascular health (Ford 2000; Klevay 2000), however inverse 
associations with cardiovascular disease risk has been suggested by some studies 
(Ford 2000; Leone et al. 2006). 
In the current study the association between copper indices with cardiovascular risk 
factors reached statistical significance in only a few cases. The positive association of 
serum copper with both serum cholesterol and LDL-cholesterol is in contrast to 
findings of inverse relationships between copper status and such markers (Ghayour- 
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Mobarhan et al. 2005; Stern et al. 2007), as well as the association of hypocupremia 
with hypercholesterolemia and decreases in serum HDL-cholesterol observed in 
copper depleted subjects (Stern et al. 2007). They were in line, however, with findings 
of positive associations of similar copper levels with LDL-cholesterol and serum 
cholesterol (Salonen et al. 1991; McMaster et al. 1992; Abiaka et al. 2003). Such 
findings suggest that lipid metabolism might be disturbed by both low and moderately 
high copper status, which may be significant in a population such as that in Tasmania 
which experiences high rates of cardiovascular disease. 
To date there have been no consistent associations between zinc status and 
cardiovascular risk factors and cardiovascular disease incidence. There have been 
some reports of high zinc intakes resulting in decreased serum HDL-cholesterol 
(Hughes and Samman 2006), however at this point the significance of any relationship 
between zinc and serum lipids is uncertain. Although Cu-Zn SOD has been suggested 
as a potential biomarker for copper status, in this sample the lack of association 
between other copper indices and SOD suggests SOD activity may not be a useful 
indicator in this population. 
Despite the limitations of a convenience sample, the findings from this study, and 
particularly given the paucity of Australian data related to this topic, provide some 
useful indicators in determining groups which may potentially be at risk of inadequate 
zinc intakes. 
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5.6 Study C: Effect of increased iron absorption in hereditary haemochromatosis 
on trace element status 
5.6.1 Background 
Hereditary haemochromatosis 
Hereditary haemochromatosis (HH) is the most common inherited autosomal 
recessive disease, affecting perhaps 1 in 200 in Caucasian populations (Merryweather-
Clarke etal. 1997). The majority of people with HH have a mutation in the HFE gene 
that prevents correct folding of the protein product which is involved in the regulation 
of gastrointestinal iron absorption. A single base transition which results in a 
substitution of an amino acid gives rise to C282Y, the most important mutation. A 
similar substitution, H63D, is common, but of lesser clinical significance (Pietrangelo 
2003). In susceptible people, unregulated iron absorption continues even when iron 
stores are sufficient and leads to an excessive accumulation of iron and eventually 
parenchymal cell damage in many organs (Trinder et al. 2002). Typically, high 
requirements for growth in adolescence and loss through menstruation in women, 
means that despite abnormal iron absorption, excess iron storage does not become a 
significant problem until middle age (Franchini and Veneri 2005). 
Relationships between iron and other trace elements 
There are some limited findings of inverse relationships between tissue selenium and 
iron levels in animals (Chareonpong-Kawamoto and Yasumoto 1995; Bartfay and 
Bartfay 2002) and direct relationships between serum selenium and markers of 
cellular iron depletion (Barany et al. 2005). The possible mechanism of such an 
association is not clear but would likely be related to regulation of body stores rather 
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than absorption, as selenium is mostly absorbed as selenomethionine or 
selenocysteine with other amino acids, whereas iron is predominantly absorbed as the 
inorganic cation Fe2+ via a metal cation transporter. More data exists from studies 
regarding iron status and other trace elements; however findings to date are 
inconsistent. 
A high rate of iron supplementation is known to result in lowered zinc (Peres et al. 
2001) and copper absorption (Wapnir 1998); similar to the effect high zinc intakes 
have on copper absorption and is likely due to competition during absorption in the 
intestine. The Divalent Metal Transporter 1 (DMT1) is an important duodenal 
transporter of divalent metal cations such as Fe 2+ , Zn2+ , Cu2+, Cd2+ and Mn2+ ; DMT1 
has a greater affinity for ferrous iron compared to other cations which may explain 
altered copper and zinc absorption in periods of high iron intake. 
DMT1 activity is known to be increased in hereditary haemochromatosis (Garrick et 
al. 2003); this may result in increased absorption of other trace elements possibly 
explaining the increased tissue levels of non-ferrous metals such as zinc, manganese 
and lead that have been observed in haemochromatosis (Barton et al. 1998). Studies 
utilising experimental iron overload (in the absence of molecular defects) have also 
shown alterations and increases in body stores of zinc, cadmium and manganese 
suggesting that other regulatory processes for metal absorption may be altered in 
states of iron overload (Vayenas etal. 1998; Zhang etal. 2009). 
The potential deleterious effects of imbalances in trace element status are reasonably 
well established but may be exacerbated in haemochromatosis given the increased 
oxidative stress experienced in iron overload conditions. As a study was being 
undertaken in northern Tasmania on trace element status, this provided the 
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opportunity to examine whether the gene or iron overload might influence the status 
of other trace elements such as selenium, copper or zinc 
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5.6.2 Results 
Genotyping using the HFE-ARMS assay resulted in detection of six genotypes (Table 
5.3); wild-type HFE homozygote, H63D heterozygote, H63D homozygote, C282Y 
heterozygote, C282Y/H63D compound heterozygote and C282Y homozygote. Study 
subjects (n = 198) were classified by iron status, as determined by serum ferritin 
levels, gender and HFE genotype producing three gender subgroups; Group 1 (normal 
HFE genotype + normal iron status), Group 2 (abnormal HFE genotype + normal iron 
status) and Group 3 (abnormal HFE genotype + abnormal iron status) (Table 5.4). In 
this classification heterozygote H63D subjects were considered to have a normal HFE 
genotype. 
Table 5.3: Distribution of HFE genotypes among study subjects. 
HFE Genotype 
Homozygous Compound Heterozygous Homozygous Heterozygous 	Normal 
C282Y 	Heterozygous 	C282Y 	H63D 	H63D 	'wild type' 
C282Y/H63D genotype 
Male 10 11 15 1 11 38 
Female 14 13 14 0 23 47 
All subjects 24 24 29 1 34 85 
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Table 5.4: Serum ferritin levels (i_tg/L) of study subgroups. 
Iron status/HFE genotype subgroup 
Group 1 
	
Group 2 
	
Group 3 
n= 119 n =42 n = 37 
Male 139.3 78.9 (13-280) 155.0 ± 83.7 (12-288) 820.7 ± 547.1 (313-2430) 
Female 71.1 ± 50.5 (7-195) 77.0 ± 54.1 (7-193) 656.9 ± 565.5 (246-2120) 
Values are mean ± sd, (range) 
Normal ferritin: Men 30-3001.1g/L; Women 15-200 ug/L 
Group 1 = normal HFE genotype and normal Fe status 
Group 2 = abnormal HFE genotype and normal Fe status 
Group 3 = abnormal HFE genotype and abnormal Fe status 
Measurement of serum ferritin determined 119 subjects with normal HFE genotype 
had normal iron status; 42 subjects with abnormal HFE genotype with normal iron 
status and 37 subjects with abnormal HFE genotypes were considered to have 
abnormally high iron status, or iron overload. 
Amongst the male subject subgroups there were no significant differences in age, 
energy intake or trace element intake. Body mass index did vary significantly among 
the male subgroups; men in the iron overloaded Group 3 had higher BMI (29.5) 
compared to both Group 1 (26.6) and Group 2 (26.5) men (P = 0.004 and P = 0.008 
respectively). Among the women, BMI was not significantly higher in Group 3 
subjects but this group was older on average (63.4 yrs) compared to Group 1 (53.5 
yrs) and Group 2 (55.0 yrs) women (P <0.001 and P = 0.007 respectively). 
Although not significantly higher than other groups, the highest mean energy and 
trace element intakes were observed in the asymptomatic Group 2 men. In women the 
highest mean energy and trace element intakes were observed in the Group 3 subjects; 
however the differences between groups were not statistically significant. 
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Few significant differences were observed in the chosen trace element and antioxidant 
biomarkers. In men, mean serum levels of selenium were highest in Group 1 but 
highest mean copper and zinc levels were observed in Group 2 men. Mean total 
antioxidant status, serum GPx, and RBC SOD were higher also in Group 1 men, but 
only RBC GPx was significantly so; RBC GPx activity in Group 1 was 25% and 34% 
higher compared to Group 2 and Group 3 respectively (P = 0.03 and P = 0.001). 
In women, only RBC GPx varied significantly; Group 2 activity was 24% lower than 
RBC GPx activity in Group 1 (P = 0.001) and 15% lower than Group 3 (P = 0.03). In 
contrast to men, the females in Group 3 (who had iron overload) had the highest mean 
serum selenium and copper levels, while Group 1 women had the highest mean serum 
zinc. Women in Group 3 also had the highest mean serum GPx activity, while RBC 
SOD activity was highest in Group 1 females. 
Table 5.5: Age and dietary intakes in male and female subgroup subjects. 
Male 
Age 
yrs 
Energy 
MJ 
Se intake 
lig/d 
Cu intake 
mg/d 
Zn intake 
mg/d 
Group 1 49 54.7± 13.4 9.43 ± 3.68 77.3 ±40.1 1.53 ±0.60 12.8± 5.8 
Group 2 15 55.0± 12.7 11.27 ± 3.55 85.0 ± 27.1 1.59 ± 0.54 14.7 ± 3.9 
Group 3 23 58.3± 10.8 9.72 ± 3.81 71.6 ± 30.7 1.33 ± 0.41 11.9 ± 3.9 
Female 
Group! 70 53.5± 13.3 6.73 ±2.08 63.5 ± 19.7 1.27 ± 0.38 10.3± 2.8 
Group 2 27 55.0± 13.9 6.43 ± 1.89 63.3 ± 35.9 1.22 ±0.59 10.1 ± 3.1 
Group 3 14 63.4 + 8.1t 7.52 ± 2.32 66.5 ± 24.7 1.58 ± 0.64 11.5 ± 4.1 
Group 1 = normal HFE genotype and normal Fe status 
Group 2 = abnormal HFE genotype and normal Fe status 
Group 3 = abnormal HFE genotype and abnormal Fe status 
tindicates significantly different (p < 0.05) compared to women in other groups 
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Table 5.6: Serum and red cell trace element and antioxidant indices for male and female subgroup subjects. 
Male 
Serum Se 
_gmol/L 
Serum Cu 
gmol/L 
Serum Zn 
gmol/L 
Serum TAS 
mmol/L 
Serum GPx 
U/L 
Red Cell GPx 
U/g Hb 
Red Cell SOD 
U/g Hb 
Group 1 49 1.11 ± 0.18 15.3 ± 2.7 13.2 ± 2.4 1.31 ±0.11 877.7± 113.6 47.8± 17.7 t 1250.9 ± 317.7 
Group 2 15 1.09 ± 0.14 16.0 ± 2.1 13.8 ± 2.4 1.31 ± 0.09 791.3 ± 176.5 38.2 ± 13.3 1223.7 ± 287.8 
Group 3 23 1.06 ± 0.16 14.8 ± 2.9 13.5± 1.8 1.29 ± 0.17 840.6± 162.1 35.7± 11.5 1139.8 ± 395.9 
Female 
Group 1 70 1.08 ± 0.19 19.0 ± 3.9 13.6 ± 3.0 1.24 ± 0.12 861.1 ± 157.3 50.8 ± 19.2 1274.1 ± 305.2 
Group 2 27 1.07 ± 0.16 19.1 ± 4.7 12.9 ± 2.4 1.16 ± 0.17 801.7± 146.1 38.6± 17.5 1180.5 ± 423.5 
Group 3 14 1.12 ± 0.19 20.7± 3.8 13.3 ±2.5 1.24± 0.11 963.2± 270.8 45.4± 18.9 1230.4± 328.9 
Group 1 = normal HFE genotype and normal Fe status 
Group 2 = abnormal HFE genotype and normal Fe status 
Group 3 = abnormal HFE genotype and abnormal Fe status 
t indicates significantly different (p <0.05) compared to men in other groups 
I indicates significantly different (p <0.05) compared to women in other groups 
5.6.3 Discussion 
Overall, the results from this sample of subjects provide little evidence to support the 
hypothesis that either abnormal HFE genotype or an associated increase in iron 
absorption has a significant effect on indicators of trace element or antioxidant status. 
A lack of significant differences in dietary measures was perhaps surprising given that 
iron overload subjects (Group 3) might have been expected to have altered diets in 
order to minimise iron intake and absorption. This appears to be reflected to some 
degree by the iron overloaded males consuming the lowest mean trace element 
intakes, but this trend was not evident in the females of this group where the highest 
mean intakes were observed. Serum levels of selenium, copper and zinc generally 
followed dietary intake trends for these metals. RBC SOD did not appear to be 
affected by intake or serum levels of copper or zinc, two trace metals which are 
components of the enzyme, and probably is not a reliable indicator of copper or zinc 
status, at least in these subjects. 
Serum TAS may have been expected to vary in the group with iron overload due to 
the potential for increases in oxidative stress in these subjects, but it did not appear to 
reflect that; either because oxidative stress in the sample was minimal or because the 
serum components that contribute to the antioxidant status measured using this system 
were not sensitive to it. That serum TAS results were generally not in line with the 
antioxidant enzyme activity is perhaps not unexpected as GPx and SOD activity is not 
directly measured in the TAS assay (Cao and Prior 1998). 
The only statistically significant difference observed in trace element or antioxidant 
measures was in RBC GPx activity, which was highest in Group 1 subjects in both 
genders. The differences between RBC GPx activities in gender sub-groups appear, as 
expected, to reflect the trends in serum selenium in each group. Serum GPx also 
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appeared to reflect serum selenium levels, although sub-group differences were not 
statistically significant. As red cell enzyme activity is considered an indicator of 
longer term selenium status, this could suggest that a small, long term difference in 
selenium status between groups may occur in these subjects. Given these observed 
GPx trends and the relatively small numbers of subjects in each subgroup it may not 
be possible to exclude a small effect between the genotype groups; however the likely 
major determining factor of trace element status measured in these subjects is 
probably gender and dietary intake. 
Although it was interesting to have the opportunity to obtain data on iron overload 
and hereditary haemochromatosis in relation to other trace elements to complement 
the small amount of existing data, for subsequent research iron status will not be 
considered. 
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5.7 Discussion of preliminary findings 
The major limitation of this preliminary research was the non-random nature of the 
sample recruitment and the bias it introduced. Men were underrepresented, as were 
subjects in younger age ranges, giving low numbers of male subjects in particular in 
some age range analyses. This study also did not collect data on socioeconomic status 
which can be an important factor in nutrition. The small sample size of the studies 
described in this chapter obviously introduces uncertainty in the estimation of the 
prevalence of inadequate intakes or status, but overall provided a useful indicator of 
areas of interest for subsequent research. 
In the area of primary interest the study suggested that, as expected, neither overt 
selenium deficiency nor toxicity was likely in this population. It did however support 
the hypothesis that many people had marginal selenium status, as indicated by a high 
prevalence of inadequate intakes (28% <EAR) and by the moderate mean serum 
selenium level and its significant association with the functional marker GPx. This 
marginal status did not appear to be limited to particular groups within the sample, 
indicating further research in the whole population is certainly warranted. 
The lack of definitive guidelines on dietary requirements and biomarker levels made 
the interpretation of copper status difficult; our preliminary research suggests that 
inadequate copper status is probably not a problem. Due to a lack of Australian data 
regarding copper status, this data collected from a convenience study may still be 
considered useful. The findings suggesting that zinc intakes, particularly those in men, 
were inadequate were also interesting. The prevalence of low zinc intakes in the 
overall sample met the level of 25% <EAR, suggested by WHO (de Benoist et al. 
2007) to indicate increased risk of deficiency. This did not translate into a high 
prevalence of low serum zinc levels but overall the results indicated that people in 
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certain age/gender groups in Tasmania may be at risk of inadequate zinc status, and 
that further study in this area would be valuable. 
Findings from the Study C, which investigated the potential effects of increased iron 
absorption in hereditary haemochromatosis on the trace elements of interest, 
suggested that it had, at best, a minimal affect on the other trace elements measured. 
There were some trends for differences between mean serum levels of selenium 
between the study groups but they did not reach statistical significance. The only 
index to demonstrate a significant difference was RBC GPx activity which was higher 
in the normal subjects compared to the iron overloaded subjects. This indicates that 
perhaps on a long term basis there may be a small difference in selenium status but 
the significance is unclear. 
As a result of this preliminary work, the major study focuses on obtaining a random 
electoral roll population sample in which to assess selenium status as a primary 
interest, with assessment of zinc and copper status in the same population sample as 
the opportunity is available. 
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Chapter 6 
Population study of selenium, copper and zinc status 
6.1 Introduction 
The findings from the preliminary research of the trace element status of people living 
in northern Tasmania indicated that the prevalence of marginal selenium status in this 
population may be quite high. It also suggested that certain sub-sections of this 
population may be at risk of inadequate zinc status. 
These findings may be important if they can be shown to hold true in a representative 
sample of the northern Tasmanian population, given the importance of these trace 
elements in many biological processes and the association of selenium in particular 
with chronic disease such as cancer. 
A cross-sectional population study recruited from the electoral roll of the Bass, Lyons 
and Braddon electoral divisions was proposed. This study would investigate the trace 
element status of a population sample using dietary and biochemical markers as used 
in the preliminary research, with particular emphasis on the selenium status of the 
sample. Recruitment of subjects and collection of biological samples would involve 
the cooperation of several Pathology departments and doctors surgeries, located 
between Campbell Town in the south, Burnie in the north west and Scottsdale in the 
east. 
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6.2 Study aims 
The primary aims for this population study were; 
- to estimate selenium intakes; in particular the prevalence of selenium 
intakes below the EAR. 
- to determine the serum selenium and GPx activities; in particular to 
determine the proportion of the subjects that have serum selenium 
concentrations below the levels associated with selenoprotein requirements 
and potential chemopreventative effects. 
to investigate the major contributors to selenium intakes, the factors 
associated with selenium status, and any specific characteristics of subjects 
with; 
a) intakes below the EAR 
b) serum selenium concentrations above 1.27 urnol/L 
c) serum selenium concentrations above 1.50 umol/L 
The secondary aims were; 
to assess copper and zinc intakes; in particular estimating the prevalence of 
low dietary intakes of zinc (<EAR). 
to determine serum copper and zinc; in particular the proportion of 
subjects with serum zinc below WHO cut-off levels. 
to identify some of the factors associated with copper and zinc status in 
this population. 
Data from the population study addressing the primary and secondary research 
objectives is presented separately in consecutive sections in this chapter: 
Study A: Selenium status in a population study in northern Tasmania 
Study B: Copper and zinc status in a population study in northern Tasmania 
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6.3 Methods 
All methods for sample selection, data collection and handling, including all dietary 
and biochemical analyses, and statistical analysis performed for the population study 
of selenium, copper and zinc status, and referred to in this chapter, were described in 
Chapter 2: General methodology. 
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6.4 Study A: Selenium status in a population study in northern 
Tasmania 
6.4.1 Background 
The suggestion that human selenium status in Tasmania may be inadequate can be 
traced to difficulties experienced previously in this state with selenium deficiency in 
livestock, particularly sheep. This idea was supported by the report of low selenium 
levels in an early study by McGlashan et al (1996) of selenium status in Tasmania, 
however, subsequent findings have been inconsistent (Daniels et al. 2000; Jacobson et 
al. 2007). The preliminary finding from the current research of marginal selenium 
intakes and serum levels also supports this hypothesis and therefore a larger, more 
representative population based study of selenium status was warranted. 
The population study of approximately 500 participants analysing dietary intakes and 
biochemical measures of selenium status such as serum selenium and GPx activity is 
the largest and most detailed study of selenium status in Australia. 
In addition to determining selenium status, and its associations with various disease 
risk factors such as smoking and serum lipids, this study has a novel addition of an 
assessment of the effect of a common GPx gene polymorphism on enzyme activity in 
this population. The GPx-1 Pro198Leu polymorphism has been associated with 
decreases in RBC GPx activity (Ravn-Haren et al. 2006) as well as increased risk of 
lung cancer (Ratnasinghe et al. 2000), bladder cancer (Ichimura et al. 2004) and 
cardiovascular disease (Hamanishi et al. 2004). 
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6.4.2 Results 
A total of 2545 people were contacted by letter, after selection from the electoral roll, 
resulting in 520 positive responses; a response rate of 20%. Seventy seven of the 
letters were returned as "undeliverable" due to the addressee no longer residing at that 
address, increasing the response rate to 21%; twenty two of the positive responders 
subsequently withdrew due to family or personal sickness or moving interstate. 
Subject characteristics 
Of the 498 subjects, 192 were male and 306 were female. The mean (± sd) age of 
subjects was 57.4 ± 12.3 years; 61% of subjects were between 55 and 74 years of age. 
Subjects also tended to be over weight; sixty two percent of subjects had a BMI 
greater than 25 kg/m2 ; mean BMI was 26.9 ± 5.0 kg/m2 . Thirty nine subjects were 
current smokers (male n = 9; female n = 30). 
Multivitamin and mineral supplements were regularly taken by 23% and 19% of 
subjects respectively. Only 8% consumed supplements which contained selenium. 
The most common self reported health-related conditions were hypertension (25%) 
and arthritis (19%); the most commonly reported medications used were anti-
hypertensives (24%), cholesterol lowering drugs (16%) and anticoagulants (12%). 
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Table 6.1: Anthropometric, biochemical and dietary indices by gender 
All Subjects 
n = 498 
Male 
n= 192 
Female 
n=306 
Age, years 57.4± 12.3 (25.0 - 82.0) 58.9 ± 12.2 56.5 ± 12.2 0.030 
BMI, kg/m2 27.0 ± 5.0 (15.9 -46.8) 27.7 ± 4.6 26.5 + 5.2 0.012 
Weight, kg 76.6± 16.7 (46.0- 155.0) 86.2± 15.1 70.6 ± 14.8 <0.001 
Height, cm 168.5 + 10.0 (144.5 - 203.0) 176.6± 7.9 163.3 ± 7.3 <0.001 
Energy, mi 7.69 ± 2.71 (2.05 - 20.90) 9.11 ± 2.72 6.81 ± 2.29 <0.00 1 
Protein, g/d 84.6 ± 31.7 (21.0 -244.0) 98.2 ± 2.4 76.1 ± 1.6 <0.001 
Carbohydrate, g/d 200.1 ± 71.6 (42.4 - 456.3) 233.4 ± 5.3 179.3 	3.6 <0.001 
Fibre, g/d 23.3 ± 9.2 (2.1 -63.6) 26.7 ± 0.7 21.1 + 0.5 <0.001 
Se intake, gg/d 69.9 + 27.5 (23.2 - 267.2) 77.4± 31.3 65.1 ± 23.7 <0.001 
Se intake, gg/kg/d 0.94 ± 0.38 (0.21 - 2.79) 0.92 ± 0.37 0.95 + 0.39 0.392 
Se intake, gg/MJ/d 9.4 ± 2.9 (3.1 - 32.4) 8.7 + 2.6 9.9 ± 2.9 <0.001 
Serum Se, gmol/L 1.13 ± 0.19 (0.57 - 2.26) 1.13 ± 0.20 1.13 ± 0.18 0.776 
Serum GPx, U/L 896.3 ± 137.0 (379.2 - 1355.8) 901.3± 132.7 893.2± 139.8 0.515 
RBC GPx, U/g Hb 61.2± 16.2 (15.7 - 127.4) 60.3 ± 16.0 61.8± 16.3 0.291 
TAS, mmol/L 1.40 ± 0.19 (0.80 - 2.15) 1.45 ± 0.20 1.36 ± 0.17 <0.001 
T-Chol, mmol/L 5.71 + 1.16 (0.87 - 9.78) 5.51 ± 1.16 5.83± 1.14 0.002 
HDL-C, mmol/L 1.40± 0.36 (0.28 - 2.80) 1.22 + 0.31 1.52 ± 0.35 <0.001 
LDL-C, mmol/L 2.95 ± 0.86 (0.40 - 5.67) 2.94 ± 0.86 2.96 ± 0.87 0.800 
Triglycerides, mmon 1.99+ 1.40 (0.36 - 17.83) 2.32+ 1.73 1.79± 1.10 <0.001 
Values are mean ± sd, (range) 
Effect of gender, smoking and age 
Men and women did not differ significantly with respect to serum selenium, serum 
and RBC GPx and serum LDL cholesterol (P > 0.05); however mean age, weight, 
height, BMI, serum TAS, serum triglycerides, and absolute intakes of selenium were 
significantly higher in men (Table 6.1) 
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Women had significantly higher levels of serum total cholesterol and serum HDL 
cholesterol. Although they consumed lower absolute intakes of selenium, their diet 
had significantly higher nutrient density for selenium; intake adjusted for bodyweight 
compared to men was also higher. 
Table 6.2: Anthropometric, biochemical and dietary indices in current smokers and 
non-smokers. 
Age, years 
Weight, kg 
Height, cm 
Current Smokers 
n = 39 
54.6+ 10.2 
76.0 ± 25.0 
169.8 + 8.4 
Non-smokers 
n = 459 
57.9+ 12.3 
76.9 ± 14.7 
168.4 ± 7.5 
0.009 
0.362 
0.657 
BMI, kg/m2 26.1 + 6.3 27.1 ± 5.0 0.145 
Energy, MJ 6.97 ± 3.03 7.76 ± 2.67 0.383 
Se intake, 1.tg/d 63.8 ± 30.4 70.4 ± 27.3 0.352 
Se intake, 1.tg/kg/d 0.92 ± 0.42 0.94 ± 0.38 0.649 
Se intake, lig/MJ/d 9.4 ± 2.4 9.4 + 2.9 0.639 
Serum Se, limn 1.07 ± 0.10 1.13 ± 0.19 0.008 
Serum GPx, U/L 847.3+ 147.1 901.7+ 136.5 0.004 
RBC GPx, U/g Hb 62.0+ 17.1 61.2± 16.4 0.876 
TAS, mmol/L 1.42 + 0.26 1.40±0.17 0.612 
Adjusted for gender 
Values are mean ± sd 
Non-smokers were older and also had significantly higher serum selenium and serum 
GPx levels in comparison to current smokers (Table 6.2). 
After adjusting for gender and smoking habit, dietary intake of selenium was not 
significantly different between age ranges (Table 6.3). The highest absolute and 
adjusted intakes were in the 35-44 yrs age range. The lowest nutrient density was 
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observed in the 25-34 yrs age range and the lowest intake by bodyweight was in the 
55-64 yrs age range. 
Biochemical markers of trace element and antioxidant status demonstrated significant 
differences between age ranges. The highest mean serum selenium concentration of 
1.16 innol/L was observed in the 45-54 yrs age range; significantly higher than the 
lowest mean value of 1.03 'Amon in the oldest subjects (75-84 yrs). 
Serum GPx activity was highest in the 55-64 yrs age range, significantly higher than 
in the 25-34 yrs and 65-74 yrs age range. Lowest RBC GPx activity was also found in 
the youngest age range (25-34 yrs) and was significantly lower than in the 45-54 yrs 
age range. The trend for both serum and RBC GPx appeared to be for mean activities 
to rise to a peak in middle age (45-64 years) and then be decreased with increasing 
age. 
Among the different age ranges, the lowest mean serum TAS was in the 35-44 yrs age 
range, significantly lower than that of the 55-64 yrs age range. Again, there appeared 
to be a trend for lower mean TAS in the youngest and oldest age ranges, with peak 
values found in the middle age ranges. 
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Table 6.3: Age group differences in dietary and biochemical indices of selenium status. 
Age range 
years ug/d 
Selenium intake 
ug/kg/d ug/MJ/d 
Serum Se 
umol/L 
Serum GPx 
U/L 
RBC GPx 
U/g Hb 
Serum TAS 
mmol/L 
25-34 27 70.6 ± 23.8 0.98 ± 0.36 8.91 ± 2.27 1.14 ± 0.18 831.1 ± 166.3 t 55.6 ± 11.0 1 1.38 ± 0.20 
35-44 57 73.6 ± 29.8 0.98 ± 0.43 9.51 ± 3.80 1.10 ± 0.22 918.2 ± 104.4 57.5 ± 15.6 1.35 ± 0.15 t 
45-54 87 70.1 ± 26.9 0.93 ± 0.38 9.37 ± 2.35 1.16 ± 0.21 t 897.5 ± 126.2 63.8* 15.9 1 1.41 ± 0.19 
55-64 160 69.8 ± 29.6 0.90 ± 0.38 9.41 ±2.88 1.13 ± 0.18 921.8± 129.4 t1 61.6* 16.6 1.39 ± 0.19 t 
65-74 144 68.8 ± 23.7 0.97 ± 0.39 9.44 ± 2.47 1.12 ± 0.16 875.3 ± 135.6 t 62.9 ± 16.2 1.43 ± 0.16 
75-84 21 66.4 ± 23.4 0.95 ± 0.31 9.27 ± 2.76 1.03 ± 0.17 t 856.1 ± 158.6 56.5 ± 17.8 1.39 ± 0.16 
Values are mean (sd) 
Adjusted for gender and smoking 
Groups denoted by t are significantly different (P <0.05) 
Groups denoted by are significantly different (P < 0.02) 
Selenium status 
The mean selenium intakes of 77.4 and 65.1 pig/d were above estimated average 
requirement (EAR) values (60 pg/d and 50 pg/d respectively) for males and females; 
a similar proportion of each gender (28% and 26% respectively) failed to consume the 
EAR. The age range with the lowest proportion of subjects estimated to consume less 
than the EAR was the 25-34 yrs age range (18%) while the three oldest age ranges 
(55-64, 65-74 and 75-84 yrs) had the highest proportions of subjects below this level 
(Table 6.4) 
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Figure 6.1: Distribution of estimated dietary selenium intakes. 
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Table 6.4: Proportions of subjects below EAR intakes and serum 
selenium threshold associated with maximal GPx activity. 
<EAR selenium 
Age range 
years 
Men 
n (%) 
Women 
n (%) 
All subjects 
n (%) 
25-34 2 (22) 3 (16) 5 (18) 
35-44 4 (22) 9 (23) 13 (23) 
45-54 4 (14) 19 (33) 23 (26) 
55-64 20 (33) 26 (26) 46 (29) 
65-74 20 (31) 20 (25) 40 (28) 
75-84 3 (27) 3 (10) 6 (29) 
All 53 (28) 80 (26) 123 (25) 
<1.27 nmol/L serum selenium 
Age range Men Women All subjects 
years n (%) n (%) n (%) 
25-34 6 (67) 15 (79) 21 (75) 
35-44 14 (78) 31 (79) 45 (79) 
45-54 19 (66) 47 (81) 66 (76) 
55-64 52 (87) 80 (80) 132 (83) 
65-74 60 (94) 65 (81) 125 (87) 
75-84 10 (91) 10 (100) 20 (95) 
All 161 (84) 248 (81) 409 (82) 
The overall mean (± sd) serum selenium was 1.13 ± 0.19 [mon. The actual 
distributions are shown later (Figure 6.2); however, eighty three percent of subjects 
had serum selenium levels below the level of 1.27 ptmol/L that is associated with 
maximal GPx activity, and hence is indicative of nutritional adequacy (Elsom et al. 
- 
2006). Accordingly, serum selenium had a strong, significant positive association with 
serum GPx activity (P < 0.001), indicating that enzyme activity had not plateaued in 
many subjects. In addition, 97% of subjects had serum selenium below the level of 
1.50 mon, the target concentration that has been suggested for potential 
chemopreventative effects of selenium (Combs 2001). 
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Figure 6.2: Frequency distribution and cumulative proportion of sample and 
. population estimates of serum selenium in northern Tasmania (dashed line indicates 
GPx requirement). 
Due to the variation in response from different age and gender sub-groups in the study 
sample, a population estimate was made that was weighted for age, gender and 
socioeconomic status, using data from the 2006 Census for this region. In the adjusted 
population estimates the prevalence of low selenium intakes and serum selenium 
levels below threshold values were not significantly different to the study sample 
(Table 6.5). 
0 
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Table 6.5: Estimates of population proportions below EAR and serum 
selenium thresholds associated with maximal GPx activity and putative 
chemopreventative effects of selenium. 
Dietary selenium intake 
% with intakes <EAR 
Sample estimate 27% 
95% C.I. (0.23 - 0.32) 
Population estimate 24% 
95% C.I. (0.23 - 0.24) 
Risk ratio 0.88 
95% C.I. (0.71 - 1.09) 
P value 0.24 
Serum selenium levels 
Mean serum selenium (umol/L) 
Sample estimate 1.13 
Population estimate 1.13 
%with serum selenium <1.27 ,umol/L 
Sample estimate 83% 
95% C.I. (0.79 - 0.86) 
Population estimate 80% 
95% C.I. (0.76 - 0.83) 
Risk ratio 0.96 
95% C.I. (0.91 - 1.02) 
P value 0.26 
%with serum selenium <1.50 umol/L 
Sample estimate 97% 
95% C.I. (0.95 - 0.99) 
Population estimate 97% 
95% C.I. (0.98 - 0.99) 
Risk ratio 1.00 
95% C.I. (0.98 - 1.02) 
P value , 0.85 
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Dietary contributions 
Subjects reporting regular use of supplements containing selenium had serum 
selenium levels nearly 10% higher than non-users (1.23 v. 1.12 [trnol/L; 95%CI of 
difference 0.04-0.18; P = 0.002). Regular consumers of Brazil nuts (3% of the 
sample) had 15% higher mean serum selenium levels (1.31 v. 1.12 pmol/L; 95%CI of 
difference 0.07-0.30; P = 0.002). 
Meat products, cereal-based foods, vegetables and dairy based foods (45%, 26%, 8% 
and 8%) were the major contributors to dietary selenium intakes overall, contributing 
on average 32 jig, 18 jig, 6 jig and 5 las of selenium respectively (Figure 6.3). 
Contributing food groups in men and women were generally similar; however, men 
consumed proportionally more from mixed dishes (135%), which includes many 
"takeaway" style foods, and alcoholic beverages (346%) compared to women (both P 
<0.001). These were, however, minor contributors to overall intakes. In women, the 
contribution of dairy foods was 25% greater than in men (P < 0.001). There were no 
significant differences between age ranges (P > 0.05). 
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Other associations 
Dietary selenium intakes (1g/d, pg/kg/d and lig/MJ/d) had significant positive 
associations with serum selenium (P = 0.005, P < 0.001 and P = 0.001 respectively). 
Also associated with serum selenium were dietary fibre (P = 0.035) and dietary 
Vitamin E (P = 0.024) (Table 6.6). 
Other factors associated with serum selenium were body weight (P = 0.017) and BMI 
(P = 0.007), as well as serum copper (P = 0.016) and serum TAS (P = 0.022). 
Serum selenium had strong positive associations with serum total cholesterol and 
serum HDL cholesterol (P = 0.015 and P <0.001). Serum GPx activity was positively 
associated with serum HDL cholesterol and serum LDL cholesterol (P < 0.001 and P 
= 0.047) and negatively associated with serum triglycerides (P = 0.013). RBC GPx 
activity was also associated with serum HDL cholesterol (P = 0.004). 
Adjusted dietary intakes of selenium (pg/kg/d) were positively associated with serum 
HDL (P = 0.008), but negatively with serum LDL and serum triglycerides (P = 0.022 
and P = 0.014). 
There was no association between serum selenium concentrations and socioeconomic 
status, as indicated by the SEIFA index. The SEIFA (socioeconomic indexes for 
areas) index used is derived from Census variables related to both advantage and 
disadvantage, including households with low or high income, unemployment rates 
and proportions of people with limited or higher education. A lower SEIFA score in a 
given Census district indicates that district is relatively disadvantaged compared to 
one with a higher score. 
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Dietary factors 
zscore - selenium consumed 
zscore - selenium/ kg/d 
consumed 
zscore - selenium/MJ/d 
consumed 
zscore - energy consumed 
zscore - saturated fat consumed 
zscore - polyunsaturated fat 
consumed 
zscore - monounsaturated fat 
consumed 
zscore - protein consumed 
zscore - carbohydrate consumed 
zscore - fibre consumed 
zscore - alcohol consumed 
zscore - vitamin E consumed 
ag/d 
ag/kg/d 
ag/MJ/d 
MJ 
g/d 
g/d 
g/d 
g/d 
g/d 
g/d 
g/d 
mg/d 
Anthropometric, demographic and 
biochemical factors 
Table 6.6: Univariate associations of anthropometric, demographic, dietary and 
biochemical factors with serum selenium. 
ASerum selenium 
innol/L 
zscore - age 
zscore - body weight 
zscore - height 
zscore - BMI 
zscore - SEIFA ranking 
zscore - serum copper 
zscore - serum zinc 
zscore - serum TAS 
years 
kg 
cm 
kg/m2 
amol/L 
amol/L 
mmol/L 
95% C.I. P value 
0.03 0.01, 0.04 0.005 
0.03 0.02, 0.05 <0.001 
0.03 0.01, 0.04 0.001 
0.01 -0.01, 0.02 0.719 
-0.01 -0.03, 0.01 0.165 
0.02 -0.01, 0.04 0.059 
0.00 -0.02, 0.02 0.882 
0.01 -0.01, 0.03 0.388 
-0.0 -0.02, 0.02 0.787 
0.02 0.01, 0.03 0.035 
0.02 -0.01, 0.04 0.171 
0.02 0.01, 0.04 0.024 
-0.01 -0.03, 0.01 0.267 
-0.02 -0.04, 0.00 0.017 
-0.01 -0.03, 0.02 0.698 
-0.02 -0.03, -0.01 0.007 
0.01 -0.01, 0.03 0.213 
-0.02 -0.04, -0.01 0.016 
0.01 -0.01, 0.03 0.153 
0.02 0.01, 0.04 0.022 
zscore: standardised normal value = (subject variable value - group mean )/standard deviation). Coefficient for demographic, 
anthropometric, dietary and biochemical factors is the effect of a I sd increase in the covariant on serum selenium (pinol/L). 
Each separate variable, adjusted for gender and smoking, was modelled using general linear modelling with robust standard error 
estimation. 0 = regression coefficient. 
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Table 6.7: Univariate associations of selenium status indices with serum lipids. 
ATotal Cholesterol 
mmol/L 
AHDL Cholesterol 
mmol/L 
ALDL Cholesterol 
mmol/L 
ATriglycerides 
mmol/L 
Biochemical factors 	 f3 95% CI P 13 95% CI P 13 95% CI P B 95% CI P 
zscore - serum selenium 1.1mouL 0.12 0.02, 0.20 0.015 0.06 0.03, 0.09 <0.001 0.03 -0.04, 0.10 0.386 -0.05 -0.13, 0.05 0.347 
zscore - serum GPx U/L -0.11 -10.67, 10.45 0.984 0.06 0.03, 0.09 <0.001 0.08 0.00, 0.16 0.047 -0.14 -0.26, -0.03 0.013 
zscore - RBC GPx tug Hb 2.31 -7.84, 12.47 0.655 0.04 0.01, 0.07 0.004 0.01 -0.06, 0.09 0.738 -0.04 -0.15, 0.07 0.500 
Dietary factors 
zscore - selenium pg/d -0.04 -0.13, 0.06 0.431 0.01 -0.02, 0.05 0.521 -0.07 -0.13, 0.00 0.051 0.050 -0.12, 0.22 0.558 
zscore - selenium/kg 
bodyweight pg/kg/d -0.03 -0.13, 0.06 0.494 0.05 0.01, 0.09 0.008 -0.08 -0.15, -0.01 0.022 -0.131 -0.24, -0.03 0.014 
zscore - selenium/MJ energy pg/MJ/d -0.04 -0.14, 0.05 0.353 -0.02 -0.04, 0.01 0.296 -0.03 -0.10, 0.05 0.454 -0.021 -0.15, 0.11 0.748 
zscore: standardised normal value = (subject variable value - group mean)/standard deviation). Coefficient for dietary and biochemical factors is the effect of a 1 sd increase in the 
covariant on serum total cholesterol (mmol/L), serum HDL (mmol/L), serum LDL (mmol/L), serum triglycerides (mmol/L). Each separate variable, adjusted for gender and smoking, 
was modelled using general linear modelling with robust standard error estimation. 1 3  = regression coefficient. 
Characteristics of selenium status groups 
Dietary and lifestyle characteristics of the various selenium status groups within the 
population sample are summarised in Table 6.8. 
Subjects with intakes <EAR values 
The main distinguishing feature of subjects with low intakes appeared to be lower 
food consumption overall. They also had differences in some major contributing food 
groups; a lower contribution proportionally from meat sources but a greater 
contribution from vegetable foods. The lower intake subjects had lower selenium 
levels. 
Subjects with serum selenium >1.27 ,umol/L 
Major defining features of subjects in this higher selenium group were a diet with 
greater nutrient density and intake by body weight, greater supplement usage and 
younger average age. 
Subjects with serum selenium >1.50 ymol/L 
Intakes (particularly absolute intakes and intakes per kg bodyweight) tended to be 
higher in the high selenium group. Socio-economic status and BMI did not appear 
different between groups; multivitamin use and consumption of Brazil nuts was much 
more common in subjects with higher selenium levels; none of the subjects in the high 
selenium level group were current smokers. 
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Table 6.8: Selenium status group characteristics in comparison to other study subjects. 
Subjects consuming <EAR selenium 	 Subjects with serum selenium > 1.27 jimol/L 	Subjects with serum selenium >1.50 gmol/L 
(n = 134) 
	
(n = 89) 	 (n = 14) 
Selenium intakes and contributors 
• 26% lower mean energy intake in men (7.26 v. 9.85 MJ) (P < 	• Absolute intake of selenium not significantly different (P = 	• Mean energy consumption and selenium intakes (absolute, 
0.001); 32% lower energy intake in women (5.03 v. 7.44 MJ) 	0.051). Adjusted intakes (gg/MJ energy and gg/kg 	 adjusted for bodyweight and energy) were higher (4%, 
(P <0.001). 	 bodyweight) were both higher (7%; P = 0.015 and 11%; P = 	11%, 23% and 4% higher respectively) but not 
• Meat contributed 7% less to intakes (P = 0.028); vegetables 
	0.009 respectively). 	 significantly. 
contributed nearly a third more (29%) than in other subjects 	• Only slightly more subjects reported regular consumption of 	• 25% reported regular consumption of Brazil nuts compared 
(P <0.001). 	 Brazil nuts (6% v. 2%). 	 to 2% of others. 
_ 
Supplement use 
• Multivitamin and mineral supplement use was similar 	 • Multivitamin use was higher (31% v. 22%). A greater 	 • Regular use of multivitamin supplements was more 
compared to other subjects (26% v. 22%); including 	 proportion of these subjects regularly consumed selenium 	 common in this group compared to the lower selenium 
supplements containing selenium (8% v. 6%). 	 containing supplements (17% v. 4%) 	 group (42% v. 23%). Use of selenium containing 
supplements was however similar (27% v. 25%). 
Other 
• No significant difference in age, smoking habit, gender 	• No significant difference in smoking, gender distribution or 	• No significant difference in age or socioeconomic status. 
distribution or economic status. 	 socioeconomic status. 	 • There were no current smokers compared to 8% of all other 
• Mean serum selenium levels were 8% lower (1.08 v. I .15 	• Mean age of subjects was 3.5 years younger than all other 	subjects 
gluon) compared to other subjects. 	 subjects (54.5 v. 58.0 yrs; P = 0.014). 
GPx-1 Pro198Leu genotype 
Distribution of GPx-1 Pro198Leu genotype was not in Hardy-Weinberg equilibrium 
(X2 = 53.18; P <0.001); frequencies of the Pro and Leu alleles were 0.742 and 0.258 
respectively. The Leu/Leu genotype group had lower mean age, RBC GPx activity 
and selenium intakes compared to other genotypes, but there were only two subjects 
with this genotype. When grouped together, genotypes containing the mutant Leu 
allele were not significantly different for any biochemical measure, including serum 
selenium, RBC GPx, serum TAS and serum lipids, compared to the homozygous Pro 
genotype (P> 0.05). 
Table 6.9: Characteristics of GPx-1 Pro198Leu genotypes in study sample. 
Pro/Pro Pro/Len Leu/Leu 
n (male/female) 243 (96/147) 253 (94/159) 2 (2/0) 
Age, years 57.5 ± 12.3 57.5 ± 12.2 42.5 ± 20.5 
Selenium intake, lig/d 69.4 ± 26.9 70.5 ± 27.2 46.1 ± 0.17* 
Serum Se, gnoi/L 1.12 ± 0.21 1.13 ± 0.17 1.13 ± 0.08 
Serum GPx, U/L 900.7 ± 130.5 891.8± 142.0 956.7 ± 170.1 
RBC GPx, U/g Hb 61.4± 15.8 61.2± 16.5 52.6 ± 4.7** 
Serum TAS, mmol/L 1.40± 0.19 1.40 ± 0.18 1.45 ± 0.06 
Dietary and biochemical indices adjusted for age and gender 
Values are mean ± sd 
*P < 0.05 compared to Pro/Pro and Leu/Leu 
**P < 0.001 compared to Pro/Pro and Pro/Leu 
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6.4.3 Discussion 
Selenium intakes 
Mean dietary intakes of selenium were above the EAR; however over one quarter of 
the study subjects were estimated to consume less than this amount, exceeding 
considerably the 3% level that FSANZ and the US Food and Nutrition Board/Institute 
of Medicine currently use as an indicator of nutritional inadequacy in a population 
(Food and Nutrition Board 2000c). The observation that similar proportions of both 
males and females were below the EAR indicates that gender does not appear to 
significantly influence the risk of consuming inadequate amounts of selenium in this 
population. Even though men and women had significantly different intakes of 
selenium, the major food groups contributed mostly similar proportions to total 
selenium intake in both genders; the major significant difference being an increased 
contribution from dairy-based foods in women, the discrepancy appearing to be 
accounted for in men by proportionally higher intakes from mixed-dish foods and 
alcoholic beverages. 
Although age range intake differences were not significant, the older age groups in 
this study had lower mean selenium intakes and hence a greater proportion of older 
subjects consumed less than the EAR. The decreases in selenium intakes with 
increasing age appear to be due mostly to a reduction in overall food consumption 
rather than changes in selenium nutrient density of the diets. This was also the case in 
smokers who had lower, although not significantly, mean intakes, which were in line 
with lower energy intakes in comparison to the non-smoking subjects. 
Selenium intakes in men were lower than in the few previous Australian estimates. 
The early studies by Fardy and co-workers (1989) and Reilly (1992) both reported 
higher mean intakes for men of 96 and 89 gg/d respectively, using direct analysis of 
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representative foods. More recently, the 20th  Australian Total Diet survey (FSANZ 
2003) also estimated higher intakes in men (range: 1.2 - 1.7 is/kg/d) compared to our 
study (mean: 0.92 ig/kg/d). Intakes for women were similar to those in the early 
studies. The estimates of Fardy et al (63 pg/d) and Reilly (59 jig/d) compare 
favourably with the estimate from the current study of 65.1 jig/d. In comparison to 
FSANZ's Total Diet survey however, the female subjects' mean adjusted intake (0.95 
jig/kg/d) was just below the range of 0.96 - 1.18 p.g/kg/d estimated by that study. 
Due to the age and methodological differences in the dietary estimates between these 
studies, any further comparison is probably imprudent. 
Serum selenium 
The overall mean serum selenium was below 1.27 [tmol/L; a level that has been 
suggested to coincide with maximal GPx activity (Elsom et al. 2006) and hence 
nutritional adequacy. Consequently a large proportion of subjects (83%) may be 
considered to have marginal selenium status. The strong positive association of serum 
selenium with serum GPx activity in this sample, suggesting GPx activity has not 
plateaued in many subjects, supports this finding, though the significance of this is 
still uncertain. 
Most subjects (97%) had serum selenium concentrations below 1.50 Knol/L; 
considered as a level where the potential chemopreventative effects of selenium may 
be achieved (Combs 2001). There have been many promising findings from 
geographical, animal, in vitro, case control and prospective studies regarding the 
association of low selenium status with cancer incidence and the protective effects of 
selenium supplementation (Rayman 2005). At this time, however, results from the 
only large randomized controlled trial are inconclusive; the recently ended SELECT 
trial in the US (Lippman et al. 2009) found no significant protective effect of 
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selenium supplementation on prostate or other cancers in 35,533 men. Unfortunately, 
this trial did not test supplementation in a low selenium population where an effect 
could be expected to be observed; most subjects in this trial, where the median 
baseline serum selenium was 1.71 gmol/L, were probably selenium replete. 
A population estimate (Table 6.5 and Figure 6.1) was weighted for age, gender and 
socioeconomic status in the study sample compared to northern Tasmanian census 
data, due to the variation in response rates in the different study age and gender sub-
groups. This analysis was not significantly different to the study sample estimates and 
hence it may be estimated that almost one quarter of the 126,958 residents from the 
northern Tasmanian region surveyed may consume inadequate selenium. Eighty per 
cent of this population was estimated to have serum selenium below the level 
associated with nutritional adequacy; while 97% were estimated to have selenium 
levels below the level that has been suggested to potentially offer chemopreventative 
benefits. 
Selenium levels in the current study were similar, but possibly slightly higher than in 
the earliest reported Tasmanian data. The studies by McGlashan et al (1996) (1.02 
gmol/L; n = 171) and Daniels et al (2000) (0.98 grnol/L; n = 25) of adult blood 
donors, did not, however collect dietary data or publish their demographic data. In 
addition, the blood donors used in these studies may not be representative of the 
population, as donors would be considered a healthy sample due to the exclusion of 
individuals with infectious diseases. 
Serum selenium was considerably lower than in Jacobson and co-workers' (2007) 
recent study of selenium status in people from southern Tasmania (n = 335). Their 
mean plasma selenium concentration of 1.39 pmol/L is the highest reported from an 
Australian population and suggests that the majority of subjects were probably 
selenium replete. There were differences in the analytical methods used (ICP-MS v. 
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GFAAS) as well as in sample type (plasma v. serum), but these are not expected to 
have caused major differences in results. Although this group encountered analytical 
difficulties when using biological matrices with this newer ICP-MS method (A. 
Townsend, personal communication, September 25, 2004), the method appeared to 
perform well; analysis of an external commercial reference material with a certified 
concentration of 1.05 ± 0.8 j.tmol/L gave a mean of 1.05 ± 0.6 imnol/L. On this basis, 
the ICP-MS method was arguably a more accurate method than the GF-AAS method 
utilised in the current study, and this may explain some of the difference in selenium 
concentration between the two studies. Unfortunately, this group did not report dietary 
data; and hence it is not possible to detect additional dietary differences which may 
also explain the apparent substantial difference in selenium levels between these two 
studies. 
Although significant differences in selenium status have been observed between close 
geographical regions of the same country, such as in New Zealand (Thomson 2004b; 
Thomson et al. 2007) and France (Arnaud et al. 2006), further research is required to 
determine if this is also the case in Tasmania. 
In comparison to other Australian states, selenium levels were similar to South 
Australian (Daniels et al. 2000) and NSW cohorts (Dhindsa et al. 1998) (1.11 and 
1.16 gmol/L respectively), but lower than in more recent Queensland (Lymbury et al. 
2008) and South Australian (Lyons et al. 2004) studies (1.27 and 1.30 [anon 
respectively). 
The mean selenium concentration was higher than those reported from the South 
Island of New Zealand (0.84 - 0.98 gmol/L) (Thomson 2004b); a region with well 
described low selenium status. It was similar to many European countries where 
selenium status is marginal, and much lower than countries with high selenium 
intakes such as the US, Canada, Japan and Venezuela (Combs 2001). 
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Interestingly, even in studies reporting very similar selenium levels to the current 
study, reported dietary intakes appear to be much lower in comparison. As an 
example, the recent small British study of Sunde and co-workers (2008) reported a 
mean plasma selenium of 1.13 mon (n = 39), but estimated dietary intake, 
calculated using diet diaries, was only 48 jig/d. The nutrient density was 
approximately 60% of that calculated in the current study. This trend can be observed 
when reported dietary intakes and serum and/or plasma selenium from various other 
countries are compared (Combs 2001), and suggests that the dietary intakes may be 
over-estimated in the current study. If this was in fact the case it could explain the 
significant discrepancy observed between the proportions of subjects consuming 
inadequate selenium (27% <EAR) and those with marginal serum selenium 
concentrations (83% < 1.27 gmol/L). An inaccuracy in estimated intakes in this case 
may result from the design of the FFQ, or the use of food content data that is not 
representative of Tasmanian foods. The food content database used in this study, 
NUTTAB2006, does not provide data specific to Tasmanian foods, but rather data 
derived from a variety of Australian sources collected since the 1980s. While this data 
is mostly determined from direct food analysis, it may also be borrowed from 
overseas tables, estimated from "like" foods, provided by food manufacturers or 
calculated by FSANZ where needed (for examples of various data sources see 
Appendix 1). 
Associations with age, smoking and lipids 
Mean serum selenium concentrations were lowest in the oldest age group, 
significantly lower than the group with highest mean levels; roughly in line with the 
trend for lower mean intakes in older subjects. A trend for decreasing selenium status 
with age has been observed in other studies (Brooks etal. 2001; De Jong etal. 2001; 
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Bates et a/. 2002a) and is of concern in populations with already marginal selenium 
status. 
Smoking and alcohol consumption have been associated with lower and higher 
selenium status respectively (Ellingsen et a/. 1997; Kafai and Ganji 2003; Galan et al. 
2005). Smokers in this study had significantly lower serum selenium and serum GPx 
activity compared to non-smokers. This appeared to be related to lower selenium 
intakes, even though differences were not significant, rather than increased turnover 
or some other unknown mechanism related to smoking. Although serum TAS was 
associated with serum selenium, there was no significant difference in antioxidant 
status as measured by TAS between smokers and non-smokers, supporting the 
suggestion that the lower selenium and GPx levels in smokers were probably not the 
result of increased oxidative stress due to smoking. 
Findings regarding the relationship between the various indices of selenium status 
with cardiovascular risk factors have been inconsistent. Several studies have reported 
positive associations between selenium and serum cholesterol (Suadicani et al. 1992; 
Gamez et al. 1997; Hercberg et al. 2005; Bleys et al. 2008); one study has reported 
positive associations with each of serum cholesterol, serum HDL, serum LDL and 
serum triglycerides (Bleys et al. 2008), while other studies have found no association 
with any serum lipid component (Ghayour-Mobarhan et a/. 2005). In this study, 
serum selenium and serum GPx were significantly associated with several lipid 
measures as well as bodyweight and BMI. The mechanisms for such associations with 
serum lipids are unknown at this time; they may be due to the effects of 
selenoproteins such as GPx or iodothyronine deiodinase on lipid metabolism or the 
result of interrelated dietary exposures as proposed by Bleys and colleagues (2008); 
which could explain the significant associations found in this study between adjusted 
intakes and serum lipid components. 
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Characteristics of subjects with low or high selenium status 
Subjects of this study were classified by selenium intake (< EAR) and by serum 
selenium concentrations (> 1.27 !mon and > 1.50 umol/L) in an attempt to identify 
factors that influenced selenium status at these levels (Table 6.8). 
For all classifications, socioeconomic status (as measured by SEIFA index) did not 
appear to be a significant factor influencing selenium status in these groups and was 
not associated with serum selenium overall (Table 6.6), despite the association 
between socioeconomic status and healthy diets in Australia and elsewhere (Giskes et 
al. 2002; Beydoun and Wang 2008). The lack of association is consistent with the 
findings in the recent Tasmanian study of Jacobson et a/ (2007) and in France 
(Arnaud et a/. 2006), but in contrast to some findings in Britain (Bates et al. 2002a; 
Bates et al. 2002b). 
Subjects who consumed less than the EAR for selenium had an 8% lower mean serum 
selenium than those who consumed adequate selenium. The major influence on 
intakes of these subjects was a significantly lower total energy intake compared to 
subjects of the same gender who consumed more than the EAR. There was lower 
dietary selenium contribution from meat products and a higher contribution from 
vegetables; the nutrient density of diets in this group was also significantly lower, 
indicating they ate a smaller and perhaps also a less nutritious diet. As well as 
socioeconomic status, age, smoking habit and gender did not appear to be significant 
influences in this comparison. 
Dietary differences were also significant when a comparison was made between 
groups of subjects with serum selenium above and below 1.27 [tmol/L; the level 
associated with selenoprotein requirements. Adjusted intakes (pg/MJ and jig/kg) were 
higher in subjects with serum selenium above 1.27 umol/L, while a similar difference 
in absolute intakes did not reach statistical significance. As well as a higher regular 
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dietary intake, this group also consumed multivitamin and mineral supplements, 
including selenium containing supplements, more commonly than the group with 
lower selenium status. The rate of reported consumption of Brazil nuts, the richest 
dietary source of selenium, was slightly higher in the group with higher selenium 
levels. Socioeconomic status, gender distribution and smoking habit were not 
significantly different between these groups; however subjects in the higher selenium 
group were significantly younger than those with low selenium. This is consistent 
with the negative, though non-significant, association between age and serum 
selenium overall, and the significant differences observed in age range comparisons. 
Dietary intakes, both absolute and adjusted, were non-significantly higher in subjects 
with serum selenium concentrations greater than 1.50 gmol/L; the level associated 
with the potential chemopreventative effect of selenium, although these differences 
could be expected to have become significant with greater numbers of subjects. In 
addition to potentially higher intakes from their normal diet in this group, the rate of 
multivitamin and mineral supplement use was higher, although the use of selenium 
containing supplements was similar. 
Brazil nut consumption was particularly common in the high selenium group, with 
one quarter of these subjects reporting regular consumption compared to only 2% of 
all other subjects. Brazil nuts have been suggested as an effective method for 
increasing selenium status in marginal populations. A study by Thomson and 
colleagues (2008) in subjects with baseline selenium status similar to that observed in 
the current study, found that despite significant variability in the selenium content of 
Brazil nuts, consumption of just two per day resulted in a 64% increase in plasma 
selenium after 12 weeks of supplementation. Their potent effect and ready supply in 
most major supermarkets year-round therefore make them an ideal candidate food for 
increasing selenium status in a population, without the need for fortification of foods 
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or use of commercial supplements. One caveat is that Brazil nuts are known to also 
contain high amounts of toxic metals such as radium and barium (Parekh et al. 2008). 
The only other apparent difference between the high selenium group and others was 
the absence of smokers amongst the high selenium subjects, while 8% of all other 
subjects were current smokers. There appears, therefore, to be a trend for subjects 
with high, selenium status (serum selenium >1.50 timol/L) to be non-smokers and to 
consume a more nutritious diet including multivitamin and mineral supplements; 
while this may be the result of a more conscientious approach to dietary and health 
related aspects of their lifestyle, it may have been affected by the low numbers of 
subjects (14) in this group. 
Effect of GPx-1 Pro198Leu genotype 
The genotype distribution of the GPx-1 Pro198Leu polymorphism was not in Hardy-
Weinberg equilibrium. There was a greater representation of heterozygotes and a 
lower representation of both homozygote genotypes than expected; this deviation was 
most likely a function of the sample size which was probably too small to allow an 
accurate estimate of the true genotype distribution in this population. 
The Leu/Leu genotype had a lower mean RBC GPx activity than other genotypes 
even though serum selenium was not significantly different. Unfortunately there were 
only two subjects with the Leu/Leu genotype, which limits the power of such 
analyses; however several selenoprotein gene polymorphisms have been shown to 
influence the response of their protein products to selenium levels including 
polymorphisms in GPx-1 (Hu and Diamond 2003; Ravn-Haren et al. 2006; Jablonska 
etal. 2009), GPx-4 (Meplan et al. 2008), SelP (Meplan etal. 2007) and Sep15 (Hu et 
al. 2001). 
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There were no significant differences in any dietary or biochemical variable when 
Pro/Pro subjects were compared with those with at least one copy of the Leu allele; 
however sample size calculations indicate that detection of a 5% difference in RBC 
GPx, such as that suggested by Ravn-Haren and colleagues (2006) to result from 1 
copy of a mutant Leu allele in GPX1, would require a sample size of 1160, more than 
twice that of the current study. 
6.4.4 Conclusion 
The major finding of this study is that dietary intakes in a significant proportion of the 
population appear likely to be inadequate to meet the physiological requirement for 
selenium. For the most part, this inadequacy had a similar prevalence across age and 
gender subgroups and appeared independent of socioeconomic status. As observed in 
other studies, however, the prevalence of inadequacy was increased in the elderly 
(75+ yrs) in this study and this may be a factor that could contribute to the decline in 
health associated with aging. Smokers were the only other population subgroup to 
have significantly lower selenium levels. This effect appeared to be related to lower 
overall dietary intakes and adds to health concerns for these subjects given the 
oxidative stress caused by smoking and the importance of selenium in antioxidant 
defence. 
Important contributing foods groups were as expected; meat products and cereal-
based foods, and their contribution to diets across population subgroups did not vary 
significantly. The use of selenium containing multivitamin and mineral supplements, 
which are becoming more common on the supermarket shelf, were associated with 
higher selenium status, but because of their generally quite low selenium content 
(often approximately 25 pg/dose) are not a realistic method of increasing selenium 
status more than a few percent. Brazil nuts, the richest natural source of selenium for 
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humans, were infrequently consumed by most subjects, but were a part of the diet for 
many who had a higher selenium status and, as has been suggested, could provide a 
reasonably convenient and cost effective mode for increasing selenium intakes in the 
population. 
The analysis of subjects by GPx-1 genotype was unfortunately hindered by the sample 
size and genotype distribution, and did not appear to be a significant factor in this 
population. Despite this finding, such polymorphisms will remain of interest due to 
the increasing evidence of associations between selenoprotein polymorphisms and 
chronic disease (Meplan et al. 2007; Cooper et al. 2008; Jablonska et al. 2008; 
Meplan et al. 2008). 
At this time, the relationships and the mechanism of any relationship between 
selenium status and serum lipids remain unclear, and the association of selenium with 
cardiovascular disease is also uncertain. However, it is noted that Tasmania has high 
rates of chronic disease, particularly cardiovascular disease, and also some cancers 
(A.B.S. 2006a). 
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6.5 Study B: Copper and zinc status in a population study in 
northern Tasmania 
6.5.1 Background 
Copper and zinc are important components of numerous proteins with wide ranging 
roles including antioxidant defence, gene expression and cellular respiration. Mild 
copper deficiency is associated with impaired immune response, altered lipid 
metabolism and haematological abnormalities while mild zinc deficiency can cause 
delayed wound healing, altered immune function and stunted growth and 
development. Like selenium, overt deficiency of copper or zinc is rare. Marginal 
copper status is thought to be much more common, and it has been suggested that 
perhaps 20% of the world's population may be affected by mild zinc deficiency 
(Sanghvi et al. 2007). Populations in developing countries are thought to be most at 
risk, but experience in developed countries with other trace elements such as selenium 
and iodine suggests that populations in these countries are not immune to such 
problems. 
Despite the importance of these trace metals, data regarding copper or zinc status in 
Australian populations is limited. Our preliminary research has suggested that some 
sub-sections of the Tasmanian population may be at risk of inadequate zinc status. 
This population study of approximately 500 participants which analyses dietary 
intakes as well as biochemical markers of copper and zinc status is the largest and 
most detailed study of its type in Australia to date. 
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6.5.2 Results 
Subject characteristics 
Sample demographics and anthropometric data are described in Chapter 6 - Study A: 
Selenium status in a population study in northern Tasmania (pg. 162). 
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Effects of gender, smoking and age 
Gender 
Mean dietary energy intake and absolute intakes of copper and zinc were significantly 
higher in men (P <0.001, P = 0.002 and P <0.001 respectively) (Table 6.10). Men 
and women did not differ with respect to serum zinc or RBC SOD (P > 0.05). Women 
had a significantly higher serum copper concentration (P < 0.001), and although 
women consumed lower absolute intakes of copper and zinc, their diet had 
significantly higher nutrient density for these minerals (both P < 0.001); they also 
consumed more copper and zinc per kg bodyweight compared to men (P = 0.003 and 
P = 0.045 respectively). 
Table 6.10: Dietary and biochemical indices of copper and zinc status 
All Subjects Male Female 
n = 498 n = 192 n = 306 
Energy, MJ 7.69 ± 2.71 (2.05 - 20.90) 9.11 ± 2.72 6.81 ± 2.29 <0.001 
Cu intake, mg/d 1.5 ± 0.5 (0.2 - 4.2) 1.6 ± 0.6 1.4 ± 0.5 0.002 
Cu intake, pg/kg/d 19.9 ± 8.8 (3.0 - 60.0) 18.5 ± 8.0 20.9 ± 9.2 0.003 
Cu intake, pg/MJ/d 0.20 ± 0.60 (0.08 - 0.41) 0.18 ± 0.05 0.21 ± 0.06 <0.001 
Zn intake, mg/d 11.6 ± 4.0 (3.5 - 33.4) 12.6 ± 4.4 10.9 ± 3.6 . <0.001 
Zn intake,i.ig/kg/d 156.4 ± 58.4 (50.0 - 510.0) 149.8 ± 56.1 160.6 ± 59.5 0.045 
Zn intake, lig/MJ/d 1.56 ± 0.39 (0.68 - 3.51) 1.41 ± 0.36 1.65 ± 0.38 <0.001 
Serum Cu, umol/L 17.6 ± 3.8 (9.5 -44.8) 15.5 ± 2.7 18.9 ± 3.9 <0.001 
Serum Zn, union 13.0 ± 2.4 - (7.5 - 24.5) 13.0 ± 2.4 13.0 ± 2.5 0.946 
RBC SOD, U/g Hb 1306 ± 253 (500 - 2363) 1323 ± 237 1295 ± 261 0.218 
Values are mean ± sd 
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Smoking 
When adjusted for gender, mean energy intakes and intakes of copper and zinc, both 
absolute and adjusted, appeared higher in non-smokers (Table 6.11), however only the 
difference in nutrient density of copper reached statistical significance (P = 0.023). 
A gender comparison of copper and zinc data was made for smokers versus non-
smokers (Appendix 2). The only significant difference observed was the higher serum 
copper in the 9 male smokers (17.6 v. 15.4 prno1/1.; P = 0.001) compared to the non-
smokers. 
Table 6.11: Dietary and biochemical indices of smokers and non-smokers 
Current Smokers 
n = 39 
Non-smokers 
n = 459 
Energy, MJ 6.97 ± 3.03 7.76 ± 2.67 0.383 
Cu intake, mg/d 1.3 ± 0.7 1.5 + 0.5 0.081 
Cu intake, gg/kg/d 18.6 ± 9.7 20.1 + 8.7 0.453 
Cu intake, ptg/MJ/d 0.18 ± 0.05 0.20 ± 0.06 0.023 
Zn intake, mg/d 10.9 ± 6.1 11.6 ± 3.7 0.521 
Zn intake, gg/kg/d 150.7 ± 65.7 156.7 ± 56.5 0.809 
Zn intake, pg/MJ/d 1.50 ± 0.34 1.56 ± 0.38 0.528 
Serum Cu, gmol/L 18.4 ± 2.8 17.5 ± 3.4 0.245 
Serum Zn, pmon 13.4 ± 2.5 13.0 ± 2.4 0.170 
RBC SOD, U/g Hb 1329.8 ± 225.7 1305.2 ± 255.4 0.632 
Adjusted for gender 
Values are mean ± sd 
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Copper 
The lowest mean copper intakes for men (1.3 mg/d) were observed in the 25-34 year 
age range; significantly lower than intakes of men in the 45-54 yrs (P = 0.027) and 
65-74 yrs ( P = 0.011) age ranges. Women in the 45-54 yrs age range apparently had 
the lowest mean copper intakes (1.3 mg/d) but it was not significantly lower than in 
other age ranges. Mean serum copper was highest in the 75-84 yrs range in men (16.2 
gmol/L) and in the 25-34 yrs range women (21.6 gmol/L) but differences between 
age ranges were not statistically significant. 
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Figure 6.4: Dietary copper intakes and serum copper concentrations in age range and 
gender sub-groups. *Copper intake in men aged 25-34 yrs significantly lower than in 
45-54 yrs (P = 0.027) and 65-74 yrs age range (P = 0.011). Values are mean ± sd. 
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Zinc 
Lowest mean zinc intakes were observed in men aged 75-84 yrs (12.2 mg/d) and in 
women aged 45-54 yrs (10.1 mg/d), however differences between age ranges for each 
gender were not significantly different. The lowest mean serum zinc for men (11.5 
gmol/L) and women (11.6 gmol/L) was observed in the 75-84 yrs age group, however 
only in men were there significant differences between age ranges. Men aged 35-44 
yrs (13.6 v. 11.5 gmol/L; 95%Cl of difference 0.7-3.5; P = 0.011) and 45-54 yrs (14.0 
v. 11.5 mon; 95%CI of difference 1.1-3.7; P = 0.001) both had higher serum zinc 
than the oldest age range. 
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Figure 6.5: Dietary zinc intakes and serum zinc concentrations in age range and 
gender sub-groups. *Serum zinc in men aged 75-84 yrs significantly lower than men 
in 35-44 yrs (P = 0.011) and 45-54 yrs age range (P = 0.001). Values are mean ± sd. 
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Copper status 
The mean dietary copper intake for men (1.6 mg/d) was below the Al of 1.7 mg/d; 
68% of men consumed less than the AI. The mean intake in women (1.4 mg/d) was 
above the Al of 1.2 mg/d; however 36% did not consume the Al. In men, subjects in 
the 25-34 yrs age range were least likely to consume the Al; 100% of male subjects 
did not consume the Al in this age range compared to 78%, 61%, 68%, 67% and 73% 
for the subsequent age ranges 35-44 yrs, 45-54 yrs, 55-64 yrs, 65-74 yrs and 75-84 yrs 
respectively. In women, 50% of subjects aged 45-54 yrs consumed less than 1.2 mg/d, 
compared to 32%, 41%, 35%, 30% and 20% in the 25-34 yrs, 35-44 yrs, 55-64 yrs, 
65-74 yrs and 75-84 yrs age ranges respectively (Table 6.12). 
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Figure 6.6: Distribution of estimated copper intakes of all subjects. 
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Only 3 subjects had serum copper concentrations below the lower end of the clinical 
reference range of 11 umol/L; 2 males and 1 female. 
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Figure 6.7: Frequency distribution and cumulative proportion of population and 
samples estimates of serum copper concentrations. 
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Zinc status 
Mean zinc intake for men was 12.6 ± 4.4 mg/d. Over half of the male subjects (52%) 
consumed less than the zinc EAR of 12 mg/d. The mean intake for women was 10.9 ± 
3.6 mg/d and only 9% of females failed to consume the EAR of 6.5 mg/day. The 
proportion of men who consumed less than the zinc EAR increased in each successive 
age range (Table 6.12). In the 25-34 yrs age range 22% of men consumed less than 
the EAR but this rose to 73% in the 75-84 yrs age range. A similar trend was not 
observed in women; no subjects in the 75-84 yrs age range consumed less than the 
EAR and the greatest proportion of subjects to do so were in the 45-54 yrs age range 
(14%). 
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Figure 6.8: Distribution of estimated zinc intakes of all subjects. 
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Table 6.12: Prevalence in age ranges of <AI intakes of copper and 
<EAR intakes of zinc. 
<AI Copper 
Age range 
years 
Men 
n (%) 
Women 
n (%) 
All subjects 
n (%) 
25-34 9 (100) 6 (32) 15 (54) 
35-44 14 (78) 15 (41) 29 (53) 
45-54 17 (61) 29 (50) 46 (53) 
55-64 41 (68) 35 (35) 76 (48) 
65-74 42 (67) 24 (30) 66 (46) 
75-84 8 (73) 2 (20) 10 (48) 
All 131 (68) 111 (36) 242 (49) 
<EAR Zinc 
Age range Men Women All subjects 
years n (%) n (%) n (%) 
25-34 2 (22) 1 (5) 3 (11) 
35-44 6 (33) 3 (8) 9 (16) 
45-54 13 (46) 8 (14) 21 (24) 
55-64 33 (55) 7 (7) 40 (25) 
65-74 38 (60) 8 (10) 46 (32) 
75-84 8 (73) 0 (0) 8 (38) 
All 100 (52) 27 (9) 127 (26) 
<WHO Serum zinc cut-off 
Age range Men Women All subjects 
years n (%) n (%) n (%) 
25-34 0 (0) 3 (16) 3 (11) 
35-44 0 (0) 2 (5) 2 (4) 
45-54 1 (3) 6 (11) 7 (8) 
55-64 10 (17) 4 (4) 14 (9) 
65-74 13 (21) 3 (4) 16 (11) 
75-84 4 (36) 3 (30) 7 (33) 
All 28 (15) 21 (7) 49 (10) 
AI - adequate intake: men 1.7 mg/d, women 1.2 mg/d 
EAR - estimated average requirement: men 12 mg/d, women 6.5 mg/d 
WHO serum zinc cut-off: men 10.7 nmol/L, women 10.1 pmol/L 
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Compared to WHO serum zinc cut-off values, 15% of males and 7% of females had 
low serum zinc (Table 6.12). In men <45 yrs there were no incidences of serum zinc 
below the WHO cut-off, however the incidence increased with age. In the 45-54 yrs 
age range only 3% had serum zinc below this value, but this increased to peak at 36% 
in the 75-84 yrs age range. In women the greatest proportion of serum zinc 
concentrations below the cut-off also occurred in the oldest age range (30%), but the 
next greatest proportion was seen in young females (25-34 yrs) with 16%. 
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Figure 6.9: Frequency distribution and cumulative proportion of population and 
sample estimates of serum zinc concentrations. 
Adjusted population estimates 
In population estimates weighted for age, gender and socioeconomic status, the 
proportion of sub-AI copper intakes was estimated to be significantly lower (51 v. 
44%; P = 0.048), but the prevalence of low zinc intakes and serum levels were not 
significantly different (Table 6.13). 
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Table 6.13: Population estimates of prevalence of <AI copper intakes, 
<EAR zinc intakes and <WHO serum zinc cut-off values. 
Dietary copper intake 
% with intakes <AI 
Sample estimate 51% 
95% C.I. (0.46 - 0.55) 
Population estimate 44% 
95% C.I. (0.40 - 0.49) 
Risk ratio 0.88 
95% C.I. (0.77 - 1.00) 
P value 0.048 
Dietary zinc intake 
% with intakes <EAR 
Sample estimate 26% 
95% C.I. (0.22 - 0.30) 
Population estimate 25% 
95% C.I. (0.21 -0.29) 
Risk ratio 0.96 
95% C.I. (0.78 — 1.19) 
P value 0.720 
Serum zinc levels 
Mean serum zinc (pmol/L) 
Sample estimate 13.0 
Population estimate 13.2 
% with serum zinc <WHO cut-off 
Sample estimate 10% 
95% C.I. (0.07 -0.13) 
Population estimate 9% 
95% C.I. (0.07 -0.12) 
Risk ratio 0.94 
95% C.I. (0.64— 1.38) 
P value 0.750 
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consumed proportionally more copper than women from meat (8.1 v. 6.9%; P < 
0.001), mixed dishes (3.4 v. 2.3 %; P <0.001) and alcoholic beverages (3.6 v. 1.5%; P 
< 0.001). In women, significantly greater contributions were made from vegetables 
(34.3 v. 32.3%; P = 0.039), dairy-based foods (5.5 v. 4.4%; P <0.001) and fruit (16.4 
v. 13.6%; P <0.001). 
Age group comparisons revealed significant differences in the contribution of meat 
between the 35-44 and the 65-74 yrs range (8.2 v. 6.7%; P = 0.024). Vegetables were 
greater contributors proportionally for the 55-64 yrs age range (35.4%) compared to 
the 25-34 yrs range (31%; P = 0.024) and 45-54 yrs range (31%: P = 0.011). Mixed 
dishes were a greater contributor in the 25-34 yrs age range (5%) compared to the 45- 
54 yrs (3.5%; P = 0.023), 55-64 yrs (2.4%), 65-74 yrs (1.9%) and 75-84 yrs .(1.4%) 
age ranges (all P < 0.001). 
Zinc 
The major contributors to zinc intakes were meat products, cereal-based foods, 
vegetables and dairy foods (Figure 6.11). In men, meat (31.6 v. 26.3%) and mixed 
dishes (5.7 v. 4.0%) made significantly higher contributions to zinc intakes compared 
to women (both P <0.001), while vegetables (19.4 v. 16.8%), dairy-based foods (20.1 
v. 16.3%) and fruit (6.7 v. 5.7%) made greater contributions (all P <0.001) to zinc 
intakes in women. 
There were also several small but significant differences amongst age groups. 
Vegetables were significantly lower contributors to zinc intakes in the 25-34 yrs 
group when compared with the 65-74yrs age group (16.1 v. 19.5%; P = 0.038). Fruit 
was a greater contributor in the 75-84 yrs age group compared to the 35-44 yrs age 
group (6.7 v. 5.0%; P = 0.048), while mixed dish foods made their highest 
contribution in the 25-34 yrs age group (7.9%); significantly higher than in the 35-44 
204 
57%004,s, 
04. 
kticv 
11:1: 
<-64' 7," 
v 
.> 
nir 
Figure 6.11: M
ajo
r contributing food  grou p
s to
 zinc intake in
 population subgroups. 
*(I
00
.0
 > 
d  
sd
no
i
a2
g  yrs group
 (5.5%
; P = 0 .008) , 55-64 yrs (4.3%
), 65-74 yrs (3.6%
) and  75-84  yrs
 (2.8%
) 
% Contribution to dietary intake 
d`i 
	
F?. 
	
1111111111111111111111111111111111 	 
1111111111111111111111111111111 
111111111111111111111111111111111111 	 
111111111111111111111111111111 	 
1111111111111111111111111111111 	 
MRMIEN1111111111111111111111111111111 	 
:::E.:::::::::::::::=111111111111111111111111111111111111 	 
111111111111111111111111111111111111 	 
&galigli 11111111111111111111111111111111111 
:s
dn
o.
16
 p
oo
l  6
up
cip
lu
o0
  
sk\.  
se
qs
!p
  p
ex
ats
j  
-n 
2 
pa
se
qi
ee
ia
o  0 a) . 
( t). 
Other associations 
Dietary intake of copper was not significantly associated with serum concentrations of 
copper (P = 0.500). Serum copper had a significant positive association with RBC 
SOD activity (P = 0.024), bodyweight (P = 0.013), BMI (P = 0.003) and dietary 
carbohydrate (P < 0.001). Serum copper was negatively associated with serum 
selenium (P = 0.013), but was not significantly associated with serum RBC GPx (P> 
0.05). A positive association was observed between serum copper and serum total 
cholesterol (P = 0.032) and serum LDL-cholesterol (P = 0.049). 
Dietary zinc was also not significantly associated with serum concentrations of zinc 
(P = 0.348). Serum zinc concentration had a strong positive association with serum 
TAS (P <0.001) but not RBC SOD (P ---- 0.178), nor serum or RBC GPX (both P> 
0.05). 
Like copper, serum zinc was positively associated with serum total cholesterol (P = 
0.001) and serum LDL-cholesterol (P < 0.001) but negatively with serum HDL-
cholesterol (P = 0.005). Serum zinc concentration was also positively associated with 
BMI (P = 0.011) but negatively with socioeconomic status (P = 0.003). 
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Characteristics of copper and zinc status groups 
Dietary and lifestyle characteristics of the various copper and zinc status groups 
within the population sample are summarised in Table 6.14 
Subjects with copper intakes <AI 
Of all the variables measured, the major commonality of subjects with low intakes 
appeared to be lower food consumption overall as indicated by lower energy intakes. 
There were small differences in the contribution of various food types, increased 
multivitamin and mineral usage and rates of smoking. 
Subjects with zinc intakes <EAR 
Subjects consuming <EAR of zinc were mostly older males. The lower intakes 
appeared to be related mainly to significantly lower food intake overall. 
Subjects with serum zinc <WHO cut-off 
Subjects with low serum zinc were mostly older males who consumed a diet with 
lower zinc nutrient density and a considerable reduction in zinc from meat sources. 
Men in this group had higher socioeconomic status and lower body mass index. 
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Table 6.14: Copper and zinc status group characteristics in comparison to other study subjects. 
Subjects consuming <AI copper 	 Subjects consuming <EAR zinc 	 Subjects with serum zinc <WHO cut-off 
(n = 242) 	 (n = 127) 	 (n = 49) 
Dietary intakes and contributors 
• 24% lower mean energy intake in men (8.31 v. 10.94 MJ) (P 	• 24% lower energy intake in men (7.91 v. 10.47 MJ) (P < 
<0.001); 29% lower energy intake in women (5.40 v. 7.62 	0.001); 41% lower energy intake in women (4.18 v. 7.06 MJ) 
MJ) (P < 0.001). 	 (P < 0.001). 
• Contributions were higher from meat (8 v. 6%) and dairy 
products (6 v. 5%), but lower from cereal-based foods (26 v. 
29%) and fruit (14 v. 17%) (all P <0.001). 
• Energy intakes not significantly different. Nutrient density 
was 8% lower (P = 0.017) in subjects with low serum zinc. 
• Meat sources provided 28% less zinc in men (P <0.001). 
Supplement use 
• Compared to others, subjects consuming <Al used 	 • Use of combined multivitamin & mineral supplements was 	• Use of combined multivitamin & mineral supplements was 
multivitamin/mineral (18% v. 28%) and mineral (13% v. 	 similar (24% v. 19%). Only 13% used individual mineral 	 similar compared to other subjects (30 v. 23%), as was use 
24%) supplements less frequently 	 supplements (eg calcium) compared to 21% of other subjects. 	of individual mineral supplements (25 v. 18%). 
Other 
• No significant difference in age, gender distribution or 	• No significant difference in smoking or socioeconomic status. 	• Men had 9% lower BM1 than other subjects (P <0.001), 
socioeconomic status. 	 • Mean age of male subjects was 5.6 years older than other 	 similar trend in women did not reach significance (P =0.063) 
• 12% of this group were current smokers compared to 4% of 	subjects (56.0 v. 61.6 yrs; P = 0.001). 	 • No significant difference in smoking rates. 
all other subjects 	 • In men, socioeconomic status was significantly higher (P = 
0.003). 
6.5.3 Discussion 
Copper 
The assessment of nutritional adequacy for copper is hindered by the lack of an 
Australian EAR value for copper intakes, and uncertainty over target levels of 
biochemical indices such as serum copper. Copper intakes are also likely to be 
underestimated when the copper content of drinking water is not considered in daily 
intakes. The major source of copper in drinking water is the copper pipes and fittings 
commonly used in household plumbing which, while relatively stable, can contribute 
significant amounts of copper to water with low pH or low hardness levels. The 
NHMRC Australian Drinking Water Guidelines (2004) suggest that copper content in 
drinking water should not exceed 2 mg/L and that while copper in major Australian 
reticulated supplies copper may range as high as 0.8 mg/L, typical levels are 
approximately 0.05 mg/L. 
Dietary intakes 
A large proportion of the study subjects were estimated to consume copper at levels 
below the Al. Such an estimate however cannot be used to suggest an inadequacy in a 
population in the same way as one can assess intakes using the EAR cut-point, as the 
Al is simply a value which is expected to exceed the requirements of almost all 
members of a given age or gender group. An Al value will be above the true nutrient 
EAR or RDI value, so when a group has a mean intake above the Al, it suggests that 
the prevalence of inadequacy is likely to be low. Because of the uncertainty of the 
specific nutrient requirements, mean intakes below the Al cannot be used in the same 
way to indicate the prevalence of inadequacy. 
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In the current study, men had mean intakes below the Al, while women's intakes were 
above the Al. Given the limitations in using an AI for nutritional assessments, the 
only conclusion that may be made is that in the women in this study, an inadequacy of 
copper intake is probably unlikely. 
Comparison of copper intakes from the current study with the US EAR of 0.7 mg/d 
produces an interesting result. In this case 20 of 498 subjects (4%) had intakes that 
fell below the US EAR which just exceeds the 3% level which has been suggested by 
the US Food and Nutrition Board/Institute of Medicine to indicate increased risk of 
inadequacy (Food and Nutrition Board 2000c). Of further interest is that 19 of the 20 
were females which equates to 6% of the female subjects in this study. While this 
EAR is a US value and the Australian Al is based on Australian intake data, the 
discrepancy between the findings based on Al and EAR values highlights the 
uncertainty that exists in copper requirements and hence the current difficulty 
associated with assessing nutritional adequacy in populations. 
Despite men consuming significantly more copper, and women eating a more copper 
dense diet, there were only minor differences in the contribution of the various food 
groups to copper intakes. As with selenium, men consumed more copper from mixed 
dishes (which includes many takeaway style foods) and alcoholic beverages, as well 
as meat products, and women having increased intakes from vegetables, fruit and 
dairy foods. The contribution of meat to copper intakes appeared to decrease slightly 
with increases in age, while intakes from fruit and vegetable sources rose, a trend 
which may be due to some of the older subjects having difficulty consuming meat 
meals. Unsurprisingly, the youngest age range consumed significantly more copper 
from mixed dishes, but what was perhaps surprising was that this group consumed the 
lowest amount from alcoholic beverages. This was not due to differences in the type 
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of alcoholic beverages consumed, but rather due to lower reported total consumption 
of alcohol in these younger subjects. 
There were few significant differences across the age ranges in either gender, however 
copper intakes and serum copper concentrations generally followed the same trend; 
the age ranges that consumed the lowest and highest copper intakes also had the 
lowest and highest serum copper concentrations respectively. 
Mean adjusted copper intakes (j.tg/MJ/d) were significantly lower in smokers 
compared to the non-smoking subjects, which may be explained by a greater 
contribution from meat and a reduction from some cereal-based foods and fruit, foods 
which have comparatively higher copper-energy densities. 
Copper intakes in the current study were lower than in most of the previously reported 
Australian data. Mean intakes of women were 10% lower than the reported intakes in 
a study of Victorian women estimated using food frequency questionnaires 
(Cleverdon 2003). Only the intakes in the 25-34 yrs (1.56 mg/d) and 75-84 yrs age 
range (1.50 mg/d) approached the mean intake of 1.56 mg/d reported in the Victorian 
study. This study also reported lower intakes in young women in contrast to the 
current study where young women consumed the highest mean intakes. The author 
suggested the lower intakes in young women were related to higher consumption of 
takeaway style foods, a trend that, though not statistically significant, was evident in 
this study. Despite this similarity, the young women in the current study consumed 
relatively high copper intakes, which appeared to be due to greater total energy 
intakes in this age range. 
The international Total Diet Study (Parr et al. 2006) estimated copper intakes from 
different Australian cities by analyzing six daily diet samples by neutron activation 
analysis. This study's median intake of 1.83 mg/d was far above the current study 
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median intake of 1.4 mg/d, however a limited sample was used, the methodology was 
direct measurement rather than diet recording and a lack of demographic data hinders 
any comparison. The Total Diet Study involved over 20 countries, and while its 
estimate of 1.82 mg/d placed Australia towards the top of the range for intakes among 
these countries, the median intake of the current study appears moderate on this scale, 
being of a similar level as the reported intakes from Italy, China and Thailand. 
The 20th  Australian Total Diet Survey undertaken by FSANZ (2003) only reported 
intakes per kg bodyweight for men and women aged 25-34 yrs. The estimate of 16 
lig/kg/d for men was higher than the current study estimate of 14.8 jig/kg/d for men of 
this age. However, women in the current study consumed considerably more 
compared to the Total Diet Survey estimate (19.5 v. 14 pig/kg/d). 
Serum copper 
An assessment of nutritional adequacy based on serum copper is equally problematic 
as there is currently no accepted serum concentration cut-off like that adopted by the 
WHO for zinc (Gibson et al. 2008), or the selenium level widely associated with 
maximal GPX activity (Elsom et al. 2006). In the absence of such cut-off target 
values, the only comparison that can be made for serum copper concentrations is with 
the clinical reference range, and in this study less than 1% of subjects had serum 
copper concentrations below the lower reference range of 11 jimol/L, indicating that 
the prevalence of clinically low serum copper in this sample was particularly low. 
Men consumed more copper than women; however, across all age ranges women had 
higher mean copper concentrations. This is not unexpected due to the influence that 
female hormones and particularly the use of oral contraceptives are known to have on 
serum copper concentrations (Johnson et al. 1992; Louro et al. 2001). The influence 
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of hormones may explain the highest serum copper in women occurring in the peak 
childbearing and oral contraceptive usage age range of 25-34 yrs and then tapering 
towards old age where hormone levels may be expected to fall. Serum copper in men, 
conversely, was relatively stable across the various age ranges. 
There is no Australian data on serum copper from comparable subjects with which the 
data from the current study can be compared. There is also limited published data 
from elsewhere in the world; however serum copper concentrations from the current 
study are similar to these. The mean serum copper in men of 15.5 mon, was slightly 
higher than that reported from an English study (14.8 timol/L; n = 95) (Ghayour-
Mobarhan et al. 2005), and slightly lower than in Northern Ireland (17.9 [anon; n = 
1144) (McMaster et al. 1992) and the US (17.5 mon; n = 2113) (Ford 2000). The 
mean serum copper in women of 18.9 mon compared to the same studies was also 
higher than the English data (17.5 mon; n = 94), but lower than the Northern 
Ireland (19.0 nmol/L; n = 1055) and US values (20.9 mon; n = 2461). 
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Zinc 
Dietary intake 
Dietary analysis in this study indicated that 26% of subjects consumed inadequate 
zinc intakes; with 52% of men and 9% of women consuming less than the EAR. 
The WHO has determined that the risk of zinc deficiency is elevated when the 
prevalence of inadequate intakes (<EAR) in a population is >25% (de Benoist et al. 
2007). The estimate of 26% of subjects from this sample who consumed inadequate 
zinc did not vary significantly when an adjusted population estimate weighted for 
gender, age and socioeconomic status was made. So, while it appears females may not 
be considered to be at risk of deficiency by the WHO definition, men in this 
population are. 
While there were no significant differences in mean zinc intakes between various age 
ranges, in men, the prevalence of sub-EAR intakes increased with each successive age 
range, until nearly three quarters of men aged 75+ years consumed inadequate zinc. A 
similar pattern was not observed in women where peak incidences of low zinc intakes 
occurred in the middle age ranges. In both men and women, sub-EAR intakes 
generally coincided with significantly lower energy intakes, suggesting that rather 
than a change in the types of foods eaten, and a subsequent decrease in nutrient 
density, the major difference was simply a reduction in the overall amount of food 
eaten in these subjects. 
The large discrepancy between the proportion of men consuming inadequate zinc 
(52%) and those with low zinc status (15%) was not evident in women; a pattern that 
was also observed in the pilot study (Chapter 5). This perhaps suggests that for men in 
this population the EAR may be higher than required and hence sub-EAR intakes may 
not be as accurate as a predictor of the risk of zinc inadequacy. Determining the 
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possible cause of this is outside of the scope of this study, but may result from a 
greater bioavailability of zinc in the foods consumed or a lower zinc 
turnover/requirement in this population. 
Major contributing food types were meat, cereal-based foods, vegetables and dairy 
foods. Meat was a significantly greater contributor to zinc intakes in men compared to 
women, and the higher bioavailability zinc from such sources (Lonnerdal 2000; 
Brown et a/. 2004), is perhaps important for men in this sample to maximize the 
absorption from seemingly inadequate intakes. 
Men in this study consumed slightly less zinc than estimated in the only other 
published Tasmanian data. The National Nutrition Survey (NNS) estimated zinc 
intakes of 13,858 Australian participants aged 19+ years (McLennan and Podger 
1995). Tasmanian men in this study were estimated to consume 13.5 mg/d, which was 
lower than the national average for men of 14.4 mg/d. Intakes in men were also lower 
than those reported in a study by English and colleagues (1997) (17% lower) and in 
the 20th  ATDS (FSANZ 2003) (13% lower). Women, however, consumed a similar 
zinc intake as estimated by English and colleagues (10.9 v. 10.5 mg/d), 20% more 
than Tasmanian women from the NNS and 30% more than estimated in the 20th  
ATDS. Whether these differences are a reflection of actual variation between the 
different populations sampled, or a product of the different methodologies, ranging 
from 241u- diet records to direct food analysis, is uncertain. There has also been some 
suggestion of changes in trace element contents in the food supply (Klevay and 
Medeiros 1996; Lyons et al. 2004). The comparison of intake data is therefore 
difficult between studies employing differing methodologies and those separated by 
considerable periods of time. 
215 
Serum zinc 
Overall, 10% of the study subjects had serum zinc concentrations below the WHO 
cut-off. The WHO has determined that a population subgroup is considered at risk of 
zinc deficiency when >20% have serum zinc levels below the respective cut-off. By 
this definition this study cohort as a whole is not considered at increased risk. 
However, when the serum zinc of each gender and age range subgroup is compared 
with the cut-off, this finding is altered. Whilst overall only 15% of men and 7% of 
women have low serum zinc, the proportion of subjects with low zinc levels rises 
substantially in particular age ranges. In men over 55 years, 20% had low serum zinc, 
while 23% of those over 65 years and 57% over 75 years had low serum zinc. In 
women 30% of those over 75 years were also below the cut-off level. 
This finding ties in with the dietary analysis, at least in the men, which estimates 
greater proportions of male subjects in the older age groups were likely to consume 
inadequate dietary zinc. In addition, a considerable decrease in protein intake in these 
men, particularly the oldest age group (17% decrease in protein compared to 25-34 
yrs and a 23% decrease compared to 35-44 yrs) and not only is zinc intake decreased 
in these subjects but bioavailability of the zinc consumed may well be reduced 
compared to other subjects. 
Men with low serum zinc were found to have a significantly lower BMI, but higher 
socioeconomic status, reflecting the associations both variables have with serum zinc 
over the whole sample. Because of the design of this study it is not possible to 
determine whether either have a causal relationship on serum zinc. BMI has 
previously been found to be inversely associated with serum zinc (Ghayour-Mobarhan 
et al. 2005), which may be because people with higher body mass have higher zinc 
requirements. In this study, however, the lower BMI of subjects with low serum zinc 
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most likely results from the direct relationship between energy intakes and zinc 
intakes. 
The inverse relationship of socioeconomic status with serum zinc appears to be in 
contrast with an association that is commonly observed between higher 
socioeconomic status and higher quality diets with increased diet nutrient density 
(Giskes et al. 2002; Beydoun and Wang 2008). In this study, zinc intakes, both 
absolute and adjusted, were not associated with socioeconomic status. The 
contribution of meat to zinc intakes appeared to be lower with increasing 
socioeconomic status. However, when analysed on a gender basis, this association 
was only observed in men, and was only statistically significant in the older age 
range, suggesting this effect was probably more related to age than socioeconomic 
status. 
In Australia, data on serum zinc concentrations is very limited. The only study to 
report serum zinc was a small study of 42 participants (Ball and Ackland 2000). Men 
(13 iimol/L; n = 21) and women (13.9 !Amon; n = 21) in this study had mean serum 
zinc similar to the current study. 
Comparable data from healthy adult populations in other countries is also limited. A 
small study in England (Ghayour-Mobarhan et al. 2005) reported similar serum zinc 
levels in a sample of slightly younger men (13.9 !Amon) and women (13.3 'Amon) 
(mean age 45 and 49 years respectively). Reported serum zinc levels were also similar 
in a large Northern Ireland study (McMaster et al. 1992) for both men (13.2 gmol/L; 
n = 1142) and women (12.7 !Amon; n = 1034). This study reported a significant 
decline in serum zinc concentrations with age in men, but not in women. In a New 
Zealand study (De Jong etal. 2001) of elderly women (mean age 74.9 years; n = 102), 
mean serum zinc (12.4 Amon) was higher than women of a similar age range in the 
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current study (11.6 umol/L). All of the aforementioned studies utilized similar FAAS 
methodology for serum zinc analysis. 
Associations with cardiovascular risk factors 
In this study both serum copper and serum zinc were observed to have significant 
associations with cardiovascular risk factors such as serum total cholesterol, serum 
LDL-cholesterol and BMI. Such findings are not unexpected, particularly for copper, 
and have been reported in a number of other studies (Salonen et al. 1991; McMaster 
etal. 1992; Abiaka etal. 2003; Ghayour-Mobarhan etal. 2005). 
Copper 
Copper has been associated with various cardiovascular risk factors, atherogenesis 
(Salonen etal. 1991) and cardiovascular disease (Ford 2000; Leone et al. 2006). 
In this study, copper was positively associated with serum total cholesterol, serum 
LDL-cholesterol and BMI in concordance with several studies (Salonen et al. 1991; 
McMaster et al. 1992; Abiaka et al. 2003), but is in contrast to others that have 
observed negative relationships between copper and such risk factors (Stern et al. 
2007). Such disagreement suggests that the relationship between copper and various 
cardiovascular risk factors is likely complicated by many factors, such as dietary 
intake levels, lifestyle factors and possibly genetic variability. 
Zinc 
In this study serum zinc was also observed to be positively related to serum total 
cholesterol and serum LDL-cholesterol but negatively with serum HDL-cholesterol. 
In contrast to copper, where there have been numerous studies indicating links 
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between copper status and various risk factors for cardiovascular disease, including 
serum lipids, findings of similar relationships with zinc are limited. A decline in 
serum HDL-cholesterol during high dose zinc supplementation has been observed in 
several studies (Hughes and Samman 2006), which is concordant with the inverse 
relationship in the current study between zinc and HDL-cholesterol. Given the wide 
range of roles in which zinc is involved through the numerous zinc proteins, it may be 
involved in lipid metabolism but at this point the basis for any such relationships is 
unknown, and hence any relationship has unknown significance in this population. 
6.5.4 Conclusion 
The assessment of copper status in this sample is limited by the constraints of our 
current incomplete understanding of copper requirements and their relationship to 
biomarkers such as serum copper. With this in mind, using the current Australian 
dietary recommendations as the basis of assessment, the copper status of women in 
this population does not appear to be inadequate; however the results are inconclusive 
for men at this time. If in the future, advancements in our knowledge of copper 
requirements can occur, the data from this study or the stored samples may be 
revisited or reanalysed and provide a more useful indication of copper status in this 
population. 
The assessment of zinc status has indicated that a significant proportion of the 
population may consume inadequate zinc. Dietary, intake data indicated that the 
prevalence of low zinc intakes exceeded the criteria used by FSANZ (>3% consuming 
<EAR) to indicate an increased risk of inadequate zinc intake (Food and Nutrition 
Board 2000c) and that used by the WHO to suggest an elevated risk of zinc deficiency 
(de Benoist et al. 2007). Older subjects and older men in particular, were at increased 
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risk of zinc deficiency. Interestingly, subjects with lower BMI also appeared to be at 
greater risk of low zinc status, which maybe simply due to a lower overall dietary 
intake in these subjects. 
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Chapter 7 
General discussion and conclusions 
The finding of selenium deficiency in the past in livestock across Tasmania has led to 
the development of a hypothesis that the human population of Tasmania may be at 
risk of inadequate selenium intakes. Previous small studies in the Tasmanian 
population have been limited and provided conflicting results. 
The research encompassed by this thesis focused on assessing the selenium status in a 
population sample from the north of the state, on which there was no previous data. 
The work toward this primary objective presented an opportunity to also assess the 
status of two other important trace elements, copper and zinc, for which published 
data is very limited in Australian populations. The study included concurrent dietary, 
lifestyle and blood analysis. A novel aspect was an initial assessment of the influence 
of some genetic factors, such as the HFE polymorphisms involved in hereditary 
haemochromatosis, and GPx-1 polymorphisms. 
This thesis therefore contributes significantly to the field of trace element nutrition. 
7.1 Preliminary research 
The findings from preliminary research (Chapter 5) suggested that a significant 
proportion of people in a convenience sample from northern Tasmania may have 
selenium intakes and serum selenium concentrations below that associated with 
maximal selenoprotein activity, and well below levels where the chemopreventative 
effects of selenium are postulated to be achieved. Copper intakes did not appear 
inadequate but, although subject numbers were low, there appeared a potential for a 
subset of men to have clinically low serum copper levels. There was also an indication 
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that a substantial proportion of men, especially older men, may be at risk of 
inadequate zinc status. 
An opportunity was also taken to investigate whether hereditary haemochromatosis, a 
genetic disorder of iron metabolism common in Tasmania, affected the status of other 
trace elements such as selenium, copper and zinc, and there appeared to be no major 
effect. 
7.2 Population study 
Selenium 
The large cross-sectional population study, based on the electoral roll, was conducted 
primarily to investigate the status of selenium, but also copper and zinc, in a more 
representative sample from this region of Tasmania (Chapter 6). The assessment of 
selenium status in a sample of nearly 500 subjects further supported the hypothesis 
that selenium intakes are inadequate in northern Tasmania. Approximately one quarter 
of both men and women consumed less than the EAR for selenium and eight out of 
every ten participants had a serum selenium concentration below that associated with 
selenoprotein requirements. Prevalence of this marginal selenium status was generally 
similar across gender and age ranges and independent of socioeconomic status; 
however the elderly appeared to be at increased risk possibly due to an overall lower 
food intake. Smokers were also at increased risk of reduced selenium status; having 
approximately 10% lower serum selenium than non-smoking subjects. 
Due to the variations in the response from different gender and age subgroups, a 
population estimate weighted for age, gender and socioeconomic status, using data 
from the 2006 Census, was made. This was not significantly different to the sample 
estimate and therefore suggests that the prevalence of marginal intakes and serum 
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levels in the population of northern Tasmania is likely to be similar to that estimated 
in the sample. 
Serum selenium levels were considerably lower than• those in a recent study of 
selenium status in the south of the state (Greater Hobart area), and while there were 
methodological differences, it raises a question of whether there may be variations in 
selenium status between different regions in the state. While the geographical area is 
small, significant regional variations in selenium status have been observed elsewhere 
in relatively small countries. A demonstration of regional variation in nutrient intakes 
in Tasmania may be significant and might be associated with the particularly high 
rates of chronic disease in certain areas in the north of the state. 
While further evidence from large randomised controlled trials is still required, a body 
of evidence suggests that people with marginal selenium status, as observed in this 
sample, could obtain possible chemopreventative benefit by increasing their selenium 
intakes. The chemopreventative action of selenium is currently thought to coincide 
with serum selenium levels >1.50 umol/L; in this sample, almost all subjects (97%) 
were below this level. If, in the future, selenium supplementation in people with 
marginal selenium status can be shown to have real benefits, there could be significant 
implications for this population. These findings, however, must be considered in light 
of some observations that selenium status in the higher range of normal may be 
associated with adverse health effects. 
Recent reports suggest that higher selenium status (Bleys et al. 2007), or selenium 
supplementation in subjects with already adequate selenium status, (Stranges et al. 
2007; Lippman etal. 2009) may be associated with increased risk of diabetes. Positive 
associations between selenium and fasting glucose levels have also been reported 
(Czernichow et al. 2006), while high levels of selenoproteins such as GPx have 
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previously been associated with insulin resistance in mice (McClung et al. 2004) and 
humans (Chen et al. 2003). 
Positive associations between selenium status and higher levels of serum lipids have 
also been reported recently, both in high selenium status populations such as the US 
(Bleys et al. 2008) as well as a marginal selenium status population in the UK 
(Stranges et al. 2009). As these were cross-sectional studies, further work in this area 
is required to determine the basis of such associations. 
Although these effects were mostly observed in populations with relatively high 
selenium status, and in some cases, in studies where secondary endpoints were used, it 
appears caution must be taken prior to recommending supplementation for 
populations which are perhaps marginally selenium replete. It seems apparent that 
from emerging evidence regarding the influence of genetic variation among 
selenoproteins on the response to dietary selenium and associations with chronic 
disease (Meplan et al. 2007; Voetsch et al. 2007; Cooper et al. 2008; Jablonska et al. 
2008; Meplan et al. 2008), it may be inappropriate to suggest supplementation for all 
members of such a population. In selenium replete populations even greater caution 
may be required. In reality, the optimal selenium status probably varies from person to 
person based on genetics, gender, age and lifestyle factors such as smoking, and as 
such determining ideal intakes may be difficult without in-depth investigation of 
individuals. 
Due to the influence of genetic variation in selenoproteins, subjects in this population 
sample were genotyped for the GPx-1 Pro I 98Leu polymorphism. Although a number 
of studies have indicated a significant effect of some selenoprotein gene SNPs on 
protein product activities, there has been no previous report on the influence of the 
GPx-1 Pro I 98Leu polymorphism, an SNP associated with decreased GPx activity, on 
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selenium status indicators in an Australian population. This study was unable to detect 
a significant effect of GPx-1 Pro198Leu genotype on selenium status indicators, 
although the sample size may have been inadequate. Growing evidence relating to the 
importance of such polymorphisms should ensure they remain of interest because of 
the potential association with decreased selenoprotein activity, some cancers and 
cardiovascular disease. 
Copper and zinc 
The population study of copper and zinc status was a first in Australia; previous 
research on these trace minerals has been much smaller in scale, in specific population 
sub-groups and collected less detailed data. Internationally, large studies are also 
relatively scarce, despite growing awareness of the importance of copper and zinc, 
and suggestions that a large proportion of the worlds' population has micronutrient 
deficiencies. While the copper data from this study was inconclusive, mostly due to 
the lack of definitive nutritional assessment criteria for this nutrient, the findings from 
the assessment of zinc status indicated that certain subsections of the population, 
particularly older men, may be at risk of mild zinc deficiency. 
The proportion of subjects who consumed inadequate zinc exceeded the threshold of 
25% used by the WHO to define populations it considers to have an elevated risk of 
deficiency. When compared to the same organisations' cut-offs for serum zinc, the 
overall proportion of subjects with low serum zinc did not exceed the level (20%) 
used to identify populations considered at risk of zinc deficiency. However, 20% of 
the sub-group of men older than 55 years had low serum zinc, and the prevalence rose 
further with age. Over 20% of women aged 75+ years also had low serum zinc. A 
weighted population estimate suggested that the prevalence of low zinc intakes and 
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serum levels in the northern Tasmanian population would not vary significantly from 
this sample. 
7.3 Study limitations 
Limitations of this research include the general limitations of a cross sectional study 
design. That is, the data collected is a snapshot of trace element status at a single point 
in time for each subject. Various personal factors, such as short term health and 
lifestyle could affect status over time. It is not possible to determine causality for the 
associations detected between the variables measured. 
The main limitations specific to this study are associated with the sample composition 
and the methodology for estimating dietary trace element intakes. 
Despite using a randomly selected database extracted from the electoral roll in the 
target regions, the variable response meant the final sample composition had a greater 
representation of females and older subjects. In key data analyses, weighted 
population estimates using Census age, gender and socioeconomic distribution data 
were thus used to correct for these sampling imbalances. Differences in the sample 
and population estimates were not significant for any of the selenium or zinc analyses, 
and only just reached statistical significance for the dietary copper analysis. 
Dietary intake estimates have some general limitations and some specific to this 
study. Although they may be validated for specific nutrients, research using doubly 
labelled water has demonstrated that the FFQ can underestimate energy intakes 
significantly. The FFQ relies on a subject's memory as it requires subjects to recall 
both frequency and the portion sizes of foods eaten. Less educated, elderly subjects or 
those with poor eyesight may have difficulty completing the questionnaire accurately, 
leading to under or over reporting of food and nutrient intakes. A desire for social 
acceptability may also lead subjects to report consumption of various foods or 
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beverages, such as alcohol, differently. Perhaps most importantly, the FFQ is reliant 
on food content data tables to determine nutrient intakes. This is particularly 
important as the source of food content data varies; for specific nutrients and food 
types there may be very few measurements or the results may be calculated or 
borrowed from overseas tables. While such variation in data sources may not result in 
significant differences for some macronutrients, they may introduce significant error 
for nutrients that could be expected to vary geographically, as selenium was in this 
study. Should the reported values for such a nutrient not be representative of the foods 
commonly consumed in the geographical region being studied, intake estimates 
generated could well be inaccurate. In this case it is probably likely given the various 
sources of food content data for selenium that are currently used in Australia (see 
Appendix 1). Comparison of estimated nutrient intakes with other reported intakes 
determined using direct food analysis is also problematic for the same reason. 
Finally, the assessment of copper status in this population was compromised by the 
current lack of clear dietary requirements for copper in Australia, or any accepted 
nutritional assessment criteria using biomarkers such as serum copper. 
7.4 Future research 
The current research has indicated that the prevalence of marginal selenium was 
similar across age range and gender sub-groups and appeared to be independent of 
socioeconomic status. Future research on this topic should include assessment of 
selenium status of a large electoral roll sample from across the whole of Tasmania 
using the same methodology, to determine if the prevalence of marginal selenium 
status is similar in different regions. A survey of Tasmanian foods eaten, plus the 
analysis of local foods, would be useful to determine what differences there may be in 
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the major contributors to intakes, compared to the values in current Australian data 
tables. Studies of selenium status in other states may also be warranted. 
This research also indicates that men and older subjects in Tasmania may be at risk of 
mild zinc deficiency. Given the importance of zinc in many areas of human 
physiology, the findings in northern Tasmania suggest further investigation is 
warranted in Australia as a whole. 
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Appendix 1 
Examples of NUTTABO6 food content table derivation codes (FSANZ 2006). 
Food 	 Derivation 	code 
12C10166 Chocolate, Milk 	 A 
09D10130 Ice Cream, Vanilla, Reduced Fat 	 LAB 
09A10077 Milk, Skim 	 A 
09C10024 Yoghurt, Vanilla 	 A 
12D10022 Jelly, Prepared, Sugar Sweetened 
02A20040 Flour, White, Breadmaking 	 NNS 
02A10148 Rice Bran, Processed 	 IND 
02A10146 Oat Bran, Unprocessed US 
02D10108 Muesli, Toasted 	 A 
02B10126 Bread, White A 
06B10036 Orange, Navel, Leng, Raw, Peeled 	 A 
13A10793 Carrot, Mature, Peeled 	 A 
13A10979 Bean, Butter, Fresh, Boiled 
13A10901 Zucchini, Green Skin 	 A 
13A10912 Tomato, Common A 
05A10282 Tuna, Canned In Water, Drained 	 IMP 
08A10338 Beef, Round Steak, Grilled, Semi Trimmed 	 A 
05A10319 Sardine, Canned In Tomato Sauce 
05A10276 Sardine, Canned In Water, Unsalted, Drained 	 UK 
08E30153 Ham, Leg, Non Canned, Lean 	 A 
08C10166 Chicken, Breast, Baked, Lean A 
08E20065 Sausage, Beef, Fried, Home Prepared 	 A 
A — Analysed: derived from food analysis 
B — Borrowed: taken from overseas food composition table (country of origin 
denoted as US, UK or NZ) 
C — Calculated: calculated by FSANZ due to lack of suitable data 
IND — Industry: Provided by Australian food manufacturer; generated by various 
means 
IMP — Imputed: nutrient value assumed from similar food type 
LAB — Label: derived from food label information 
NNS — National Nutrition Survey: derived from data generated from the 1995 
National Nutrition Survey 
R — Recipe: derived from individual ingredient proportion of common recipe 
259 
Appendix 2 
Table: Gender comparison of copper and zinc data in currently smoking and non-smoking 
population study subjects. 
Men Current smokers 
n = 9 
Non-smokers 
n= 179 
Energy, MJ 9.05 ± 0.90 9.12± 0.93 0.935 
Cu intake, mg/d 1.35 ± 0.17 1.58 ± 0.17 0.179 
Cu intake, gg/kg/d 16.3 ± 2.5 18.6 ± 2.5 0.346 
Cu intake, pg/MJ/d 0.15 ± 0.01 0.18 ± 0.13 0.059 
Zn intake, mg/d 11.8± 1.9 12.6± 1.9 0.670 
Zn intake, gg/kg/d 133.8± 13.0 150.3 ± 13.7 0.226 
Zn intake, gg/MJ/d 1.28 ± 0.09 1.42 ± 0.10 0.168 
Serum Cu, gmol/L 17.6 ± 0.6 15.4 ± 0.7 0.001 
Serum Zn, pmol/L 12.5 ± 0.7 13.0 ± 0.8 0.455 
RBC SOD, U/g Hb 1377.3 ± 70.6 1321.4 ± 72.8 0.443 
Women Current smokers Nth9 1cPrs 
I n = 30 n 
Energy, mJ 6.35 ± 0.51 6.86 ± 0.53 0.339 
Cu intake, mg/d 1.24 ± 0.14 1.43 ± 0.14 0.177 
Cu intake, gg/kg/d 20.0 ± 2.0 21.0 ± 2.1 0.640 
Cu intake, gg/MJ/d 0.19± 0.01 0.22 ± 0.01 0.088 
Zn intake, mg/d 10.5± 1.0 10.9± 1.0 0.623 
Zn intake, gg/kg/d 161.3± 15.1 160.5 ± 15.4 0.956 
Zn intake, gg/MJ/d 1.65 ± 0.06 1.65 ± 0.07 0.982 
Serum Cu, pmol/L 18.9 ± 0.6 18.8 ± 0.7 0.880 
Serum Zn, pmol/L 13.9 ± 0.5 13.0 ± 0.5 0.050 
RBC SOD, U/g Hb 1299.9 ± 37.7 1295.0 ± 41.0 0.905 
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